data_2enz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2enz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.452 ' OD1' ' CD2' ' A' ' 280' ' ' LEU . 12.6 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.812 0.339 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 32.5 mtm -124.4 143.73 43.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.587 0.708 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 173.24 11.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 0.0 112.283 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.479 ' CB ' ' CE2' ' A' ' 234' ' ' PHE . 90.0 m-70 -92.29 116.51 29.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -69.99 69.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.479 ' CE2' ' CB ' ' A' ' 232' ' ' HIS . 43.9 m-85 -78.63 120.19 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -124.42 137.49 54.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 257' ' ' ARG . 59.7 t -55.4 146.76 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.78 ' CD1' ' CD2' ' A' ' 239' ' ' TYR . 1.9 t80 -142.8 131.16 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -101.82 98.11 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.78 ' CD2' ' CD1' ' A' ' 237' ' ' TYR . 0.1 OUTLIER -140.3 173.85 11.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 83.83 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 28.9 p -161.07 149.33 12.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.1 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 252' ' ' LEU . 1.1 p -92.86 148.49 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -122.26 135.9 54.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -77.53 141.43 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.67 6.81 44.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.47 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 54.7 t60 -119.36 -68.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 17.3 p -77.76 -14.08 59.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.33 54.45 34.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.0 p -138.75 -179.35 5.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.62 163.31 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -123.32 124.04 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -109.95 105.47 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -141.9 -176.18 15.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.529 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -124.19 -56.82 1.62 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.07 -28.56 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' GLY . 80.0 mtt180 -109.02 43.36 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.44 86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 52.61 -154.63 5.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 14.9 mt -138.87 156.88 46.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.927 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 tmmm? -136.65 124.17 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.25 121.05 14.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.89 -0.67 49.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -96.57 -74.14 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -79.71 -38.57 33.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.95 65.28 0.82 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -131.06 147.71 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -110.63 116.73 31.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.29 157.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -64.54 173.67 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.67 -38.95 92.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -89.01 -40.68 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 72.9 m -61.14 -12.8 13.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 275' ' ' THR . 7.2 pt20 -75.35 -45.38 39.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 3.1 p -72.75 2.71 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 25.6 mtpp -101.87 -17.36 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.48 157.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.08 154.73 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -94.43 41.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.452 ' CD2' ' OD1' ' A' ' 229' ' ' ASP . 39.4 mt -121.78 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 7.2 t -94.6 116.12 28.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.25 -35.57 4.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 5.3 mp -71.8 -27.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.0 mtm -130.17 143.98 51.33 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.15 15.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.659 2.239 . . . . 0.0 112.314 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -93.65 122.85 36.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.412 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 84.8 mtt-85 -69.96 72.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.31 132.46 37.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -144.57 129.67 18.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.81 117.89 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.574 ' CE1' ' CB ' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -144.58 153.68 42.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -91.89 121.07 33.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 241' ' ' SER . 0.7 OUTLIER -118.67 178.78 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -123.48 168.95 11.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 1.5 t 62.22 147.15 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.691 0.757 . . . . 0.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.74 54.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.424 ' CG2' ' CD1' ' A' ' 252' ' ' LEU . 1.0 OUTLIER -139.53 136.74 34.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 38.7 m-85 -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 250' ' ' THR . 9.4 t -53.32 109.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.1 -2.83 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 66.0 t60 -93.14 -67.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.0 p -89.3 -13.5 37.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.15 -22.05 28.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -79.93 156.36 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.52 ' O ' ' CE1' ' A' ' 270' ' ' HIS . 3.8 mt -68.92 175.11 3.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 243' ' ' THR . 12.4 mt -96.43 178.08 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . 0.578 ' CE2' ' CD2' ' A' ' 270' ' ' HIS . 0.3 OUTLIER -144.28 130.95 20.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 258' ' ' GLN . . . 137.57 -170.26 23.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.57 -72.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.17 -36.12 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.414 ' HG2' ' NE2' ' A' ' 271' ' ' HIS . 38.7 ttp180 -104.3 41.89 1.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 254' ' ' GLY . 8.0 tt0 -70.13 84.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.413 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 76.55 -154.27 43.69 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.58 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 4.8 mt -147.02 130.02 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.574 ' CB ' ' CE1' ' A' ' 237' ' ' TYR . 11.1 tptm -102.87 122.49 44.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 6.3 t -65.98 131.82 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -99.39 11.95 37.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.415 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -109.05 -31.89 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -129.93 -45.59 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.69 79.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 5.9 ttp -150.19 139.53 21.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.9 OUTLIER -105.73 132.62 51.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.66 155.89 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.578 ' CD2' ' CE2' ' A' ' 253' ' ' TRP . 12.5 m80 -52.63 -175.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . 0.414 ' NE2' ' HG2' ' A' ' 257' ' ' ARG . 20.0 m-70 -76.65 -36.5 57.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.43 -42.83 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 66.7 m -47.03 -26.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.58 ' NE2' ' CD1' ' A' ' 260' ' ' LEU . 6.3 pt20 -62.68 -45.52 92.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 13.7 t -75.08 5.32 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 26.1 mtpt -108.64 -19.06 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.75 158.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.091 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 160.83 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.066 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.63 45.74 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.74 86.08 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . 0.415 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 22.3 t -93.45 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 73.02 35.35 57.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.5 mm -105.87 -20.92 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.134 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.419 ' C ' ' OD1' ' A' ' 284' ' ' ASN . 15.5 p30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.1 mmt -117.97 143.16 32.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.605 0.717 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 173.22 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 93.1 m-70 -88.67 123.13 32.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -69.39 70.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 48.3 m-85 -71.8 138.85 48.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -155.29 122.81 5.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.37 133.66 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.115 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 72.1 t80 -143.32 164.12 31.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 237' ' ' TYR . 4.5 t30 -92.0 124.81 36.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.516 ' CZ ' ' NE2' ' A' ' 258' ' ' GLN . 3.6 m-30 -102.29 176.34 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 7.43 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.6 m -161.39 150.1 13.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 113.78 3.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.6 m -100.01 164.14 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.45 126.44 54.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.9 t -52.18 133.68 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -85.58 9.36 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.5 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 74.7 t60 -119.33 -71.64 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.9 p -75.5 -28.9 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.406 ' C ' HG21 ' A' ' 250' ' ' THR . . . 75.15 49.93 9.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.515 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.406 HG21 ' C ' ' A' ' 249' ' ' GLY . 30.8 p -136.82 142.71 42.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.192 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.76 157.8 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.9 mp -108.72 97.72 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -51.31 -69.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -42.86 138.42 3.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.63 -74.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -48.26 -23.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 258' ' ' GLN . 36.4 ttm180 -103.71 -39.49 6.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.516 ' NE2' ' CZ ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER 34.32 43.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.418 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 70.52 -119.91 8.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.418 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 6.8 mt -148.75 154.01 38.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -133.65 102.62 5.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 132.85 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.23 1.46 57.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.415 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -101.65 -71.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.063 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.62 -42.19 22.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.97 40.17 2.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.51 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -102.37 149.96 23.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.86 123.22 45.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 234' ' ' PHE . 11.5 m -149.89 148.66 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -52.19 -174.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -30.27 42.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -93.14 -36.41 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 75.8 m -64.51 -14.79 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.524 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.2 pt20 -71.01 -35.05 71.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 9.8 t -79.52 8.46 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.5 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 60.0 mttt -115.47 -14.19 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.943 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.03 170.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.29 156.1 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.09 30.93 3.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.35 93.0 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . 0.415 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 18.3 t -90.17 112.05 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.33 -41.39 2.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.41 -27.63 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' A' ' 280' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.758 0.313 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.18 142.73 87.58 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.557 0.694 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 173.19 11.33 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.375 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 97.0 m-70 -95.65 120.07 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 72.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.18 114.11 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.7 132.16 45.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.96 138.64 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -146.31 154.31 41.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -99.86 105.68 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.418 ' OH ' ' ND2' ' A' ' 268' ' ' ASN . 30.0 m-85 -90.79 137.3 32.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -95.76 29.8 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.2 p -170.28 150.62 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.627 0.727 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 100.53 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.297 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 6.7 m -93.72 149.68 21.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -95.16 146.07 24.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 7.9 t -71.67 130.86 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.14 7.83 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 50.2 t60 -116.52 -69.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 p -80.05 -26.74 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.83 50.68 10.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 29.8 p -138.51 148.76 44.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 14.2 mt -44.7 168.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.14 178.2 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -168.59 129.28 1.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 159.04 131.06 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.449 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.37 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.8 0.333 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -113.45 -33.59 5.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -84.99 68.51 10.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -73.55 78.49 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 65.67 -148.79 51.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 11.9 mt -148.8 131.14 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 0.1 OUTLIER -113.41 142.86 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.38 132.98 38.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -93.71 10.73 31.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.427 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -112.67 -71.39 0.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -82.06 -45.31 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.08 65.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.03 139.55 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -106.17 125.4 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 234' ' ' PHE . 29.3 m -144.17 146.78 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -51.58 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -35.95 66.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.95 -37.4 11.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.49 -21.08 14.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.51 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 3.3 pt20 -65.49 -40.88 93.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 t -75.2 -3.61 34.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 43.7 mttp -97.43 -14.86 20.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.37 166.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.43 27.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -88.35 34.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 229' ' ' ASP . 8.2 mt -116.15 88.46 2.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 15.0 t -93.14 125.29 37.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.04 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.407 HG13 ' CD2' ' A' ' 280' ' ' LEU . 50.7 mm -44.58 -25.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.441 ' O ' ' C ' ' A' ' 279' ' ' ASN . 17.5 mtm -124.61 143.77 44.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.858 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 171.54 14.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.259 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -91.75 129.4 37.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.402 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 55.7 mtp85 -69.69 69.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 34.9 m-85 -68.83 143.42 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -162.59 121.07 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.41 142.93 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 16.5 t80 -147.24 154.95 41.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 238' ' ' ASN . 18.2 p-10 -91.95 96.9 10.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD2' ' OE1' ' A' ' 258' ' ' GLN . 0.1 OUTLIER -91.79 163.6 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 -27.29 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 239' ' ' TYR . 2.3 m -99.26 156.77 35.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.681 0.753 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 149.95 67.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.1 p -135.21 155.61 50.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -117.95 108.51 15.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 6.9 t -56.81 101.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.8 -6.09 19.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.536 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 31.4 t60 -82.67 -70.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 28.7 p -79.87 -36.36 36.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 106.86 20.5 8.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 73.0 p -131.94 139.94 48.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.28 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.512 ' CD1' ' CD2' ' A' ' 270' ' ' HIS . 2.6 mm? -93.3 149.37 21.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -119.3 12.84 12.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -79.68 -176.15 48.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.444 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 255' ' ' LEU . 1.4 mm? -108.41 -64.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.908 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.71 26.55 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 0.2 OUTLIER -127.15 -30.61 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.575 ' OE1' ' CD2' ' A' ' 239' ' ' TYR . 5.8 pt20 35.84 38.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.471 ' O ' ' CE1' ' A' ' 271' ' ' HIS . . . 79.86 -107.16 2.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.458 ' CD1' ' CD ' ' A' ' 274' ' ' GLN . 44.8 mt -154.54 146.22 23.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.461 ' HE3' ' ND2' ' A' ' 268' ' ' ASN . 3.0 tppp? -125.45 117.38 23.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 4.3 t -64.45 134.87 55.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.09 -2.7 27.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.81 -34.36 14.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.5 p -126.43 -40.17 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.73 83.25 1.72 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.0 ttp -145.82 135.92 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.461 ' ND2' ' HE3' ' A' ' 261' ' ' LYS . 0.6 OUTLIER -99.27 127.53 45.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.412 HG22 ' CE1' ' A' ' 234' ' ' PHE . 35.0 m -149.52 156.03 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.512 ' CD2' ' CD1' ' A' ' 252' ' ' LEU . 16.5 m80 -58.77 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . 0.471 ' CE1' ' O ' ' A' ' 259' ' ' GLY . 42.1 m-70 -74.95 -35.37 62.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -93.31 -38.71 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.7 m -52.66 -16.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.484 ' CG ' ' N ' ' A' ' 275' ' ' THR . 10.0 pt20 -68.91 -47.05 66.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.484 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 2.0 t -73.01 1.96 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.536 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 44.6 mttm -102.56 -23.58 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.01 172.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -93.83 150.86 20.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 230' ' ' MET . 25.8 m-80 -79.9 52.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 280' ' ' LEU . 3.1 mm? -127.78 73.85 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 53.4 t -92.0 121.13 33.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 61.49 11.72 29.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 284' ' ' ASN . 10.0 mm -72.66 -89.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 283' ' ' ILE . 2.1 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 42.4 mtm -122.97 142.26 37.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.412 ' HA ' ' CG ' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.76 173.18 11.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.361 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 69.8 m-70 -90.59 116.11 28.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -63.63 74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 24.8 m-85 -84.64 140.7 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.93 120.07 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 42.8 t -44.59 127.08 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.498 ' CE1' ' O ' ' A' ' 238' ' ' ASN . 42.6 t80 -145.38 141.43 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.498 ' O ' ' CE1' ' A' ' 237' ' ' TYR . 31.0 t-20 -86.97 122.2 30.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -126.28 179.38 5.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -130.81 -62.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 13.6 m -43.34 144.45 1.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.66 0.743 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.48 28.02 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.438 ' CG2' ' CD1' ' A' ' 252' ' ' LEU . 4.3 t -136.35 153.54 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.23 140.86 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.85 143.71 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.63 9.1 38.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 26.1 t60 -121.76 -67.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.0 p -75.45 -29.41 59.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 38.2 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.459 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.0 p -138.99 141.8 38.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 111.157 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 173.37 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.473 ' CD2' ' CD2' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -121.78 163.33 19.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -153.16 126.32 8.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -168.4 151.67 18.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.6 -65.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.92 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.77 -55.96 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -70.45 73.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 88.91 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 57.25 -147.71 34.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 8.1 mt -147.09 119.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -100.17 110.65 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -55.42 130.52 42.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.5 1.6 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.431 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -98.21 -50.82 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.02 -35.62 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.37 73.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.0 ttp -145.25 135.5 24.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -95.11 115.83 27.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.463 HG23 ' CZ ' ' A' ' 234' ' ' PHE . 4.3 m -134.96 150.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.473 ' CD2' ' CD2' ' A' ' 252' ' ' LEU . 28.4 m80 -64.25 167.13 7.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -61.32 -26.9 68.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.417 ' HG3' ' NZ ' ' A' ' 276' ' ' LYS . 4.8 tpt180 -93.87 -63.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.484 ' HB3' ' CD2' ' A' ' 247' ' ' HIS . 4.6 m -46.47 -20.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.542 ' CG ' ' N ' ' A' ' 275' ' ' THR . 0.6 OUTLIER -46.94 -50.66 18.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.9 OUTLIER -67.54 -41.42 84.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.556 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 0.7 OUTLIER -50.24 -26.21 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.03 126.76 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.111 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -44.59 136.62 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.088 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.412 ' CG ' ' HA ' ' A' ' 231' ' ' PRO . 4.1 t30 -75.93 51.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 280' ' ' LEU . 4.9 mp -125.37 78.63 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.94 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . 0.431 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 6.9 t -88.69 142.57 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.55 -7.46 76.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.418 ' CG1' ' HB3' ' A' ' 280' ' ' LEU . 3.9 mm -73.71 -28.87 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 35.4 mtm -128.58 143.76 49.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.608 0.718 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 164.24 35.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 86.0 m-70 -87.45 120.41 28.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.487 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 15.0 mmt85 -70.94 68.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 51.7 m-85 -71.59 138.1 48.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.49 128.71 18.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.09 127.15 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.81 148.87 32.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.553 ' CE2' ' CB ' ' A' ' 258' ' ' GLN . 7.1 p90 -113.23 120.79 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.457 ' HE2' ' N ' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -86.39 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 52.6 p -39.0 144.35 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.7 0.762 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 138.03 36.75 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 2.8 t -145.83 146.9 31.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 251' ' ' LEU . 7.4 m-85 -106.02 132.61 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 250' ' ' THR . 7.5 t -63.35 103.85 0.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.74 -7.41 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 52.3 t60 -87.23 -70.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.86 -9.82 56.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 245' ' ' CYS . . . 85.21 -19.77 20.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -81.19 157.14 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.555 HD13 ' CE2' ' A' ' 244' ' ' PHE . 7.3 mt -76.83 -176.87 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -145.94 145.31 30.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -173.23 130.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -177.21 -134.32 1.98 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 258' ' ' GLN . 2.5 mm? -83.98 178.07 8.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . . . -37.61 -34.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -86.65 36.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.553 ' CB ' ' CE2' ' A' ' 239' ' ' TYR . 73.4 mt-30 -41.28 -74.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.72 -162.9 10.83 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 26.5 mt -131.72 126.36 34.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -106.59 114.37 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 3.7 t -62.45 125.78 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.61 18.13 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.22 -40.52 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -119.78 -44.95 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 108.4 78.82 1.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.2 ttp -146.17 141.17 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -106.03 122.59 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.453 HG22 ' CE1' ' A' ' 234' ' ' PHE . 35.6 m -142.4 154.95 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 251' ' ' LEU . 13.7 m80 -51.64 179.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -69.13 -36.5 77.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 274' ' ' GLN . 27.4 mtt-85 -93.89 -49.13 5.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.3 m -39.29 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 275' ' ' THR . 12.6 pt20 -52.46 -49.77 63.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.7 OUTLIER -70.55 -37.35 74.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.562 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 0.4 OUTLIER -54.82 -31.82 59.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.31 172.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -94.28 155.61 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -79.22 52.84 1.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.02 78.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 13.1 t -89.16 116.52 27.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.46 -30.14 11.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.4 mp -83.45 -77.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.847 0.356 . . . . 0.0 111.103 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 230' ' ' MET . 4.7 mpp? -125.29 143.61 44.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.496 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 52.9 Cg_endo -69.82 173.19 11.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 82.6 m-70 -95.7 122.89 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.431 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 59.4 mtt180 -71.23 67.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.555 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 34.5 m-85 -80.28 124.34 28.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -126.77 121.44 31.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 257' ' ' ARG . 2.3 t -51.21 113.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 14.5 t80 -120.87 159.24 25.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.541 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.5 t30 -118.37 97.3 5.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.43 167.32 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.432 ' CD ' ' C ' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.41 -52.26 2.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 21.7 m -39.09 153.23 0.18 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.65 13.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 2.7 m -130.51 108.53 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -89.87 141.68 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.66 112.69 11.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -76.96 3.32 12.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.561 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t60 -97.65 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.3 p -82.56 -18.4 41.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.81 -12.68 68.79 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.4 159.88 19.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 252' ' ' LEU . 0.5 OUTLIER -82.85 134.89 35.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 251' ' ' LEU . 29.8 mt -46.24 172.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -173.74 133.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.7 43.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.5 mp -90.67 -74.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -121.11 -31.06 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.448 ' HB2' ' CG1' ' A' ' 236' ' ' VAL . 14.0 ptt180 -89.93 29.66 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 257' ' ' ARG . 30.6 mt-30 -36.48 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 42.14 -150.96 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.446 ' CD2' HG22 ' A' ' 236' ' ' VAL . 17.2 mt -147.46 148.01 30.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.462 ' HD3' ' ND2' ' A' ' 268' ' ' ASN . 12.7 tptm -122.97 117.03 24.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 1.8 t -65.06 128.47 35.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -93.1 -3.14 54.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.421 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -93.93 -60.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.2 p -96.03 -34.86 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.57 73.26 1.19 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.5 ttp -143.81 130.17 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -94.23 128.22 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.419 HG23 ' CZ ' ' A' ' 234' ' ' PHE . 22.8 m -152.53 152.49 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.416 ' NE2' ' HA ' ' A' ' 252' ' ' LEU . 14.1 m80 -48.56 172.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 2.2 t60 -69.05 -32.31 71.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -94.14 -47.17 6.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . 0.412 ' HA ' ' CG ' ' A' ' 276' ' ' LYS . 63.6 m -44.72 -31.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.555 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 9.8 pt20 -51.6 -50.4 60.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.535 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 11.9 p -66.88 -10.44 48.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.561 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -85.92 -29.82 23.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.27 150.11 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.47 143.68 52.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.496 ' ND2' ' N ' ' A' ' 231' ' ' PRO . 2.4 t30 -78.82 54.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 11.7 mt -129.63 82.55 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 11.0 t -92.56 128.44 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.47 -10.96 60.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.7 mt -90.66 -79.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.771 0.32 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 7.8 mtt -103.07 97.03 8.86 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.595 0.712 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 165.1 32.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.5 115.59 20.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.16 63.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 38.4 m-85 -59.52 152.18 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.19 118.43 7.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -46.49 126.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.63 148.81 39.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.44 134.25 34.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.84 115.71 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -86.39 -12.19 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.52 152.42 46.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 108.61 2.14 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -104.55 147.26 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -103.52 129.42 50.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.61 124.99 23.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -78.25 8.99 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -117.8 -72.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.1 p -75.51 -25.93 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.95 43.09 18.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.9 p -139.73 159.16 42.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.03 175.94 6.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.17 113.37 13.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -100.38 151.97 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 139.45 -9.72 3.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 19.6 mt 40.32 31.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -167.92 145.8 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 45.22 26.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -42.03 104.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 40.4 -149.83 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.37 170.58 15.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -137.58 131.68 32.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.0 t -75.7 140.55 42.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -97.56 6.28 48.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -107.42 -60.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.89 -44.42 9.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.24 52.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 21.4 ttp -115.39 163.74 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -124.47 128.39 48.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 234' ' ' PHE . 16.2 m -149.69 150.98 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -51.28 -175.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -76.54 -35.67 58.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -93.94 -38.45 11.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 46.2 m -50.07 -19.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 7.6 pt20 -71.15 -36.9 72.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.4 p -77.81 2.78 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.157 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -109.74 -8.82 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -85.03 175.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -89.18 159.93 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.13 48.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.34 84.34 2.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 53.7 t -94.01 114.15 26.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.8 -5.58 38.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.25 -23.22 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.804 0.335 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.407 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 1.6 mpt? -125.67 97.01 37.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.532 0.682 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.79 139.71 40.79 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.65 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 99.3 m-70 -55.75 116.68 3.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -74.35 67.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 62.3 m-85 -59.28 146.0 41.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -153.65 137.2 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.31 119.52 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -136.07 161.28 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.08 147.83 24.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.23 153.45 33.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -8.35 8.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.8 m -133.21 160.08 70.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.752 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 118.85 5.93 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -127.37 147.24 50.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.61 134.42 50.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -48.87 144.38 4.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.29 8.83 25.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.497 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 53.4 t60 -127.98 -68.13 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.88 -16.94 59.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 59.57 52.94 50.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.1 p -139.97 150.55 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.108 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.6 mp -56.56 167.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.76 -178.84 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -158.66 145.4 17.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.44 -164.79 19.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.4 mt -116.79 -70.42 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.92 -64.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.3 ttp-105 -83.48 69.39 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.421 ' O ' ' NE2' ' A' ' 271' ' ' HIS . 26.1 mt-30 -78.48 -53.5 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.91 -148.24 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.09 154.15 48.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 111.96 12.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.37 124.38 15.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.33 7.43 32.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -103.04 -47.81 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.9 p -113.59 -45.18 3.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.59 60.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -124.39 124.8 43.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -88.62 118.58 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 35.2 m -139.88 146.32 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -50.93 -178.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 258' ' ' GLN . 64.2 m-70 -75.75 -38.82 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -88.19 -43.51 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.1 m -50.25 -24.11 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 12.2 pt20 -61.15 -33.73 73.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 43.2 p -78.98 11.16 2.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.497 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -114.63 -33.08 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.82 156.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -77.08 150.08 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.412 ' N ' HD21 ' A' ' 279' ' ' ASN . 1.0 OUTLIER -86.64 30.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -103.34 67.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.2 t -92.76 106.42 18.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.52 -27.24 6.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.33 -26.56 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.1 mmt -126.32 97.04 35.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.834 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 158.47 56.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.297 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.45 116.08 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.28 62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CE1' HG22 ' A' ' 269' ' ' VAL . 31.1 m-85 -61.01 136.11 57.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -138.48 123.85 19.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.2 t -51.93 127.9 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.82 162.93 38.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.621 HD21 ' N ' ' A' ' 238' ' ' ASN . 0.9 OUTLIER -87.39 113.39 23.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -63.33 153.02 36.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -134.82 10.08 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 4.1 m -167.64 154.26 7.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.64 0.733 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 122.92 9.6 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.36 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.57 163.55 16.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.36 104.06 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.69 128.91 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -86.57 8.67 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 73.5 t60 -113.75 -71.22 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.5 p -75.45 -35.96 60.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.65 42.7 6.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 35.1 p -139.47 159.51 42.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.6 mp -63.9 -179.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 252' ' ' LEU . 1.7 pt? -171.04 124.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -172.46 153.02 2.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 161.73 -117.91 0.79 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.462 ' N ' ' HG3' ' A' ' 258' ' ' GLN . 2.7 mm? -68.14 160.2 29.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.08 57.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.61 47.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 255' ' ' LEU . 6.5 mm100 -99.88 146.47 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 51.7 179.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 34.4 mt -142.96 152.81 42.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.6 117.36 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.95 141.16 28.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.09 7.73 41.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.74 -68.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 24.1 p -84.0 -46.05 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.57 61.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.9 ttp -122.86 145.74 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -111.41 123.48 50.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 234' ' ' PHE . 12.1 m -146.18 165.6 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -64.52 -178.71 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -75.3 -38.42 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 13.5 mtm-85 -89.2 -39.9 13.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.4 m -54.93 -21.2 10.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.485 ' CG ' ' N ' ' A' ' 275' ' ' THR . 4.7 pt20 -64.68 -47.81 77.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.485 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 9.9 t -70.32 -0.69 8.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 61.8 mttt -101.52 -26.94 13.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.08 148.79 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.55 153.28 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -81.09 53.58 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 66.1 mt -121.74 73.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 23.7 t -83.32 112.23 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.27 23.54 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 19.7 mm -70.44 -24.43 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 28.1 mtm -103.47 96.99 9.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 157.28 61.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.619 2.213 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.23 121.66 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -76.01 52.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.525 ' CE1' HG23 ' A' ' 269' ' ' VAL . 23.7 m-85 -51.75 132.33 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -139.03 134.27 32.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.29 125.47 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 7.0 t80 -142.1 140.67 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.403 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.1 p30 -101.46 111.24 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 158.9 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -94.51 -58.06 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.1 p -44.22 151.08 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 116.21 4.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.1 m -116.2 132.27 56.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -110.21 153.24 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.3 t -71.15 137.07 48.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.52 9.19 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -120.93 -68.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.3 p -77.67 -14.34 59.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.05 52.67 49.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.496 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 10.6 p -138.06 157.72 45.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.96 166.6 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.508 ' C ' ' CE3' ' A' ' 253' ' ' TRP . 3.2 mt -113.59 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . 0.508 ' CE3' ' C ' ' A' ' 252' ' ' LEU . 6.6 m-90 -151.14 -175.89 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 98.1 172.06 32.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.68 -51.27 2.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -105.15 -64.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -75.69 70.69 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -93.28 99.13 11.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 50.35 -165.41 0.6 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.501 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.6 163.14 24.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.372 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -139.37 123.6 18.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.6 t -62.43 131.76 50.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.41 15.87 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.88 -66.61 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -88.52 -47.02 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 111.67 65.16 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.9 ttp -125.97 152.95 45.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -117.3 115.18 24.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.525 HG23 ' CE1' ' A' ' 234' ' ' PHE . 20.7 m -136.03 159.61 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -65.87 -175.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -76.09 -39.29 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -89.82 -47.06 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 86.4 m -44.91 -25.04 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.427 ' CG ' ' N ' ' A' ' 275' ' ' THR . 1.2 pt20 -57.45 -44.88 85.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 27.5 p -64.5 -6.94 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -94.7 -30.89 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.9 126.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -47.84 173.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -99.9 46.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 53.9 mt -124.88 93.37 3.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.4 t -93.82 115.07 27.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.64 -29.15 3.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.5 mt -75.7 -28.56 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 12.1 mtm -107.52 97.03 17.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.528 0.68 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 127.05 13.98 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.233 . . . . 0.0 112.348 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -48.37 115.59 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -74.62 61.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.545 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 43.4 m-85 -52.68 139.87 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 127.23 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.422 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 54.0 t -54.94 124.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -134.27 138.56 45.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.39 97.66 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 258' ' ' GLN . 2.1 p90 -125.04 120.45 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -83.15 67.89 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.8 m -142.07 145.14 34.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.707 0.765 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 77.87 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 18.6 m -95.09 142.55 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -111.5 128.34 55.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 9.4 t -46.92 139.77 5.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.61 3.15 56.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.554 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 43.5 t60 -110.94 -73.02 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.66 -31.33 59.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 53.1 6.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.41 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 251' ' ' LEU . 55.3 p -137.03 131.85 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 250' ' ' THR . 1.0 OUTLIER -34.58 126.16 0.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.449 ' O ' ' C ' ' A' ' 253' ' ' TRP . 9.9 mp -67.46 135.41 53.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . 0.449 ' C ' ' O ' ' A' ' 252' ' ' LEU . 70.4 m95 -34.64 -74.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 118.96 56.43 0.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 258' ' ' GLN . 4.6 mp -129.69 165.97 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.66 -25.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.504 ' CD ' ' NE2' ' A' ' 271' ' ' HIS . 13.3 ttp180 -100.49 34.81 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 239' ' ' TYR . 6.6 mm-40 -36.04 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 34.8 -148.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.6 141.87 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.26 104.84 10.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -47.99 118.55 2.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.79 4.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.9 -74.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.088 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.2 p -80.7 -46.0 16.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.6 ttp -104.88 145.17 30.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -106.08 116.14 31.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.545 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 2.6 m -139.55 149.67 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -54.92 -174.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . 0.504 ' NE2' ' CD ' ' A' ' 257' ' ' ARG . 1.5 m-70 -82.1 -34.24 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -94.0 -25.61 17.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.0 m -71.69 -25.98 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 2.8 pt20 -63.23 -38.45 91.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -74.68 -5.34 42.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.554 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 41.4 mttm -98.5 -10.48 23.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.42 165.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -88.32 156.14 19.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -84.89 56.66 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.19 81.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 111.31 22.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.11 -26.27 21.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 6.6 mm -45.81 -28.33 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.117 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 97.01 44.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.49 18.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.699 2.266 . . . . 0.0 112.373 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.402 ' CD2' HG12 ' A' ' 277' ' ' VAL . 98.3 m-70 -85.69 118.17 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -78.97 59.38 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.565 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 39.5 m-85 -55.99 126.24 25.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt -131.54 133.7 45.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.535 ' CG1' ' NE ' ' A' ' 257' ' ' ARG . 2.2 t -51.58 134.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.455 ' OH ' ' CE1' ' A' ' 239' ' ' TYR . 1.5 p90 -144.27 157.09 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.15 109.5 18.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.455 ' CE1' ' OH ' ' A' ' 237' ' ' TYR . 20.6 m-85 -49.17 130.81 19.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.02 11.62 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.944 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 32.5 m -167.73 149.29 5.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 78.82 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.426 HG23 ' ND2' ' A' ' 268' ' ' ASN . 1.2 m -98.33 143.68 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . 0.539 ' CE2' HD23 ' A' ' 251' ' ' LEU . 5.4 m-85 -102.24 151.34 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 4.3 t -61.56 137.81 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.91 -3.45 54.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 81.4 t60 -101.56 -70.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.0 p -77.2 -19.38 56.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.2 43.59 63.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.45 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.1 p -140.0 150.68 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.539 HD23 ' CE2' ' A' ' 244' ' ' PHE . 15.8 mt -62.18 154.55 26.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -124.68 54.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -39.12 94.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 252' ' ' LEU . . . -177.36 140.4 4.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 mt -135.04 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . 71.81 47.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 236' ' ' VAL . 4.7 mmm180 74.89 50.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -102.57 -4.35 25.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -140.18 -164.49 9.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.437 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.85 158.7 43.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.12 114.56 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 10.3 t -58.57 119.1 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -83.76 2.39 38.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -95.3 -57.57 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.3 p -104.35 -34.61 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.0 73.87 1.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.446 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.0 ttp -138.44 140.56 39.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.426 ' ND2' HG23 ' A' ' 243' ' ' THR . 0.2 OUTLIER -105.33 122.35 45.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.521 HG23 ' CE1' ' A' ' 234' ' ' PHE . 34.4 m -139.81 164.85 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.455 ' CG ' HD21 ' A' ' 252' ' ' LEU . 16.8 m80 -60.07 177.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.37 -32.04 64.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -93.96 -46.89 6.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.5 m -45.84 -24.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.565 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 11.6 pt20 -60.11 -47.88 84.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 1.6 p -70.09 -13.23 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.564 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 26.0 mtpp -85.44 -33.96 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 232' ' ' HIS . 1.9 t -62.12 142.4 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.51 173.65 6.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.42 50.67 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.56 73.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 23.3 t -93.77 116.08 28.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.14 -4.89 85.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 10.4 mm -58.25 -20.51 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.349 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.825 0.345 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 37.8 mtp -107.79 97.05 18.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.45 69.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.358 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.458 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.5 m-70 -66.09 116.19 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.406 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 73.1 mtt85 -73.46 64.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 35.3 m-85 -67.89 125.85 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -127.18 139.61 52.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.425 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 91.4 t -60.63 132.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -148.49 154.75 40.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.29 128.42 34.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 258' ' ' GLN . 55.5 m-85 -107.09 116.85 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -92.45 26.01 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.2 m -170.69 156.38 5.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 139.2 39.73 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.405 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 4.7 p -139.14 159.64 41.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -106.37 144.75 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.5 t -76.0 121.49 22.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.38 5.79 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.495 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 58.7 t60 -110.03 -73.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.1 p -75.56 -33.88 60.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 43.29 5.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 251' ' ' LEU . 43.0 p -139.99 138.13 35.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.788 0.327 . . . . 0.0 111.164 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 250' ' ' THR . 10.0 mt -34.78 146.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.01 121.42 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -102.63 148.6 25.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 147.49 157.32 7.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.87 -69.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.6 -41.66 4.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 259' ' ' GLY . 0.2 OUTLIER -80.07 12.36 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.466 ' O ' ' CE1' ' A' ' 239' ' ' TYR . 22.7 tt0 -37.84 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 59.16 -171.7 4.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.78 160.98 32.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -122.32 126.49 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 266' ' ' GLY . 11.5 t -77.27 104.38 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.45 -5.71 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.14 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.97 -29.5 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 262' ' ' CYS . . . 91.23 83.88 1.43 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 11.5 ttp -144.45 130.05 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.14 119.13 30.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.78 154.67 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -59.04 -175.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -75.43 -32.59 60.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -92.91 -41.44 10.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 78.4 m -57.06 -12.58 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -63.79 -41.03 98.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.949 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 11.77 37.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.495 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 34.2 mtmt -100.85 -24.93 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.69 -179.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.69 150.0 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -84.78 27.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.9 79.48 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.88 129.31 34.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.38 -21.82 19.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 36.7 mm -61.44 -28.19 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.814 0.34 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.402 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 32.9 mtm -116.15 97.09 48.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.553 0.692 . . . . 0.0 110.856 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 127.51 14.71 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 97.2 m-70 -44.86 117.78 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -72.99 65.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 43.1 m-85 -60.87 139.81 57.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -143.54 132.87 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.409 HG22 ' CD2' ' A' ' 260' ' ' LEU . 19.6 t -60.38 122.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.481 ' OH ' ' CE2' ' A' ' 239' ' ' TYR . 3.0 p90 -145.6 163.96 33.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.12 128.32 36.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.481 ' CE2' ' OH ' ' A' ' 237' ' ' TYR . 30.1 m-85 -80.15 123.73 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -102.64 -5.62 23.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.959 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 65.1 m -142.83 153.3 60.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 88.57 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.259 . . . . 0.0 112.371 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.5 m -93.88 161.47 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -122.91 124.42 43.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.46 146.81 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.23 -0.66 57.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.531 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 78.1 t60 -115.94 -67.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 14.6 p -78.18 -15.95 58.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 54.04 62.6 5.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 38.1 p -139.43 179.41 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.507 ' CD1' ' C ' ' A' ' 251' ' ' LEU . 0.3 OUTLIER -94.57 113.13 24.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.552 ' HG ' ' CE1' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -88.71 112.08 22.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -45.6 141.24 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -111.54 47.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.6 -64.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -172.8 144.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 44.7 50.25 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -116.45 147.09 42.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 47.59 -170.41 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.439 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 3.0 mt -146.46 161.17 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -126.87 138.76 53.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.2 t -86.72 122.76 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.59 8.74 18.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -106.54 -67.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.5 p -88.58 -44.69 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 115.22 22.87 4.72 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.1 ttp -86.97 156.34 19.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -130.33 115.59 17.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.27 166.08 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.552 ' CE1' ' HG ' ' A' ' 252' ' ' LEU . 16.4 m80 -70.12 -176.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -37.43 12.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.21 -25.1 65.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.52 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.4 pt20 -60.87 -43.33 98.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 7.6 p -69.82 -6.63 33.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 1.4 mmpt? -96.09 -13.07 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.84 158.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -79.75 141.62 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.403 ' C ' HD23 ' A' ' 280' ' ' LEU . 9.7 p30 -80.06 52.08 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 279' ' ' ASN . 2.8 mm? -127.75 70.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.7 155.96 18.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 60.68 18.19 51.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.2 mm -101.57 -25.41 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.841 0.353 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.4 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 3.9 ptp -126.69 97.0 34.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.0 Cg_endo -69.75 163.58 37.73 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.324 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.468 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 95.0 m-70 -86.66 115.4 24.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.468 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 26.5 mtt-85 -72.23 66.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.531 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 53.9 m-85 -62.28 149.9 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 234' ' ' PHE . 68.3 mttt -158.61 137.97 11.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.48 137.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -148.23 146.52 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -97.94 96.86 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.28 141.86 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 94.96 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.1 t -176.1 146.71 0.81 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.648 0.737 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 87.04 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.711 2.274 . . . . 0.0 112.377 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 m -106.71 138.21 43.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 244' ' ' PHE . 4.5 m-85 -106.36 140.21 39.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.1 t -56.56 129.55 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -86.93 5.8 35.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 37.3 t60 -110.64 -70.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.61 -33.11 60.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.1 39.31 6.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 28.4 p -138.08 150.13 46.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.526 ' HB3' ' CZ2' ' A' ' 253' ' ' TRP . 16.8 mt -64.33 175.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 253' ' ' TRP . 1.7 pt? -155.39 152.1 28.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . 0.526 ' CZ2' ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -154.8 158.54 39.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 155.78 -172.05 33.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.37 179.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.851 0.358 . . . . 0.0 110.869 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -70.39 69.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 259' ' ' GLY . 8.0 mm100 -85.13 114.97 22.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 258' ' ' GLN . . . 34.96 -146.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.429 ' CD1' ' HG2' ' A' ' 274' ' ' GLN . 3.0 mt -147.35 131.01 16.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -102.08 118.26 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 8.4 t -64.59 104.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -57.87 -18.68 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.29 -73.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.08 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.1 p -86.19 -42.05 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.0 60.76 0.75 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 9.4 ttp -125.33 119.86 29.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -90.09 120.19 31.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.531 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 31.6 m -137.53 179.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -70.32 165.2 22.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -62.46 -31.77 72.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -91.81 -47.75 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.4 m -50.71 -32.18 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.53 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 0.9 OUTLIER -53.12 -37.44 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.419 HG23 ' NE2' ' A' ' 274' ' ' GLN . 2.2 p -85.77 -11.83 52.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.56 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -87.03 -23.36 25.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.47 143.3 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.091 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -50.09 150.49 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -83.22 41.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.94 104.63 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 232' ' ' HIS . 15.4 t -93.65 140.77 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.85 -33.94 3.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.451 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.8 mp -63.79 -17.63 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.423 ' C ' ' OD1' ' A' ' 279' ' ' ASN . 55.3 mtm -107.16 96.99 16.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.555 0.693 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.437 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.74 164.65 33.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.8 m-70 -78.24 121.04 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -73.95 64.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 30.8 m-85 -63.79 131.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -141.74 130.86 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -45.82 132.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 238' ' ' ASN . 82.1 t80 -148.22 161.04 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.591 ' O ' ' CE2' ' A' ' 237' ' ' TYR . 0.6 OUTLIER -92.12 144.76 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -106.35 133.76 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.57 4.49 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 35.3 m -139.36 154.55 71.92 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.687 0.756 . . . . 0.0 110.818 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 244' ' ' PHE . 53.8 m -113.76 149.97 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . 0.422 ' N ' HG21 ' A' ' 243' ' ' THR . 12.3 m-85 -117.94 128.61 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.35 140.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.01 9.05 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 71.1 t60 -123.56 -66.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.7 p -78.87 -17.42 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.31 48.06 78.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.3 p -137.71 152.65 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.594 ' O ' ' CZ3' ' A' ' 253' ' ' TRP . 11.4 mt -64.73 159.66 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.46 174.37 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . 0.594 ' CZ3' ' O ' ' A' ' 251' ' ' LEU . 2.8 p90 -173.52 129.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . 0.424 ' C ' ' CD2' ' A' ' 255' ' ' LEU . . . 151.07 -124.98 1.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.536 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 255' ' ' LEU . 0.0 OUTLIER -135.35 179.76 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -39.08 -35.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -93.56 57.61 2.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 253' ' ' TRP . 30.2 tp60 -113.74 157.21 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . 0.411 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 41.05 -159.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.518 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 18.2 mt -153.98 161.34 42.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.22 139.53 51.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 5.5 t -91.88 114.75 27.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -78.19 7.03 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.4 -65.1 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.6 p -93.69 -40.4 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.81 33.85 3.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 17.0 ttp -106.52 119.04 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -87.56 139.95 30.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' A' ' 234' ' ' PHE . 4.1 m -150.34 164.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -67.54 -176.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.22 -36.57 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 272' ' ' ARG . 0.0 OUTLIER -94.07 -42.05 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 67.9 m -48.71 -22.37 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.539 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 3.0 pt20 -64.01 -41.08 97.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 10.6 t -74.46 -6.03 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 35.4 mttt -95.21 -12.41 26.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -85.5 171.27 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -92.9 171.73 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 231' ' ' PRO . 35.2 t-20 -104.12 50.95 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.12 59.43 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.45 128.93 34.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.77 -17.86 50.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.69 -28.23 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 28.7 p30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.784 0.326 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 11.0 mmt -112.78 97.04 39.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.693 2.262 . . . . 0.0 112.344 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -83.44 115.74 22.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.417 ' HB3' ' NH1' ' A' ' 233' ' ' ARG . 14.3 mtp-105 -74.72 62.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 36.9 m-85 -60.58 135.84 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -141.49 132.45 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.3 129.67 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.61 115.6 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . 0.411 ' OD1' ' C ' ' A' ' 238' ' ' ASN . 36.0 t-20 -88.61 108.27 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -126.93 173.62 9.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' SER . 0.3 OUTLIER -109.81 -53.16 2.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' LYS . 84.5 p -36.34 150.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 116.56 4.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 3.8 m -121.32 141.79 50.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -119.85 145.01 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.78 125.03 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.8 9.25 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -119.13 -73.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.3 p -75.48 -22.82 56.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 66.76 46.19 77.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.8 p -133.23 153.72 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 13.0 mt -65.21 160.72 20.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.465 ' CD1' ' NE2' ' A' ' 270' ' ' HIS . 2.8 mm? -87.47 179.53 6.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -141.15 151.44 43.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 92.69 -156.57 23.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.75 -70.09 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -88.02 -178.0 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 4.7 mpt_? 44.88 26.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -54.2 108.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 37.95 -151.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.82 170.46 15.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -142.84 128.29 18.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.4 t -72.06 114.36 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.88 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -83.86 -71.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 26.7 p -86.39 -46.5 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.88 60.37 0.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 10.5 ttp -118.83 146.85 44.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.338 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.96 122.33 46.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 15.3 m -143.19 179.89 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.465 ' NE2' ' CD1' ' A' ' 252' ' ' LEU . 11.1 m80 -86.24 -176.01 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . 0.402 ' O ' ' NE2' ' A' ' 274' ' ' GLN . 67.8 m-70 -77.55 -35.28 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -94.09 -38.53 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 95.0 m -55.61 -27.32 48.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.441 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 24.6 pt20 -61.53 -35.16 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 31.8 p -80.01 7.04 9.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -114.31 -8.19 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.09 174.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -84.57 -178.64 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -117.57 30.88 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.9 mp -106.83 65.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 44.5 t -83.6 122.84 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.58 -38.34 3.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.53 -19.65 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.924 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.869 0.366 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -111.52 97.08 35.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.56 0.695 . . . . 0.0 110.847 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.8 153.51 68.65 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.335 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 99.0 m-70 -70.05 116.94 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -70.96 70.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 232' ' ' HIS . 51.0 m-85 -62.21 139.16 58.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . 0.439 ' HA ' ' CE ' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -146.2 135.13 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 257' ' ' ARG . 2.5 t -52.67 126.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.85 145.19 28.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -85.2 108.45 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -79.62 82.13 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.14 -33.29 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.4 149.75 41.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.94 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' THR . . . . . 0.419 ' C ' HD22 ' A' ' 251' ' ' LEU . 93.7 m -115.58 126.26 53.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' PHE . . . . . 0.498 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 37.8 m-85 -70.04 122.31 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 12.9 t -47.93 124.7 7.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.95 7.29 7.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 52.3 t60 -110.89 -70.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.09 -15.41 53.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 -20.09 28.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.13 152.51 29.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.139 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' A' ' 244' ' ' PHE . 6.4 mt -76.44 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' LEU . . . . . 0.657 ' CD2' ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -136.57 160.83 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -143.68 155.53 44.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 157.6 -177.71 34.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.41 -40.02 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 0.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' ARG . . . -144.51 159.24 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ARG . . . . . 0.432 ' CB ' HG12 ' A' ' 236' ' ' VAL . 24.9 ptt180 36.15 44.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -54.45 -39.66 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.82 -168.07 13.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.416 ' CD2' HG21 ' A' ' 236' ' ' VAL . 4.8 mt -126.13 131.07 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -103.49 144.57 31.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.7 t -85.13 119.7 25.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -84.34 3.65 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -97.63 -48.65 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.3 p -113.12 -39.82 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.79 65.11 0.72 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' A' ' 268' ' ' ASN . 7.0 ttp -121.66 159.44 26.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 267' ' ' MET . 10.7 m-20 -122.81 122.68 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 171.38 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' HIS . . . . . 0.657 ' CD2' ' CD2' ' A' ' 252' ' ' LEU . 12.8 m80 -71.77 -177.95 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' HIS . . . . . 0.406 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 46.7 m-70 -72.19 -36.38 69.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -93.95 -44.06 8.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.36 -31.84 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 275' ' ' THR . 9.8 pt20 -52.66 -50.54 63.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' THR . . . . . 0.536 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 24.8 p -76.5 -5.36 47.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' LYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -94.69 -17.82 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.9 t -74.49 176.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.094 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -84.54 162.58 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -98.25 50.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.82 75.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.9 t -82.0 140.97 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.2 -36.01 2.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 283' ' ' ILE . 2.1 mp -65.03 -24.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 31.3 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.9 t -168.22 171.88 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.9 t -110.09 105.82 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.25 -145.89 14.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.495 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.5 t -149.88 147.12 27.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.4 m -125.14 163.97 21.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -127.46 -101.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 227' ' ' LYS . 5.8 mmtp -87.08 139.61 30.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.78 145.77 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.452 ' OD1' ' CD2' ' A' ' 280' ' ' LEU . 12.6 m-20 -136.07 134.66 38.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 32.5 mtm -124.4 143.73 43.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.587 0.708 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 173.24 11.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 0.0 112.283 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.479 ' CB ' ' CE2' ' A' ' 234' ' ' PHE . 90.0 m-70 -92.29 116.51 29.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -69.99 69.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.479 ' CE2' ' CB ' ' A' ' 232' ' ' HIS . 43.9 m-85 -78.63 120.19 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -124.42 137.49 54.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.463 ' CG1' ' HA ' ' A' ' 257' ' ' ARG . 59.7 t -55.4 146.76 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.78 ' CD1' ' CD2' ' A' ' 239' ' ' TYR . 1.9 t80 -142.8 131.16 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -101.82 98.11 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.78 ' CD2' ' CD1' ' A' ' 237' ' ' TYR . 0.1 OUTLIER -140.3 173.85 11.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 83.83 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 28.9 p -161.07 149.33 12.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.1 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.487 ' O ' ' CD1' ' A' ' 252' ' ' LEU . 1.1 p -92.86 148.49 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -122.26 135.9 54.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -77.53 141.43 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.67 6.81 44.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.47 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 54.7 t60 -119.36 -68.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 17.3 p -77.76 -14.08 59.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.33 54.45 34.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.0 p -138.75 -179.35 5.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.62 163.31 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.487 ' CD1' ' O ' ' A' ' 243' ' ' THR . 0.2 OUTLIER -123.32 124.04 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -109.95 105.47 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -141.9 -176.18 15.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.529 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -124.19 -56.82 1.62 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.07 -28.56 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' GLY . 80.0 mtt180 -109.02 43.36 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.44 86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 52.61 -154.63 5.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 14.9 mt -138.87 156.88 46.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.927 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 tmmm? -136.65 124.17 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.25 121.05 14.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.89 -0.67 49.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -96.57 -74.14 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -79.71 -38.57 33.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.95 65.28 0.82 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -131.06 147.71 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -110.63 116.73 31.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.29 157.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -64.54 173.67 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.67 -38.95 92.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -89.01 -40.68 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 72.9 m -61.14 -12.8 13.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.451 ' CG ' ' N ' ' A' ' 275' ' ' THR . 7.2 pt20 -75.35 -45.38 39.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 3.1 p -72.75 2.71 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 25.6 mtpp -101.87 -17.36 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.48 157.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.08 154.73 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -94.43 41.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.452 ' CD2' ' OD1' ' A' ' 229' ' ' ASP . 39.4 mt -121.78 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 7.2 t -94.6 116.12 28.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.25 -35.57 4.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 5.3 mp -71.8 -27.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 111.123 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.932 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.8 t -166.33 165.68 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 43.2 t -153.34 -176.99 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.72 84.51 0.1 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.9 p -113.05 171.58 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.879 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.8 p -149.6 160.53 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.21 -109.27 2.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -105.47 64.18 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 8.6 mm -106.75 100.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -119.81 135.7 54.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.0 mtm -130.17 143.98 51.33 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.15 15.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.659 2.239 . . . . 0.0 112.314 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -93.65 122.85 36.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.412 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 84.8 mtt-85 -69.96 72.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.478 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.31 132.46 37.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -144.57 129.67 18.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.81 117.89 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.574 ' CE1' ' CB ' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -144.58 153.68 42.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -91.89 121.07 33.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 241' ' ' SER . 0.7 OUTLIER -118.67 178.78 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -123.48 168.95 11.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 1.5 t 62.22 147.15 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.691 0.757 . . . . 0.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.74 54.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.424 ' CG2' ' CD1' ' A' ' 252' ' ' LEU . 1.0 OUTLIER -139.53 136.74 34.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 38.7 m-85 -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 250' ' ' THR . 9.4 t -53.32 109.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.1 -2.83 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.528 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 66.0 t60 -93.14 -67.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.0 p -89.3 -13.5 37.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.15 -22.05 28.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -79.93 156.36 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.52 ' O ' ' CE1' ' A' ' 270' ' ' HIS . 3.8 mt -68.92 175.11 3.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.424 ' CD1' ' CG2' ' A' ' 243' ' ' THR . 12.4 mt -96.43 178.08 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . 0.578 ' CE2' ' CD2' ' A' ' 270' ' ' HIS . 0.3 OUTLIER -144.28 130.95 20.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.456 ' O ' ' NE2' ' A' ' 258' ' ' GLN . . . 137.57 -170.26 23.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.57 -72.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.17 -36.12 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.414 ' HG2' ' NE2' ' A' ' 271' ' ' HIS . 38.7 ttp180 -104.3 41.89 1.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.456 ' NE2' ' O ' ' A' ' 254' ' ' GLY . 8.0 tt0 -70.13 84.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.413 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 76.55 -154.27 43.69 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.58 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 4.8 mt -147.02 130.02 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.574 ' CB ' ' CE1' ' A' ' 237' ' ' TYR . 11.1 tptm -102.87 122.49 44.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 6.3 t -65.98 131.82 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -99.39 11.95 37.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.415 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -109.05 -31.89 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -129.93 -45.59 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.69 79.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 5.9 ttp -150.19 139.53 21.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.9 OUTLIER -105.73 132.62 51.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.66 155.89 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.578 ' CD2' ' CE2' ' A' ' 253' ' ' TRP . 12.5 m80 -52.63 -175.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.414 ' NE2' ' HG2' ' A' ' 257' ' ' ARG . 20.0 m-70 -76.65 -36.5 57.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -93.43 -42.83 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 66.7 m -47.03 -26.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.58 ' NE2' ' CD1' ' A' ' 260' ' ' LEU . 6.3 pt20 -62.68 -45.52 92.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 13.7 t -75.08 5.32 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 26.1 mtpt -108.64 -19.06 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -73.75 158.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.091 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 160.83 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.066 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.63 45.74 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.74 86.08 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . 0.415 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 22.3 t -93.45 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 73.02 35.35 57.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.5 mm -105.87 -20.92 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.134 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.419 ' C ' ' OD1' ' A' ' 284' ' ' ASN . 15.5 p30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 222' ' ' SER . 8.7 t -139.68 175.73 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.857 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.419 ' N ' ' OG ' ' A' ' 221' ' ' SER . 27.4 t -140.27 167.91 21.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -82.07 -174.76 49.98 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.447 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.2 t -159.52 162.94 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.9 p -39.62 114.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.37 17.7 52.78 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -112.74 83.87 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.302 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.33 108.59 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -68.57 113.19 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.1 mmt -117.97 143.16 32.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.605 0.717 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 173.22 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.564 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 93.1 m-70 -88.67 123.13 32.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -69.39 70.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.564 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 48.3 m-85 -71.8 138.85 48.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -155.29 122.81 5.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 89.2 t -55.37 133.66 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.115 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 72.1 t80 -143.32 164.12 31.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 237' ' ' TYR . 4.5 t30 -92.0 124.81 36.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.516 ' CZ ' ' NE2' ' A' ' 258' ' ' GLN . 3.6 m-30 -102.29 176.34 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 7.43 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.6 m -161.39 150.1 13.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 113.78 3.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.6 m -100.01 164.14 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.45 126.44 54.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.9 t -52.18 133.68 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -85.58 9.36 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.5 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 74.7 t60 -119.33 -71.64 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.9 p -75.5 -28.9 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.406 ' C ' HG21 ' A' ' 250' ' ' THR . . . 75.15 49.93 9.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.515 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.406 HG21 ' C ' ' A' ' 249' ' ' GLY . 30.8 p -136.82 142.71 42.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.192 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.76 157.8 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.9 mp -108.72 97.72 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -51.31 -69.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -42.86 138.42 3.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -102.63 -74.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -48.26 -23.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 258' ' ' GLN . 36.4 ttm180 -103.71 -39.49 6.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.516 ' NE2' ' CZ ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER 34.32 43.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.418 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 70.52 -119.91 8.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.418 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 6.8 mt -148.75 154.01 38.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -133.65 102.62 5.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 132.85 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.23 1.46 57.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.415 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -101.65 -71.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.063 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.62 -42.19 22.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.97 40.17 2.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.51 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -102.37 149.96 23.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.86 123.22 45.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.42 HG21 ' CZ ' ' A' ' 234' ' ' PHE . 11.5 m -149.89 148.66 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -52.19 -174.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -30.27 42.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 79.8 mtm180 -93.14 -36.41 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 75.8 m -64.51 -14.79 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.524 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.2 pt20 -71.01 -35.05 71.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 9.8 t -79.52 8.46 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.5 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 60.0 mttt -115.47 -14.19 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.943 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.03 170.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.067 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -67.29 156.1 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.09 30.93 3.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.35 93.0 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . 0.415 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 18.3 t -90.17 112.05 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.33 -41.39 2.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.41 -27.63 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.7 p -163.17 165.36 24.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.89 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.3 m -153.94 -178.74 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 161.73 115.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.8 m -78.11 161.53 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.369 . . . . 0.0 110.889 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 85.3 p -122.41 94.67 4.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -104.62 166.56 15.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.29 99.51 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.319 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 pp -133.25 161.65 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' A' ' 280' ' ' LEU . 0.3 OUTLIER -40.84 102.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.18 142.73 87.58 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.557 0.694 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 173.19 11.33 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.375 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 97.0 m-70 -95.65 120.07 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 72.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.18 114.11 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.7 132.16 45.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.96 138.64 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -146.31 154.31 41.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -99.86 105.68 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.418 ' OH ' ' ND2' ' A' ' 268' ' ' ASN . 30.0 m-85 -90.79 137.3 32.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -95.76 29.8 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.2 p -170.28 150.62 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.627 0.727 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 100.53 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.297 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 6.7 m -93.72 149.68 21.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -95.16 146.07 24.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 7.9 t -71.67 130.86 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.14 7.83 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 50.2 t60 -116.52 -69.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 p -80.05 -26.74 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.83 50.68 10.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 29.8 p -138.51 148.76 44.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 14.2 mt -44.7 168.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 13.8 mt -108.14 178.2 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -168.59 129.28 1.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 159.04 131.06 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.449 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.37 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.8 0.333 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -113.45 -33.59 5.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -84.99 68.51 10.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -73.55 78.49 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 65.67 -148.79 51.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 11.9 mt -148.8 131.14 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.408 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 0.1 OUTLIER -113.41 142.86 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.38 132.98 38.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -93.71 10.73 31.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.427 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -112.67 -71.39 0.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -82.06 -45.31 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.08 65.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.03 139.55 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -106.17 125.4 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.456 HG21 ' CZ ' ' A' ' 234' ' ' PHE . 29.3 m -144.17 146.78 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -51.58 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -35.95 66.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -93.95 -37.4 11.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.49 -21.08 14.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.51 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 3.3 pt20 -65.49 -40.88 93.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 15.3 t -75.2 -3.61 34.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 43.7 mttp -97.43 -14.86 20.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.37 166.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -80.21 155.43 27.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -88.35 34.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.438 ' CD2' ' HB3' ' A' ' 229' ' ' ASP . 8.2 mt -116.15 88.46 2.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . 0.427 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 15.0 t -93.14 125.29 37.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.04 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.407 HG13 ' CD2' ' A' ' 280' ' ' LEU . 50.7 mm -44.58 -25.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.8 p -159.58 154.41 24.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 t -149.42 152.81 36.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -127.31 -157.38 9.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.6 p -148.91 155.03 40.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.861 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.8 m -124.13 141.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -86.07 153.54 26.85 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 48.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 229' ' ' ASP . 1.2 pt -123.15 151.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 228' ' ' ILE . 13.9 p-10 -37.47 114.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.441 ' O ' ' C ' ' A' ' 279' ' ' ASN . 17.5 mtm -124.61 143.77 44.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.858 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 171.54 14.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.259 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -91.75 129.4 37.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.402 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 55.7 mtp85 -69.69 69.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 34.9 m-85 -68.83 143.42 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -162.59 121.07 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.41 142.93 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 16.5 t80 -147.24 154.95 41.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 238' ' ' ASN . 18.2 p-10 -91.95 96.9 10.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD2' ' OE1' ' A' ' 258' ' ' GLN . 0.1 OUTLIER -91.79 163.6 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 -27.29 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 239' ' ' TYR . 2.3 m -99.26 156.77 35.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.681 0.753 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 149.95 67.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.1 p -135.21 155.61 50.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -117.95 108.51 15.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 6.9 t -56.81 101.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.8 -6.09 19.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.536 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 31.4 t60 -82.67 -70.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 28.7 p -79.87 -36.36 36.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 106.86 20.5 8.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 73.0 p -131.94 139.94 48.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.28 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.512 ' CD1' ' CD2' ' A' ' 270' ' ' HIS . 2.6 mm? -93.3 149.37 21.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -119.3 12.84 12.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -79.68 -176.15 48.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.444 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 255' ' ' LEU . 1.4 mm? -108.41 -64.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.908 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.71 26.55 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 0.2 OUTLIER -127.15 -30.61 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.575 ' OE1' ' CD2' ' A' ' 239' ' ' TYR . 5.8 pt20 35.84 38.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.471 ' O ' ' CE1' ' A' ' 271' ' ' HIS . . . 79.86 -107.16 2.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.458 ' CD1' ' CD ' ' A' ' 274' ' ' GLN . 44.8 mt -154.54 146.22 23.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.461 ' HE3' ' ND2' ' A' ' 268' ' ' ASN . 3.0 tppp? -125.45 117.38 23.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 4.3 t -64.45 134.87 55.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.09 -2.7 27.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -91.81 -34.36 14.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.5 p -126.43 -40.17 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.73 83.25 1.72 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.0 ttp -145.82 135.92 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.461 ' ND2' ' HE3' ' A' ' 261' ' ' LYS . 0.6 OUTLIER -99.27 127.53 45.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.412 HG22 ' CE1' ' A' ' 234' ' ' PHE . 35.0 m -149.52 156.03 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.169 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.512 ' CD2' ' CD1' ' A' ' 252' ' ' LEU . 16.5 m80 -58.77 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.471 ' CE1' ' O ' ' A' ' 259' ' ' GLY . 42.1 m-70 -74.95 -35.37 62.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -93.31 -38.71 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.884 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.7 m -52.66 -16.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.484 ' CG ' ' N ' ' A' ' 275' ' ' THR . 10.0 pt20 -68.91 -47.05 66.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.484 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 2.0 t -73.01 1.96 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.536 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 44.6 mttm -102.56 -23.58 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -68.01 172.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -93.83 150.86 20.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 230' ' ' MET . 25.8 m-80 -79.9 52.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.468 ' N ' HD22 ' A' ' 280' ' ' LEU . 3.1 mm? -127.78 73.85 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 53.4 t -92.0 121.13 33.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 61.49 11.72 29.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 284' ' ' ASN . 10.0 mm -72.66 -89.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 283' ' ' ILE . 2.1 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.0 t -155.48 130.71 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.908 0.385 . . . . 0.0 110.799 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.2 p -70.03 160.11 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.823 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -129.47 -146.74 6.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.5 m -148.44 120.94 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.5 m -154.44 174.24 15.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.95 179.18 29.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -115.91 113.6 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 9.7 mt -129.03 140.23 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -126.6 -175.02 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 42.4 mtm -122.97 142.26 37.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.412 ' HA ' ' CG ' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.76 173.18 11.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.361 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.559 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 69.8 m-70 -90.59 116.11 28.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 23.0 mtp180 -63.63 74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 24.8 m-85 -84.64 140.7 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.93 120.07 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 42.8 t -44.59 127.08 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.498 ' CE1' ' O ' ' A' ' 238' ' ' ASN . 42.6 t80 -145.38 141.43 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.498 ' O ' ' CE1' ' A' ' 237' ' ' TYR . 31.0 t-20 -86.97 122.2 30.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -126.28 179.38 5.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -130.81 -62.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 13.6 m -43.34 144.45 1.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.66 0.743 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.48 28.02 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.438 ' CG2' ' CD1' ' A' ' 252' ' ' LEU . 4.3 t -136.35 153.54 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.23 140.86 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.85 143.71 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.63 9.1 38.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.556 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 26.1 t60 -121.76 -67.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.0 p -75.45 -29.41 59.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 38.2 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.459 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.0 p -138.99 141.8 38.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 111.157 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 173.37 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.473 ' CD2' ' CD2' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -121.78 163.33 19.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -153.16 126.32 8.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -168.4 151.67 18.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.6 -65.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.92 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.77 -55.96 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -70.45 73.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 88.91 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 57.25 -147.71 34.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 8.1 mt -147.09 119.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -100.17 110.65 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -55.42 130.52 42.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.5 1.6 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.431 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -98.21 -50.82 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.02 -35.62 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.37 73.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.0 ttp -145.25 135.5 24.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -95.11 115.83 27.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.463 HG23 ' CZ ' ' A' ' 234' ' ' PHE . 4.3 m -134.96 150.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.473 ' CD2' ' CD2' ' A' ' 252' ' ' LEU . 28.4 m80 -64.25 167.13 7.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -61.32 -26.9 68.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.417 ' HG3' ' NZ ' ' A' ' 276' ' ' LYS . 4.8 tpt180 -93.87 -63.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . 0.484 ' HB3' ' CD2' ' A' ' 247' ' ' HIS . 4.6 m -46.47 -20.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.542 ' CG ' ' N ' ' A' ' 275' ' ' THR . 0.6 OUTLIER -46.94 -50.66 18.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.9 OUTLIER -67.54 -41.42 84.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.556 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 0.7 OUTLIER -50.24 -26.21 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.03 126.76 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.111 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -44.59 136.62 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.088 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.412 ' CG ' ' HA ' ' A' ' 231' ' ' PRO . 4.1 t30 -75.93 51.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 280' ' ' LEU . 4.9 mp -125.37 78.63 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.94 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . 0.431 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 6.9 t -88.69 142.57 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.55 -7.46 76.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.418 ' CG1' ' HB3' ' A' ' 280' ' ' LEU . 3.9 mm -73.71 -28.87 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.4 m -106.59 176.29 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.6 m -152.6 178.03 10.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -71.21 121.08 8.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.2 p -76.47 149.09 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.89 179.9 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.54 -97.24 1.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -130.81 -175.65 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.67 76.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.082 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.92 140.25 51.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 35.4 mtm -128.58 143.76 49.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.608 0.718 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 164.24 35.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.551 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 86.0 m-70 -87.45 120.41 28.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.487 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 15.0 mmt85 -70.94 68.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.551 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 51.7 m-85 -71.59 138.1 48.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.49 128.71 18.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.09 127.15 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.81 148.87 32.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.553 ' CE2' ' CB ' ' A' ' 258' ' ' GLN . 7.1 p90 -113.23 120.79 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.457 ' HE2' ' N ' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -86.39 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 52.6 p -39.0 144.35 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.7 0.762 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 138.03 36.75 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 2.8 t -145.83 146.9 31.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.555 ' CE2' HD13 ' A' ' 251' ' ' LEU . 7.4 m-85 -106.02 132.61 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 250' ' ' THR . 7.5 t -63.35 103.85 0.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.74 -7.41 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 52.3 t60 -87.23 -70.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.86 -9.82 56.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 245' ' ' CYS . . . 85.21 -19.77 20.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -81.19 157.14 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.555 HD13 ' CE2' ' A' ' 244' ' ' PHE . 7.3 mt -76.83 -176.87 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -145.94 145.31 30.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -173.23 130.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -177.21 -134.32 1.98 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 258' ' ' GLN . 2.5 mm? -83.98 178.07 8.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . . . -37.61 -34.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -86.65 36.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.553 ' CB ' ' CE2' ' A' ' 239' ' ' TYR . 73.4 mt-30 -41.28 -74.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.72 -162.9 10.83 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 26.5 mt -131.72 126.36 34.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -106.59 114.37 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 3.7 t -62.45 125.78 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.61 18.13 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.22 -40.52 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -119.78 -44.95 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 108.4 78.82 1.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.2 ttp -146.17 141.17 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -106.03 122.59 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.453 HG22 ' CE1' ' A' ' 234' ' ' PHE . 35.6 m -142.4 154.95 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 251' ' ' LEU . 13.7 m80 -51.64 179.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -69.13 -36.5 77.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 274' ' ' GLN . 27.4 mtt-85 -93.89 -49.13 5.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.3 m -39.29 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 275' ' ' THR . 12.6 pt20 -52.46 -49.77 63.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.511 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.7 OUTLIER -70.55 -37.35 74.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.562 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 0.4 OUTLIER -54.82 -31.82 59.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.2 t -65.31 172.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -94.28 155.61 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -79.22 52.84 1.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -123.02 78.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 13.1 t -89.16 116.52 27.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.46 -30.14 11.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.4 mp -83.45 -77.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.847 0.356 . . . . 0.0 111.103 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 62.1 p -144.19 -175.47 4.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.4 t -130.1 132.96 46.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -103.29 110.2 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 31.8 m -85.69 110.8 19.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.849 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 226' ' ' GLY . 13.2 t -114.62 178.75 4.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . 0.424 ' N ' ' OG ' ' A' ' 225' ' ' SER . . . 167.1 -145.35 9.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -104.45 160.23 15.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 110.947 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 8.1 mt -144.24 117.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.105 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.42 148.98 51.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 230' ' ' MET . 4.7 mpp? -125.29 143.61 44.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.496 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 52.9 Cg_endo -69.82 173.19 11.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.475 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 82.6 m-70 -95.7 122.89 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.431 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 59.4 mtt180 -71.23 67.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.555 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 34.5 m-85 -80.28 124.34 28.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -126.77 121.44 31.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 257' ' ' ARG . 2.3 t -51.21 113.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 14.5 t80 -120.87 159.24 25.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.541 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.5 t30 -118.37 97.3 5.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.43 167.32 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.432 ' CD ' ' C ' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.41 -52.26 2.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 21.7 m -39.09 153.23 0.18 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.65 13.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 2.7 m -130.51 108.53 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -89.87 141.68 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.66 112.69 11.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -76.96 3.32 12.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.561 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t60 -97.65 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.3 p -82.56 -18.4 41.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.81 -12.68 68.79 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.4 159.88 19.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 252' ' ' LEU . 0.5 OUTLIER -82.85 134.89 35.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 251' ' ' LEU . 29.8 mt -46.24 172.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -173.74 133.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.7 43.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.5 mp -90.67 -74.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -121.11 -31.06 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.448 ' HB2' ' CG1' ' A' ' 236' ' ' VAL . 14.0 ptt180 -89.93 29.66 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 257' ' ' ARG . 30.6 mt-30 -36.48 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 42.14 -150.96 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.446 ' CD2' HG22 ' A' ' 236' ' ' VAL . 17.2 mt -147.46 148.01 30.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.462 ' HD3' ' ND2' ' A' ' 268' ' ' ASN . 12.7 tptm -122.97 117.03 24.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 1.8 t -65.06 128.47 35.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -93.1 -3.14 54.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.421 ' CB ' ' SG ' ' A' ' 281' ' ' CYS . . . -93.93 -60.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.2 p -96.03 -34.86 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.57 73.26 1.19 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.5 ttp -143.81 130.17 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -94.23 128.22 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.419 HG23 ' CZ ' ' A' ' 234' ' ' PHE . 22.8 m -152.53 152.49 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.416 ' NE2' ' HA ' ' A' ' 252' ' ' LEU . 14.1 m80 -48.56 172.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.416 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 2.2 t60 -69.05 -32.31 71.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -94.14 -47.17 6.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . 0.412 ' HA ' ' CG ' ' A' ' 276' ' ' LYS . 63.6 m -44.72 -31.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.555 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 9.8 pt20 -51.6 -50.4 60.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.535 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 11.9 p -66.88 -10.44 48.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.561 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -85.92 -29.82 23.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.27 150.11 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.47 143.68 52.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.496 ' ND2' ' N ' ' A' ' 231' ' ' PRO . 2.4 t30 -78.82 54.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 11.7 mt -129.63 82.55 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . 0.421 ' SG ' ' CB ' ' A' ' 264' ' ' ALA . 11.0 t -92.56 128.44 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.47 -10.96 60.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.7 mt -90.66 -79.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.85 45.08 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.1 p -67.82 155.33 39.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -149.6 -170.95 17.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 14.8 m -126.88 -176.35 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.844 0.354 . . . . 0.0 110.879 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.0 t -153.08 142.68 21.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 165.33 -161.23 34.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -141.28 161.22 38.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pt -122.4 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.143 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.68 109.8 21.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 7.8 mtt -103.07 97.03 8.86 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.595 0.712 . . . . 0.0 110.868 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 165.1 32.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 0.0 112.345 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.5 115.59 20.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.16 63.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.473 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 38.4 m-85 -59.52 152.18 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.19 118.43 7.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -46.49 126.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.63 148.81 39.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.44 134.25 34.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.84 115.71 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -86.39 -12.19 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.52 152.42 46.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 108.61 2.14 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -104.55 147.26 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -103.52 129.42 50.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.61 124.99 23.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -78.25 8.99 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -117.8 -72.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.1 p -75.51 -25.93 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.95 43.09 18.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.9 p -139.73 159.16 42.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 29.2 mt -74.03 175.94 6.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.17 113.37 13.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -100.38 151.97 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 139.45 -9.72 3.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 19.6 mt 40.32 31.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -167.92 145.8 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 45.22 26.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -42.03 104.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 40.4 -149.83 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.37 170.58 15.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -137.58 131.68 32.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.0 t -75.7 140.55 42.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -97.56 6.28 48.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -107.42 -60.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.89 -44.42 9.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.24 52.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 21.4 ttp -115.39 163.74 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -124.47 128.39 48.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.462 HG23 ' CE1' ' A' ' 234' ' ' PHE . 16.2 m -149.69 150.98 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.133 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 14.1 m80 -51.28 -175.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 -76.54 -35.67 58.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -93.94 -38.45 11.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 46.2 m -50.07 -19.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.473 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 7.6 pt20 -71.15 -36.9 72.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.4 p -77.81 2.78 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.157 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -109.74 -8.82 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -85.03 175.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -89.18 159.93 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.13 48.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.34 84.34 2.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 53.7 t -94.01 114.15 26.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.8 -5.58 38.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.25 -23.22 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -150.09 142.68 24.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -160.68 178.34 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.34 172.76 37.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.9 t -107.46 76.48 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.9 p -103.62 76.33 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -126.77 -138.36 4.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 133.65 55.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.19 134.62 44.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -148.32 172.65 14.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.407 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 1.6 mpt? -125.67 97.01 37.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.532 0.682 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.79 139.71 40.79 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.65 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 99.3 m-70 -55.75 116.68 3.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -74.35 67.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 62.3 m-85 -59.28 146.0 41.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -153.65 137.2 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 42.1 t -59.31 119.52 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -136.07 161.28 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.08 147.83 24.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.23 153.45 33.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -8.35 8.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.8 m -133.21 160.08 70.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.752 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 118.85 5.93 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -127.37 147.24 50.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.61 134.42 50.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -48.87 144.38 4.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.29 8.83 25.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.497 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 53.4 t60 -127.98 -68.13 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.88 -16.94 59.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 59.57 52.94 50.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.1 p -139.97 150.55 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.108 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.6 mp -56.56 167.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -96.76 -178.84 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -158.66 145.4 17.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.44 -164.79 19.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.4 mt -116.79 -70.42 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.92 -64.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 6.3 ttp-105 -83.48 69.39 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.421 ' O ' ' NE2' ' A' ' 271' ' ' HIS . 26.1 mt-30 -78.48 -53.5 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.91 -148.24 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.09 154.15 48.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 111.96 12.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.37 124.38 15.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.33 7.43 32.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -103.04 -47.81 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.9 p -113.59 -45.18 3.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.59 60.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -124.39 124.8 43.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -88.62 118.58 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 35.2 m -139.88 146.32 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -50.93 -178.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 258' ' ' GLN . 64.2 m-70 -75.75 -38.82 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -88.19 -43.51 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.1 m -50.25 -24.11 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.479 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 12.2 pt20 -61.15 -33.73 73.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 43.2 p -78.98 11.16 2.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.497 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -114.63 -33.08 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.8 t -63.82 156.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -77.08 150.08 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.412 ' N ' HD21 ' A' ' 279' ' ' ASN . 1.0 OUTLIER -86.64 30.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -103.34 67.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.2 t -92.76 106.42 18.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.52 -27.24 6.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.33 -26.56 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m -119.38 143.09 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 110.84 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.6 t -165.53 156.46 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 146.41 -148.6 20.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 36.6 t -135.76 149.28 49.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 m -79.47 121.96 25.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 168.02 -52.26 0.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -155.31 118.71 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 50.4 mt -98.07 142.85 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.66 129.99 14.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.1 mmt -126.32 97.04 35.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.834 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 158.47 56.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.297 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.45 116.08 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.28 62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.515 ' CE1' HG22 ' A' ' 269' ' ' VAL . 31.1 m-85 -61.01 136.11 57.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -138.48 123.85 19.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.2 t -51.93 127.9 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.133 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.82 162.93 38.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.621 HD21 ' N ' ' A' ' 238' ' ' ASN . 0.9 OUTLIER -87.39 113.39 23.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -63.33 153.02 36.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -134.82 10.08 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 4.1 m -167.64 154.26 7.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.64 0.733 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 122.92 9.6 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.36 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.57 163.55 16.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.36 104.06 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.69 128.91 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -86.57 8.67 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 73.5 t60 -113.75 -71.22 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.5 p -75.45 -35.96 60.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.65 42.7 6.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 35.1 p -139.47 159.51 42.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.6 mp -63.9 -179.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 252' ' ' LEU . 1.7 pt? -171.04 124.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -172.46 153.02 2.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 161.73 -117.91 0.79 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.462 ' N ' ' HG3' ' A' ' 258' ' ' GLN . 2.7 mm? -68.14 160.2 29.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -50.85 -50.08 57.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.61 47.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.462 ' HG3' ' N ' ' A' ' 255' ' ' LEU . 6.5 mm100 -99.88 146.47 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 51.7 179.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 34.4 mt -142.96 152.81 42.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.6 117.36 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.95 141.16 28.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.09 7.73 41.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -110.74 -68.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 24.1 p -84.0 -46.05 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.57 61.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.9 ttp -122.86 145.74 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -111.41 123.48 50.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 234' ' ' PHE . 12.1 m -146.18 165.6 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -64.52 -178.71 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -75.3 -38.42 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 13.5 mtm-85 -89.2 -39.9 13.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.4 m -54.93 -21.2 10.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.485 ' CG ' ' N ' ' A' ' 275' ' ' THR . 4.7 pt20 -64.68 -47.81 77.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.485 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 9.9 t -70.32 -0.69 8.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 61.8 mttt -101.52 -26.94 13.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 3.2 t -69.08 148.79 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.55 153.28 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.482 ' ND2' ' H ' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -81.09 53.58 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 66.1 mt -121.74 73.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 23.7 t -83.32 112.23 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.27 23.54 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 19.7 mm -70.44 -24.43 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.927 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.9 p -118.4 165.42 13.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.7 p -87.33 159.81 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -163.17 120.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 109.55 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.2 m -94.72 85.81 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -151.57 -172.73 20.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.502 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.96 136.94 36.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.4 pt -106.87 165.63 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -162.66 114.32 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 28.1 mtm -103.47 96.99 9.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 157.28 61.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.619 2.213 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.23 121.66 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -76.01 52.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.525 ' CE1' HG23 ' A' ' 269' ' ' VAL . 23.7 m-85 -51.75 132.33 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -139.03 134.27 32.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.29 125.47 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 7.0 t80 -142.1 140.67 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.403 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.1 p30 -101.46 111.24 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 158.9 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -94.51 -58.06 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.1 p -44.22 151.08 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 116.21 4.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.1 m -116.2 132.27 56.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -110.21 153.24 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.3 t -71.15 137.07 48.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.52 9.19 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -120.93 -68.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.3 p -77.67 -14.34 59.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.05 52.67 49.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.496 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 10.6 p -138.06 157.72 45.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.96 166.6 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.508 ' C ' ' CE3' ' A' ' 253' ' ' TRP . 3.2 mt -113.59 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . 0.508 ' CE3' ' C ' ' A' ' 252' ' ' LEU . 6.6 m-90 -151.14 -175.89 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 98.1 172.06 32.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.2 tt -111.68 -51.27 2.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -105.15 -64.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -75.69 70.69 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -93.28 99.13 11.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 50.35 -165.41 0.6 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.501 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.6 163.14 24.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.372 . . . . 0.0 110.887 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -139.37 123.6 18.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.6 t -62.43 131.76 50.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.41 15.87 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -115.88 -66.61 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -88.52 -47.02 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 111.67 65.16 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.9 ttp -125.97 152.95 45.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -117.3 115.18 24.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.525 HG23 ' CE1' ' A' ' 234' ' ' PHE . 20.7 m -136.03 159.61 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -65.87 -175.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -76.09 -39.29 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -89.82 -47.06 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 86.4 m -44.91 -25.04 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.427 ' CG ' ' N ' ' A' ' 275' ' ' THR . 1.2 pt20 -57.45 -44.88 85.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 27.5 p -64.5 -6.94 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -94.7 -30.89 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.9 126.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -47.84 173.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -99.9 46.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 53.9 mt -124.88 93.37 3.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.4 t -93.82 115.07 27.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.64 -29.15 3.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.5 mt -75.7 -28.56 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.64 129.55 1.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.9 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.7 t -109.03 89.89 3.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -65.34 138.63 38.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.468 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.0 t -78.42 145.41 35.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 110.87 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.3 p -160.64 125.73 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.803 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -137.74 124.25 2.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -72.56 142.45 48.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.92 144.11 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -120.07 133.87 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 12.1 mtm -107.52 97.03 17.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.528 0.68 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 127.05 13.98 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.233 . . . . 0.0 112.348 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -48.37 115.59 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -74.62 61.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.545 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 43.4 m-85 -52.68 139.87 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 127.23 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.422 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 54.0 t -54.94 124.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -134.27 138.56 45.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -100.39 97.66 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 258' ' ' GLN . 2.1 p90 -125.04 120.45 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -83.15 67.89 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.8 m -142.07 145.14 34.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.707 0.765 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 77.87 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 18.6 m -95.09 142.55 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -111.5 128.34 55.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 9.4 t -46.92 139.77 5.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.61 3.15 56.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.554 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 43.5 t60 -110.94 -73.02 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.66 -31.33 59.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 53.1 6.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.41 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 251' ' ' LEU . 55.3 p -137.03 131.85 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 250' ' ' THR . 1.0 OUTLIER -34.58 126.16 0.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.449 ' O ' ' C ' ' A' ' 253' ' ' TRP . 9.9 mp -67.46 135.41 53.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . 0.449 ' C ' ' O ' ' A' ' 252' ' ' LEU . 70.4 m95 -34.64 -74.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 118.96 56.43 0.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 258' ' ' GLN . 4.6 mp -129.69 165.97 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.66 -25.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.504 ' CD ' ' NE2' ' A' ' 271' ' ' HIS . 13.3 ttp180 -100.49 34.81 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 239' ' ' TYR . 6.6 mm-40 -36.04 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 34.8 -148.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.6 141.87 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.26 104.84 10.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -47.99 118.55 2.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.79 4.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.9 -74.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.088 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.2 p -80.7 -46.0 16.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.6 ttp -104.88 145.17 30.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -106.08 116.14 31.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.545 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 2.6 m -139.55 149.67 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -54.92 -174.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.504 ' NE2' ' CD ' ' A' ' 257' ' ' ARG . 1.5 m-70 -82.1 -34.24 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -94.0 -25.61 17.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.0 m -71.69 -25.98 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 2.8 pt20 -63.23 -38.45 91.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -74.68 -5.34 42.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.554 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 41.4 mttm -98.5 -10.48 23.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.42 165.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -88.32 156.14 19.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -84.89 56.66 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 56.2 mt -131.19 81.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 111.31 22.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.11 -26.27 21.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 6.6 mm -45.81 -28.33 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.117 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.1 t -148.4 161.99 40.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.0 t -68.17 122.96 19.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -127.63 88.61 0.33 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.516 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.2 m -149.26 131.37 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.1 t -157.14 148.53 22.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 148.67 121.17 1.14 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.514 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -103.21 143.91 32.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.58 131.11 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.72 -179.16 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 97.01 44.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.49 18.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.699 2.266 . . . . 0.0 112.373 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.402 ' CD2' HG12 ' A' ' 277' ' ' VAL . 98.3 m-70 -85.69 118.17 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -78.97 59.38 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.565 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 39.5 m-85 -55.99 126.24 25.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt -131.54 133.7 45.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.535 ' CG1' ' NE ' ' A' ' 257' ' ' ARG . 2.2 t -51.58 134.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.455 ' OH ' ' CE1' ' A' ' 239' ' ' TYR . 1.5 p90 -144.27 157.09 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.15 109.5 18.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.455 ' CE1' ' OH ' ' A' ' 237' ' ' TYR . 20.6 m-85 -49.17 130.81 19.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.02 11.62 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.944 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 32.5 m -167.73 149.29 5.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 78.82 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.426 HG23 ' ND2' ' A' ' 268' ' ' ASN . 1.2 m -98.33 143.68 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.539 ' CE2' HD23 ' A' ' 251' ' ' LEU . 5.4 m-85 -102.24 151.34 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 4.3 t -61.56 137.81 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.91 -3.45 54.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.564 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 81.4 t60 -101.56 -70.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.0 p -77.2 -19.38 56.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.2 43.59 63.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.45 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.1 p -140.0 150.68 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.539 HD23 ' CE2' ' A' ' 244' ' ' PHE . 15.8 mt -62.18 154.55 26.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' A' ' 254' ' ' GLY . 0.1 OUTLIER -124.68 54.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -39.12 94.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 252' ' ' LEU . . . -177.36 140.4 4.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 mt -135.04 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . 71.81 47.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 236' ' ' VAL . 4.7 mmm180 74.89 50.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -102.57 -4.35 25.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -140.18 -164.49 9.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.437 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.85 158.7 43.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.12 114.56 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 10.3 t -58.57 119.1 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -83.76 2.39 38.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -95.3 -57.57 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.126 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.3 p -104.35 -34.61 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.0 73.87 1.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.446 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.0 ttp -138.44 140.56 39.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.426 ' ND2' HG23 ' A' ' 243' ' ' THR . 0.2 OUTLIER -105.33 122.35 45.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.521 HG23 ' CE1' ' A' ' 234' ' ' PHE . 34.4 m -139.81 164.85 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.455 ' CG ' HD21 ' A' ' 252' ' ' LEU . 16.8 m80 -60.07 177.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.37 -32.04 64.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -93.96 -46.89 6.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.5 m -45.84 -24.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.565 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 11.6 pt20 -60.11 -47.88 84.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 1.6 p -70.09 -13.23 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.564 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 26.0 mtpp -85.44 -33.96 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 232' ' ' HIS . 1.9 t -62.12 142.4 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.51 173.65 6.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.42 50.67 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.56 73.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 23.3 t -93.77 116.08 28.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.14 -4.89 85.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 10.4 mm -58.25 -20.51 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.349 . . . . 0.0 111.108 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.4 p -119.82 179.1 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 63.0 p -140.44 173.94 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.825 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.4 22.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.0 m -132.42 137.69 47.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 35.6 p -143.04 120.05 11.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -135.21 148.09 19.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.81 123.6 28.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.766 0.317 . . . . 0.0 110.931 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.9 pt -69.41 179.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.19 115.27 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 37.8 mtp -107.79 97.05 18.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.45 69.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.358 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.458 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.5 m-70 -66.09 116.19 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.406 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 73.1 mtt85 -73.46 64.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 35.3 m-85 -67.89 125.85 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -127.18 139.61 52.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.425 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 91.4 t -60.63 132.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -148.49 154.75 40.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.29 128.42 34.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 258' ' ' GLN . 55.5 m-85 -107.09 116.85 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -92.45 26.01 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.2 m -170.69 156.38 5.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 139.2 39.73 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.405 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 4.7 p -139.14 159.64 41.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -106.37 144.75 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.5 t -76.0 121.49 22.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.38 5.79 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.495 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 58.7 t60 -110.03 -73.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.1 p -75.56 -33.88 60.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 43.29 5.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 251' ' ' LEU . 43.0 p -139.99 138.13 35.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.788 0.327 . . . . 0.0 111.164 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 250' ' ' THR . 10.0 mt -34.78 146.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 70.1 mt -94.01 121.42 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -102.63 148.6 25.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 147.49 157.32 7.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.87 -69.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.6 -41.66 4.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 259' ' ' GLY . 0.2 OUTLIER -80.07 12.36 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.466 ' O ' ' CE1' ' A' ' 239' ' ' TYR . 22.7 tt0 -37.84 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 59.16 -171.7 4.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 8.7 mt -130.78 160.98 32.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -122.32 126.49 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 266' ' ' GLY . 11.5 t -77.27 104.38 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.45 -5.71 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.14 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.97 -29.5 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 262' ' ' CYS . . . 91.23 83.88 1.43 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 11.5 ttp -144.45 130.05 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.14 119.13 30.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.78 154.67 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -59.04 -175.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -75.43 -32.59 60.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -92.91 -41.44 10.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 78.4 m -57.06 -12.58 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -63.79 -41.03 98.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.949 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 11.77 37.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.495 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 34.2 mtmt -100.85 -24.93 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.1 t -73.69 -179.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -83.69 150.0 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -84.78 27.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.9 79.48 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.88 129.31 34.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.38 -21.82 19.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 36.7 mm -61.44 -28.19 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.2 t -171.94 161.47 5.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.875 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.0 m -112.37 104.06 12.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.39 39.2 3.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.545 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.7 t -64.86 125.33 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.2 m -140.79 159.34 42.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.834 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.75 174.1 15.05 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.458 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -100.01 153.51 19.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -114.47 106.47 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.07 126.32 8.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.402 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 32.9 mtm -116.15 97.09 48.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.553 0.692 . . . . 0.0 110.856 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 127.51 14.71 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 97.2 m-70 -44.86 117.78 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -72.99 65.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.52 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 43.1 m-85 -60.87 139.81 57.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -143.54 132.87 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.409 HG22 ' CD2' ' A' ' 260' ' ' LEU . 19.6 t -60.38 122.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.481 ' OH ' ' CE2' ' A' ' 239' ' ' TYR . 3.0 p90 -145.6 163.96 33.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.12 128.32 36.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.481 ' CE2' ' OH ' ' A' ' 237' ' ' TYR . 30.1 m-85 -80.15 123.73 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -102.64 -5.62 23.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.959 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 65.1 m -142.83 153.3 60.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 88.57 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.259 . . . . 0.0 112.371 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.5 m -93.88 161.47 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -122.91 124.42 43.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.46 146.81 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.23 -0.66 57.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.531 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 78.1 t60 -115.94 -67.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 14.6 p -78.18 -15.95 58.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 54.04 62.6 5.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 38.1 p -139.43 179.41 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.507 ' CD1' ' C ' ' A' ' 251' ' ' LEU . 0.3 OUTLIER -94.57 113.13 24.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.552 ' HG ' ' CE1' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -88.71 112.08 22.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -45.6 141.24 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -111.54 47.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.6 -64.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -172.8 144.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 12.5 mmt85 44.7 50.25 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -116.45 147.09 42.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.405 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 47.59 -170.41 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.439 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 3.0 mt -146.46 161.17 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -126.87 138.76 53.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.2 t -86.72 122.76 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.59 8.74 18.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -106.54 -67.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.5 p -88.58 -44.69 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 115.22 22.87 4.72 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.1 ttp -86.97 156.34 19.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -130.33 115.59 17.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 6.2 m -131.27 166.08 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.552 ' CE1' ' HG ' ' A' ' 252' ' ' LEU . 16.4 m80 -70.12 -176.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -37.43 12.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.21 -25.1 65.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.52 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.4 pt20 -60.87 -43.33 98.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 7.6 p -69.82 -6.63 33.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.531 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 1.4 mmpt? -96.09 -13.07 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.84 158.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -79.75 141.62 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.403 ' C ' HD23 ' A' ' 280' ' ' LEU . 9.7 p30 -80.06 52.08 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.403 HD23 ' C ' ' A' ' 279' ' ' ASN . 2.8 mm? -127.75 70.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 52.9 t -90.7 155.96 18.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 60.68 18.19 51.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.2 mm -101.57 -25.41 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.7 m -136.8 136.88 39.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.857 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.5 m -106.91 136.07 47.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 169.21 61.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -151.17 131.04 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.84 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 89.9 p -55.48 117.05 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.8 -82.17 1.32 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.54 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -123.74 107.45 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.82 120.09 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -162.09 137.53 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.4 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 3.9 ptp -126.69 97.0 34.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.0 Cg_endo -69.75 163.58 37.73 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.324 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.468 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 95.0 m-70 -86.66 115.4 24.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.468 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 26.5 mtt-85 -72.23 66.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.531 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 53.9 m-85 -62.28 149.9 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 234' ' ' PHE . 68.3 mttt -158.61 137.97 11.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.48 137.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -148.23 146.52 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -97.94 96.86 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.28 141.86 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 94.96 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.1 t -176.1 146.71 0.81 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.648 0.737 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 87.04 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.711 2.274 . . . . 0.0 112.377 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 m -106.71 138.21 43.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 244' ' ' PHE . 4.5 m-85 -106.36 140.21 39.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.1 t -56.56 129.55 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -86.93 5.8 35.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 37.3 t60 -110.64 -70.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.61 -33.11 60.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.1 39.31 6.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 28.4 p -138.08 150.13 46.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.526 ' HB3' ' CZ2' ' A' ' 253' ' ' TRP . 16.8 mt -64.33 175.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 253' ' ' TRP . 1.7 pt? -155.39 152.1 28.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . 0.526 ' CZ2' ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -154.8 158.54 39.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 155.78 -172.05 33.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.37 179.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.851 0.358 . . . . 0.0 110.869 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -70.39 69.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 259' ' ' GLY . 8.0 mm100 -85.13 114.97 22.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 258' ' ' GLN . . . 34.96 -146.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.429 ' CD1' ' HG2' ' A' ' 274' ' ' GLN . 3.0 mt -147.35 131.01 16.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -102.08 118.26 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 8.4 t -64.59 104.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -57.87 -18.68 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -76.29 -73.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.08 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.1 p -86.19 -42.05 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.0 60.76 0.75 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 9.4 ttp -125.33 119.86 29.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -90.09 120.19 31.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.531 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 31.6 m -137.53 179.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -70.32 165.2 22.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -62.46 -31.77 72.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -91.81 -47.75 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.4 m -50.71 -32.18 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.53 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 0.9 OUTLIER -53.12 -37.44 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.419 HG23 ' NE2' ' A' ' 274' ' ' GLN . 2.2 p -85.77 -11.83 52.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.56 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -87.03 -23.36 25.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.2 t -70.47 143.3 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.091 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -50.09 150.49 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -83.22 41.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 2.8 mp -127.94 104.63 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 232' ' ' HIS . 15.4 t -93.65 140.77 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.85 -33.94 3.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.451 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.8 mp -63.79 -17.63 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.5 t -83.26 -72.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.82 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.6 t -145.7 145.88 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.93 124.32 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.6 p -86.46 107.96 18.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 73.5 m -60.73 131.19 49.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -69.24 148.96 48.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.504 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -73.84 94.77 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 7.9 pt -115.82 164.75 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -140.24 130.48 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.423 ' C ' ' OD1' ' A' ' 279' ' ' ASN . 55.3 mtm -107.16 96.99 16.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.555 0.693 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.437 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.74 164.65 33.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.423 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.8 m-70 -78.24 121.04 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -73.95 64.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.539 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 30.8 m-85 -63.79 131.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -141.74 130.86 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -45.82 132.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 238' ' ' ASN . 82.1 t80 -148.22 161.04 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.591 ' O ' ' CE2' ' A' ' 237' ' ' TYR . 0.6 OUTLIER -92.12 144.76 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -106.35 133.76 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.57 4.49 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 35.3 m -139.36 154.55 71.92 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.687 0.756 . . . . 0.0 110.818 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.422 HG21 ' N ' ' A' ' 244' ' ' PHE . 53.8 m -113.76 149.97 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.422 ' N ' HG21 ' A' ' 243' ' ' THR . 12.3 m-85 -117.94 128.61 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.35 140.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.01 9.05 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 71.1 t60 -123.56 -66.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.7 p -78.87 -17.42 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.31 48.06 78.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.3 p -137.71 152.65 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.594 ' O ' ' CZ3' ' A' ' 253' ' ' TRP . 11.4 mt -64.73 159.66 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.46 174.37 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . 0.594 ' CZ3' ' O ' ' A' ' 251' ' ' LEU . 2.8 p90 -173.52 129.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . 0.424 ' C ' ' CD2' ' A' ' 255' ' ' LEU . . . 151.07 -124.98 1.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.536 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 255' ' ' LEU . 0.0 OUTLIER -135.35 179.76 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -39.08 -35.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -93.56 57.61 2.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 253' ' ' TRP . 30.2 tp60 -113.74 157.21 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . 0.411 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 41.05 -159.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.518 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 18.2 mt -153.98 161.34 42.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.22 139.53 51.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 5.5 t -91.88 114.75 27.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -78.19 7.03 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.4 -65.1 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.6 p -93.69 -40.4 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.81 33.85 3.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 17.0 ttp -106.52 119.04 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -87.56 139.95 30.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' A' ' 234' ' ' PHE . 4.1 m -150.34 164.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -67.54 -176.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.846 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.22 -36.57 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 272' ' ' ARG . 0.0 OUTLIER -94.07 -42.05 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 67.9 m -48.71 -22.37 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.539 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 3.0 pt20 -64.01 -41.08 97.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 10.6 t -74.46 -6.03 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 35.4 mttt -95.21 -12.41 26.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -85.5 171.27 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -92.9 171.73 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 231' ' ' PRO . 35.2 t-20 -104.12 50.95 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.12 59.43 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.45 128.93 34.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.77 -17.86 50.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.69 -28.23 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 28.7 p30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.2 m -166.11 147.06 6.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.8 t -121.67 132.24 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 148.8 117.52 0.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.6 t -110.17 117.59 34.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.806 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.6 p -60.55 167.84 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -150.55 -168.27 15.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.54 109.36 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.37 124.23 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -151.79 159.67 43.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 11.0 mmt -112.78 97.04 39.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.693 2.262 . . . . 0.0 112.344 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -83.44 115.74 22.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.417 ' HB3' ' NH1' ' A' ' 233' ' ' ARG . 14.3 mtp-105 -74.72 62.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.441 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 36.9 m-85 -60.58 135.84 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -141.49 132.45 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.3 129.67 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.61 115.6 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . 0.411 ' OD1' ' C ' ' A' ' 238' ' ' ASN . 36.0 t-20 -88.61 108.27 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -126.93 173.62 9.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' SER . 0.3 OUTLIER -109.81 -53.16 2.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' LYS . 84.5 p -36.34 150.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 116.56 4.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 3.8 m -121.32 141.79 50.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -119.85 145.01 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.78 125.03 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.8 9.25 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -119.13 -73.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.3 p -75.48 -22.82 56.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 66.76 46.19 77.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 5.8 p -133.23 153.72 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.135 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 13.0 mt -65.21 160.72 20.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.465 ' CD1' ' NE2' ' A' ' 270' ' ' HIS . 2.8 mm? -87.47 179.53 6.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -141.15 151.44 43.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 92.69 -156.57 23.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.75 -70.09 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -88.02 -178.0 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 4.7 mpt_? 44.88 26.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -54.2 108.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 37.95 -151.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.82 170.46 15.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -142.84 128.29 18.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.4 t -72.06 114.36 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.88 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -83.86 -71.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.144 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 26.7 p -86.39 -46.5 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.88 60.37 0.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 10.5 ttp -118.83 146.85 44.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.338 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.96 122.33 46.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 15.3 m -143.19 179.89 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.465 ' NE2' ' CD1' ' A' ' 252' ' ' LEU . 11.1 m80 -86.24 -176.01 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.402 ' O ' ' NE2' ' A' ' 274' ' ' GLN . 67.8 m-70 -77.55 -35.28 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -94.09 -38.53 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 95.0 m -55.61 -27.32 48.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.441 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 24.6 pt20 -61.53 -35.16 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 31.8 p -80.01 7.04 9.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -114.31 -8.19 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.09 174.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -84.57 -178.64 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -117.57 30.88 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 3.9 mp -106.83 65.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 44.5 t -83.6 122.84 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.58 -38.34 3.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.53 -19.65 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -110.33 153.4 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.846 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 28.0 m -144.62 123.69 12.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -145.52 175.97 24.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 38.9 m -78.84 140.43 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.904 0.383 . . . . 0.0 110.851 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 61.7 m -63.42 171.35 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -125.52 155.8 19.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -70.25 122.9 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.5 pt -122.45 72.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.66 140.99 52.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -111.52 97.08 35.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.56 0.695 . . . . 0.0 110.847 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.8 153.51 68.65 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.335 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 99.0 m-70 -70.05 116.94 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -70.96 70.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' PHE . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 232' ' ' HIS . 51.0 m-85 -62.21 139.16 58.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . 0.439 ' HA ' ' CE ' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -146.2 135.13 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 257' ' ' ARG . 2.5 t -52.67 126.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.85 145.19 28.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -85.2 108.45 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -79.62 82.13 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.14 -33.29 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.4 149.75 41.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.94 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' THR . . . . . 0.419 ' C ' HD22 ' A' ' 251' ' ' LEU . 93.7 m -115.58 126.26 53.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' PHE . . . . . 0.498 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 37.8 m-85 -70.04 122.31 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 12.9 t -47.93 124.7 7.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.95 7.29 7.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 52.3 t60 -110.89 -70.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.09 -15.41 53.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 -20.09 28.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.13 152.51 29.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.139 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' A' ' 244' ' ' PHE . 6.4 mt -76.44 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' LEU . . . . . 0.657 ' CD2' ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -136.57 160.83 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -143.68 155.53 44.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 157.6 -177.71 34.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.41 -40.02 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 0.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' ARG . . . -144.51 159.24 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . 0.432 ' CB ' HG12 ' A' ' 236' ' ' VAL . 24.9 ptt180 36.15 44.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -54.45 -39.66 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.82 -168.07 13.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.416 ' CD2' HG21 ' A' ' 236' ' ' VAL . 4.8 mt -126.13 131.07 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -103.49 144.57 31.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.7 t -85.13 119.7 25.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -84.34 3.65 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -97.63 -48.65 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.3 p -113.12 -39.82 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.79 65.11 0.72 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' A' ' 268' ' ' ASN . 7.0 ttp -121.66 159.44 26.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.415 ' N ' ' CG ' ' A' ' 267' ' ' MET . 10.7 m-20 -122.81 122.68 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 171.38 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . 0.657 ' CD2' ' CD2' ' A' ' 252' ' ' LEU . 12.8 m80 -71.77 -177.95 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' HIS . . . . . 0.406 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 46.7 m-70 -72.19 -36.38 69.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -93.95 -44.06 8.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 81.5 m -47.36 -31.84 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 275' ' ' THR . 9.8 pt20 -52.66 -50.54 63.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' THR . . . . . 0.536 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 24.8 p -76.5 -5.36 47.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.531 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -94.69 -17.82 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.9 t -74.49 176.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.094 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -84.54 162.58 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -98.25 50.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.82 75.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.9 t -82.0 140.97 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.2 -36.01 2.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . 0.436 ' N ' HD13 ' A' ' 283' ' ' ILE . 2.1 mp -65.03 -24.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 31.3 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.513 ' HB3' HD23 ' A' ' 280' ' ' LEU . 12.6 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.812 0.339 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 32.5 mtm -124.4 143.73 43.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.587 0.708 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 173.24 11.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 0.0 112.283 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.479 ' CB ' ' CE2' ' A' ' 234' ' ' PHE . 90.0 m-70 -92.29 116.51 29.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -69.99 69.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.479 ' CE2' ' CB ' ' A' ' 232' ' ' HIS . 43.9 m-85 -78.63 120.19 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -124.42 137.49 54.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 257' ' ' ARG . 59.7 t -55.4 146.76 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.78 ' CD1' ' CD2' ' A' ' 239' ' ' TYR . 1.9 t80 -142.8 131.16 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -101.82 98.11 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.78 ' CD2' ' CD1' ' A' ' 237' ' ' TYR . 0.1 OUTLIER -140.3 173.85 11.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 83.83 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 28.9 p -161.07 149.33 12.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.1 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.547 ' OG1' HD13 ' A' ' 252' ' ' LEU . 1.1 p -92.86 148.49 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -122.26 135.9 54.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -77.53 141.43 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.67 6.81 44.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.49 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 54.7 t60 -119.36 -68.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 17.3 p -77.76 -14.08 59.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.33 54.45 34.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.0 p -138.75 -179.35 5.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.62 163.31 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 252' ' ' LEU . 0.2 OUTLIER -123.32 124.04 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -109.95 105.47 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -141.9 -176.18 15.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.529 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 255' ' ' LEU . 3.2 tm? -124.19 -56.82 1.62 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.07 -28.56 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' GLY . 80.0 mtt180 -109.02 43.36 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.44 86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 52.61 -154.63 5.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 236' ' ' VAL . 14.9 mt -138.87 156.88 46.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.927 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.415 ' HD2' ' C ' ' A' ' 261' ' ' LYS . 6.1 tmmm? -136.65 124.17 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.25 121.05 14.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.89 -0.67 49.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.672 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -96.57 -74.14 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -79.71 -38.57 33.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.95 65.28 0.82 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -131.06 147.71 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -110.63 116.73 31.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 274' ' ' GLN . 2.9 m -142.29 157.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -64.54 173.67 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.67 -38.95 92.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -89.01 -40.68 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 72.9 m -61.14 -12.8 13.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HA ' HG21 ' A' ' 269' ' ' VAL . 5.9 pt20 -75.35 -45.38 39.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 3.1 p -72.75 2.71 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.49 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 25.6 mtpp -101.87 -17.36 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.48 157.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.08 154.73 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -94.43 41.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 229' ' ' ASP . 39.4 mt -121.78 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 7.2 t -94.6 116.12 28.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.25 -35.57 4.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 283' ' ' ILE . 5.3 mp -71.8 -27.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 111.123 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.0 mtm -130.17 143.98 51.33 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.15 15.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.659 2.239 . . . . 0.0 112.314 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -93.65 122.85 36.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.412 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 84.8 mtt-85 -69.96 72.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.31 132.46 37.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -144.57 129.67 18.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.81 117.89 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -144.58 153.68 42.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -91.89 121.07 33.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 241' ' ' SER . 0.7 OUTLIER -118.67 178.78 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -123.48 168.95 11.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 1.5 t 62.22 147.15 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.691 0.757 . . . . 0.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.74 54.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.692 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.0 OUTLIER -139.53 136.74 34.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 38.7 m-85 -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 250' ' ' THR . 9.4 t -53.32 109.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.1 -2.83 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 66.0 t60 -93.14 -67.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.0 p -89.3 -13.5 37.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.15 -22.05 28.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -79.93 156.36 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 243' ' ' THR . 3.8 mt -68.92 175.11 3.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.495 HD11 ' CG2' ' A' ' 243' ' ' THR . 12.4 mt -96.43 178.08 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.578 ' CE2' ' CD2' ' A' ' 270' ' ' HIS . 0.3 OUTLIER -144.28 130.95 20.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 255' ' ' LEU . . . 137.57 -170.26 23.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 254' ' ' GLY . 9.9 mp -125.57 -72.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.17 -36.12 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 271' ' ' HIS . 38.7 ttp180 -104.3 41.89 1.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 254' ' ' GLY . 8.0 tt0 -70.13 84.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 76.55 -154.27 43.69 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 4.8 mt -147.02 130.02 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 237' ' ' TYR . 11.1 tptm -102.87 122.49 44.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 6.3 t -65.98 131.82 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -99.39 11.95 37.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -109.05 -31.89 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -129.93 -45.59 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.69 79.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 5.9 ttp -150.19 139.53 21.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.9 OUTLIER -105.73 132.62 51.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.66 155.89 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.578 ' CD2' ' CE2' ' A' ' 253' ' ' TRP . 12.5 m80 -52.63 -175.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 257' ' ' ARG . 20.0 m-70 -76.65 -36.5 57.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.735 ' O ' HG22 ' A' ' 275' ' ' THR . 0.3 OUTLIER -93.43 -42.83 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 66.7 m -47.03 -26.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 8.4 pt20 -62.68 -45.52 92.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.735 HG22 ' O ' ' A' ' 272' ' ' ARG . 13.7 t -75.08 5.32 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 26.1 mtpt -108.64 -19.06 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 277' ' ' VAL . 1.7 t -73.75 158.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.091 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 160.83 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.066 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.63 45.74 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.74 86.08 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 22.3 t -93.45 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 73.02 35.35 57.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.5 mm -105.87 -20.92 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.134 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.419 ' C ' ' OD1' ' A' ' 284' ' ' ASN . 15.5 p30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.426 ' CB ' HD23 ' A' ' 280' ' ' LEU . 1.2 p30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.1 mmt -117.97 143.16 32.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.605 0.717 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 173.22 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 93.1 m-70 -88.67 123.13 32.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -69.39 70.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 269' ' ' VAL . 48.3 m-85 -71.8 138.85 48.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -155.29 122.81 5.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 257' ' ' ARG . 89.2 t -55.37 133.66 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 72.1 t80 -143.32 164.12 31.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 237' ' ' TYR . 4.5 t30 -92.0 124.81 36.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.501 ' CG ' ' HG2' ' A' ' 258' ' ' GLN . 3.6 m-30 -102.29 176.34 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 7.43 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.6 m -161.39 150.1 13.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 113.78 3.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.541 HG21 HD22 ' A' ' 268' ' ' ASN . 13.6 m -100.01 164.14 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.54 ' N ' HG22 ' A' ' 243' ' ' THR . 36.2 m-85 -111.45 126.44 54.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.9 t -52.18 133.68 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -85.58 9.36 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.5 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 74.7 t60 -119.33 -71.64 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.9 p -75.5 -28.9 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.15 49.93 9.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 30.8 p -136.82 142.71 42.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.192 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.76 157.8 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.9 mp -108.72 97.72 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.515 ' O ' HD22 ' A' ' 255' ' ' LEU . 20.9 m95 -51.31 -69.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -42.86 138.42 3.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.515 HD22 ' O ' ' A' ' 253' ' ' TRP . 2.2 mm? -102.63 -74.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -48.26 -23.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.547 ' O ' ' NE2' ' A' ' 258' ' ' GLN . 36.4 ttm180 -103.71 -39.49 6.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 4.0 pp0? 34.32 43.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.432 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 70.52 -119.91 8.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 6.8 mt -148.75 154.01 38.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -133.65 102.62 5.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 132.85 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.23 1.46 57.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.686 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -101.65 -71.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.063 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.62 -42.19 22.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.97 40.17 2.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.51 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.439 ' HE1' HG11 ' A' ' 277' ' ' VAL . 0.6 OUTLIER -102.37 149.96 23.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.541 HD22 HG21 ' A' ' 243' ' ' THR . 0.5 OUTLIER -117.86 123.22 45.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 234' ' ' PHE . 11.5 m -149.89 148.66 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -52.19 -174.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -79.33 -30.27 42.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.829 ' O ' HG22 ' A' ' 275' ' ' THR . 79.8 mtm180 -93.14 -36.41 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 75.8 m -64.51 -14.79 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.2 pt20 -71.01 -35.05 71.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.8 t -79.52 8.46 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.5 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 60.0 mttt -115.47 -14.19 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.943 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -77.03 170.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -67.29 156.1 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.09 30.93 3.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -129.35 93.0 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 18.3 t -90.17 112.05 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.33 -41.39 2.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.41 -27.63 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.442 ' HB3' HD23 ' A' ' 280' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.758 0.313 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.18 142.73 87.58 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.557 0.694 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 173.19 11.33 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.375 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 97.0 m-70 -95.65 120.07 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 72.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.18 114.11 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.7 132.16 45.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.96 138.64 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -146.31 154.31 41.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -99.86 105.68 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.418 ' OH ' ' ND2' ' A' ' 268' ' ' ASN . 30.0 m-85 -90.79 137.3 32.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -95.76 29.8 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.2 p -170.28 150.62 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.627 0.727 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 100.53 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.297 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.508 ' O ' HD12 ' A' ' 252' ' ' LEU . 6.7 m -93.72 149.68 21.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -95.16 146.07 24.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 7.9 t -71.67 130.86 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.14 7.83 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 50.2 t60 -116.52 -69.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 p -80.05 -26.74 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.83 50.68 10.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 29.8 p -138.51 148.76 44.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 14.2 mt -44.7 168.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 243' ' ' THR . 13.8 mt -108.14 178.2 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -168.59 129.28 1.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 159.04 131.06 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.449 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.37 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.8 0.333 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -113.45 -33.59 5.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -84.99 68.51 10.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -73.55 78.49 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 65.67 -148.79 51.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 11.9 mt -148.8 131.14 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.411 ' HD2' ' C ' ' A' ' 261' ' ' LYS . 0.1 OUTLIER -113.41 142.86 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.38 132.98 38.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -93.71 10.73 31.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -112.67 -71.39 0.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -82.06 -45.31 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.08 65.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.03 139.55 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -106.17 125.4 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 274' ' ' GLN . 29.3 m -144.17 146.78 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -51.58 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -35.95 66.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.826 ' O ' HG22 ' A' ' 275' ' ' THR . 9.5 mpt_? -93.95 -37.4 11.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.49 -21.08 14.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 3.3 pt20 -65.49 -40.88 93.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.826 HG22 ' O ' ' A' ' 272' ' ' ARG . 15.3 t -75.2 -3.61 34.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 43.7 mttp -97.43 -14.86 20.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -81.37 166.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -80.21 155.43 27.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -88.35 34.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 229' ' ' ASP . 8.2 mt -116.15 88.46 2.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.0 t -93.14 125.29 37.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.04 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 280' ' ' LEU . 50.7 mm -44.58 -25.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.441 ' O ' ' C ' ' A' ' 279' ' ' ASN . 17.5 mtm -124.61 143.77 44.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.858 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 171.54 14.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.259 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -91.75 129.4 37.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.402 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 55.7 mtp85 -69.69 69.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 34.9 m-85 -68.83 143.42 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -162.59 121.07 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.41 142.93 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 16.5 t80 -147.24 154.95 41.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.415 ' CG ' ' O ' ' A' ' 238' ' ' ASN . 18.2 p-10 -91.95 96.9 10.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD2' ' OE1' ' A' ' 258' ' ' GLN . 0.1 OUTLIER -91.79 163.6 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 -27.29 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 239' ' ' TYR . 2.3 m -99.26 156.77 35.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.681 0.753 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 149.95 67.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.797 ' OG1' HD23 ' A' ' 252' ' ' LEU . 1.1 p -135.21 155.61 50.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -117.95 108.51 15.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 6.9 t -56.81 101.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.8 -6.09 19.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 31.4 t60 -82.67 -70.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 28.7 p -79.87 -36.36 36.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 106.86 20.5 8.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 73.0 p -131.94 139.94 48.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.28 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.797 HD23 ' OG1' ' A' ' 243' ' ' THR . 2.6 mm? -93.3 149.37 21.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -119.3 12.84 12.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.541 ' C ' HD22 ' A' ' 255' ' ' LEU . . . -79.68 -176.15 48.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.444 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.663 HD22 ' N ' ' A' ' 255' ' ' LEU . 1.4 mm? -108.41 -64.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.908 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.71 26.55 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 257' ' ' ARG . 0.2 OUTLIER -127.15 -30.61 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.575 ' OE1' ' CD2' ' A' ' 239' ' ' TYR . 5.8 pt20 35.84 38.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 271' ' ' HIS . . . 79.86 -107.16 2.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.458 ' CD1' ' CD ' ' A' ' 274' ' ' GLN . 44.8 mt -154.54 146.22 23.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.486 ' HE3' ' ND2' ' A' ' 268' ' ' ASN . 3.0 tppp? -125.45 117.38 23.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 4.3 t -64.45 134.87 55.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.09 -2.7 27.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -91.81 -34.36 14.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.5 p -126.43 -40.17 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.73 83.25 1.72 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.0 ttp -145.82 135.92 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.486 ' ND2' ' HE3' ' A' ' 261' ' ' LYS . 0.6 OUTLIER -99.27 127.53 45.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.52 156.03 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.169 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.512 ' CD2' ' CD1' ' A' ' 252' ' ' LEU . 16.5 m80 -58.77 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.442 ' CD2' ' HA2' ' A' ' 259' ' ' GLY . 20.7 m170 -74.95 -35.37 62.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 275' ' ' THR . 11.6 ptp180 -93.31 -38.71 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.7 m -52.66 -16.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.484 ' CG ' ' N ' ' A' ' 275' ' ' THR . 10.0 pt20 -68.91 -47.05 66.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 272' ' ' ARG . 2.0 t -73.01 1.96 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 44.6 mttm -102.56 -23.58 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.7 t -68.01 172.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.613 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -93.83 150.86 20.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.798 ' C ' HD22 ' A' ' 280' ' ' LEU . 25.8 m-80 -79.9 52.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.798 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.1 mm? -127.78 73.85 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.4 t -92.0 121.13 33.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 61.49 11.72 29.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.705 HG21 HD12 ' A' ' 280' ' ' LEU . 10.0 mm -72.66 -89.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ASN . . . . . 0.637 ' N ' HG22 ' A' ' 283' ' ' ILE . 2.1 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 42.4 mtm -122.97 142.26 37.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 173.18 11.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.361 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 69.8 m-70 -90.59 116.11 28.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 264' ' ' ALA . 23.0 mtp180 -63.63 74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 24.8 m-85 -84.64 140.7 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.93 120.07 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 257' ' ' ARG . 42.8 t -44.59 127.08 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.498 ' CE1' ' O ' ' A' ' 238' ' ' ASN . 42.6 t80 -145.38 141.43 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.498 ' O ' ' CE1' ' A' ' 237' ' ' TYR . 31.0 t-20 -86.97 122.2 30.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -126.28 179.38 5.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -130.81 -62.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 13.6 m -43.34 144.45 1.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.66 0.743 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.48 28.02 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 252' ' ' LEU . 4.3 t -136.35 153.54 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.23 140.86 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.85 143.71 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.63 9.1 38.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.631 ' CE1' ' HG2' ' A' ' 276' ' ' LYS . 5.5 t-80 -121.76 -67.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.0 p -75.45 -29.41 59.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 38.2 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.459 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.0 p -138.99 141.8 38.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 111.157 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 173.37 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.692 HD23 ' ND1' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -121.78 163.33 19.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -153.16 126.32 8.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -168.4 151.67 18.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.6 -65.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.92 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.77 -55.96 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.439 ' HA ' HG13 ' A' ' 236' ' ' VAL . 51.1 mtm180 -70.45 73.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 88.91 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 57.25 -147.71 34.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 259' ' ' GLY . 8.1 mt -147.09 119.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -100.17 110.65 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -55.42 130.52 42.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.5 1.6 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -98.21 -50.82 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.02 -35.62 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.37 73.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.0 ttp -145.25 135.5 24.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -95.11 115.83 27.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 277' ' ' VAL . 4.3 m -134.96 150.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.692 ' ND1' HD23 ' A' ' 252' ' ' LEU . 73.6 m-70 -64.25 167.13 7.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -61.32 -26.9 68.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.415 ' HG3' ' NZ ' ' A' ' 276' ' ' LYS . 4.8 tpt180 -93.87 -63.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 277' ' ' VAL . 4.6 m -46.47 -20.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.542 ' CG ' ' N ' ' A' ' 275' ' ' THR . 4.3 pt20 -46.94 -50.66 18.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.9 OUTLIER -67.54 -41.42 84.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.631 ' HG2' ' CE1' ' A' ' 247' ' ' HIS . 0.7 OUTLIER -50.24 -26.21 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 269' ' ' VAL . 1.8 t -76.03 126.76 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.111 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.869 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -44.59 136.62 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.088 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -75.93 51.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.869 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 4.9 mp -125.37 78.63 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.94 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 6.9 t -88.69 142.57 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.55 -7.46 76.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 280' ' ' LEU . 3.9 mm -73.71 -28.87 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 35.4 mtm -128.58 143.76 49.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.608 0.718 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 164.24 35.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.571 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 86.0 m-70 -87.45 120.41 28.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.487 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 15.0 mmt85 -70.94 68.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 51.7 m-85 -71.59 138.1 48.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.49 128.71 18.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.09 127.15 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.81 148.87 32.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.553 ' CE2' ' CB ' ' A' ' 258' ' ' GLN . 7.1 p90 -113.23 120.79 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -86.39 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 52.6 p -39.0 144.35 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.7 0.762 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 138.03 36.75 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.831 ' O ' HD23 ' A' ' 251' ' ' LEU . 2.8 t -145.83 146.9 31.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 251' ' ' LEU . 7.4 m-85 -106.02 132.61 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 250' ' ' THR . 7.5 t -63.35 103.85 0.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.74 -7.41 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 52.3 t60 -87.23 -70.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.86 -9.82 56.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 245' ' ' CYS . . . 85.21 -19.77 20.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -81.19 157.14 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 243' ' ' THR . 7.3 mt -76.83 -176.87 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.545 HD12 ' CZ ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -145.94 145.31 30.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -173.23 130.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -177.21 -134.32 1.98 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 258' ' ' GLN . 2.5 mm? -83.98 178.07 8.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . . . -37.61 -34.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -86.65 36.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.553 ' CB ' ' CE2' ' A' ' 239' ' ' TYR . 73.4 mt-30 -41.28 -74.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.72 -162.9 10.83 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 26.5 mt -131.72 126.36 34.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -106.59 114.37 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 3.7 t -62.45 125.78 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.61 18.13 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.22 -40.52 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -119.78 -44.95 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 108.4 78.82 1.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.2 ttp -146.17 141.17 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -106.03 122.59 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.6 m -142.4 154.95 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 251' ' ' LEU . 13.7 m80 -51.64 179.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -69.13 -36.5 77.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.654 ' O ' HG22 ' A' ' 275' ' ' THR . 27.4 mtt-85 -93.89 -49.13 5.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 277' ' ' VAL . 61.3 m -39.29 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 275' ' ' THR . 12.6 pt20 -52.46 -49.77 63.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 272' ' ' ARG . 0.7 OUTLIER -70.55 -37.35 74.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.604 ' CE ' HG23 ' A' ' 275' ' ' THR . 0.4 OUTLIER -54.82 -31.82 59.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 273' ' ' CYS . 2.2 t -65.31 172.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -94.28 155.61 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 280' ' ' LEU . 5.8 m-20 -79.22 52.84 1.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 280' ' ' LEU . 4.2 mm? -123.02 78.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 13.1 t -89.16 116.52 27.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.46 -30.14 11.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 283' ' ' ILE . 4.4 mp -83.45 -77.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.847 0.356 . . . . 0.0 111.103 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.934 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 230' ' ' MET . 4.7 mpp? -125.29 143.61 44.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.64 ' HB3' HD22 ' A' ' 279' ' ' ASN . 52.9 Cg_endo -69.82 173.19 11.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 82.6 m-70 -95.7 122.89 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' A' ' 264' ' ' ALA . 59.4 mtt180 -71.23 67.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 34.5 m-85 -80.28 124.34 28.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -126.77 121.44 31.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 257' ' ' ARG . 2.3 t -51.21 113.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 14.5 t80 -120.87 159.24 25.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.541 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.5 t30 -118.37 97.3 5.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.43 167.32 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.432 ' CD ' ' C ' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.41 -52.26 2.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 21.7 m -39.09 153.23 0.18 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.65 13.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.613 ' HB ' HD12 ' A' ' 252' ' ' LEU . 2.7 m -130.51 108.53 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -89.87 141.68 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.66 112.69 11.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -76.96 3.32 12.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t60 -97.65 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.3 p -82.56 -18.4 41.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.81 -12.68 68.79 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.4 159.88 19.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.5 OUTLIER -82.85 134.89 35.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 1.09 ' N ' HD12 ' A' ' 251' ' ' LEU . 29.8 mt -46.24 172.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -173.74 133.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.7 43.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.5 mp -90.67 -74.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -121.11 -31.06 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.489 ' HB2' HG13 ' A' ' 236' ' ' VAL . 14.0 ptt180 -89.93 29.66 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 257' ' ' ARG . 30.6 mt-30 -36.48 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 42.14 -150.96 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 271' ' ' HIS . 17.2 mt -147.46 148.01 30.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.48 ' HD3' ' ND2' ' A' ' 268' ' ' ASN . 12.7 tptm -122.97 117.03 24.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 1.8 t -65.06 128.47 35.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -93.1 -3.14 54.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.703 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -93.93 -60.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.2 p -96.03 -34.86 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.57 73.26 1.19 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.5 ttp -143.81 130.17 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -94.23 128.22 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 22.8 m -152.53 152.49 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 252' ' ' LEU . 14.1 m80 -48.56 172.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 2.2 t60 -69.05 -32.31 71.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -94.14 -47.17 6.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 276' ' ' LYS . 63.6 m -44.72 -31.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.56 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 9.8 pt20 -51.6 -50.4 60.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.535 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 11.9 p -66.88 -10.44 48.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -85.92 -29.82 23.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.27 150.11 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.47 143.68 52.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.64 HD22 ' HB3' ' A' ' 231' ' ' PRO . 4.9 t-20 -78.82 54.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 11.7 mt -129.63 82.55 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 11.0 t -92.56 128.44 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.47 -10.96 60.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.7 mt -90.66 -79.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.771 0.32 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 7.8 mtt -103.07 97.03 8.86 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.595 0.712 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.6 Cg_endo -69.75 165.1 32.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 0.0 112.345 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.5 115.59 20.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.16 63.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 38.4 m-85 -59.52 152.18 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.403 ' NZ ' ' HA ' ' A' ' 235' ' ' LYS . 0.0 OUTLIER -148.19 118.43 7.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -46.49 126.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.63 148.81 39.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.44 134.25 34.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.84 115.71 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -86.39 -12.19 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.52 152.42 46.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 108.61 2.14 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.537 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.3 m -104.55 147.26 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -103.52 129.42 50.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.61 124.99 23.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -78.25 8.99 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -117.8 -72.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.1 p -75.51 -25.93 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.95 43.09 18.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.9 p -139.73 159.16 42.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 243' ' ' THR . 29.2 mt -74.03 175.94 6.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.576 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -132.17 113.37 13.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -100.38 151.97 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 139.45 -9.72 3.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 19.6 mt 40.32 31.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -167.92 145.8 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 45.22 26.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -42.03 104.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 40.4 -149.83 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.428 HD21 ' CE1' ' A' ' 271' ' ' HIS . 0.5 OUTLIER -142.37 170.58 15.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -137.58 131.68 32.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.0 t -75.7 140.55 42.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -97.56 6.28 48.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.62 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -107.42 -60.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.89 -44.42 9.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.24 52.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 21.4 ttp -115.39 163.74 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -124.47 128.39 48.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.69 150.98 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.576 ' CD2' HD23 ' A' ' 252' ' ' LEU . 14.1 m80 -51.28 -175.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.428 ' CE1' HD21 ' A' ' 260' ' ' LEU . 41.1 m-70 -76.54 -35.67 58.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -93.94 -38.45 11.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 46.2 m -50.07 -19.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.488 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 7.6 pt20 -71.15 -36.9 72.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.4 p -77.81 2.78 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.157 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -109.74 -8.82 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.03 175.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -89.18 159.93 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.13 48.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.34 84.34 2.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.7 t -94.01 114.15 26.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.8 -5.58 38.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.25 -23.22 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.804 0.335 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 1.6 mpt? -125.67 97.01 37.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.532 0.682 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.79 139.71 40.79 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.65 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 99.3 m-70 -55.75 116.68 3.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -74.35 67.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 62.3 m-85 -59.28 146.0 41.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -153.65 137.2 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 ' HD2' ' A' ' 257' ' ' ARG . 42.1 t -59.31 119.52 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -136.07 161.28 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.08 147.83 24.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.23 153.45 33.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -8.35 8.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.8 m -133.21 160.08 70.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.752 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 118.85 5.93 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -127.37 147.24 50.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.61 134.42 50.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -48.87 144.38 4.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.29 8.83 25.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -127.98 -68.13 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.88 -16.94 59.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 59.57 52.94 50.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.1 p -139.97 150.55 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.108 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.6 mp -56.56 167.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.546 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.7 mm? -96.76 -178.84 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -158.66 145.4 17.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.44 -164.79 19.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.4 mt -116.79 -70.42 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.92 -64.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HD2' HG21 ' A' ' 236' ' ' VAL . 6.3 ttp-105 -83.48 69.39 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.421 ' O ' ' NE2' ' A' ' 271' ' ' HIS . 35.2 mt-30 -78.48 -53.5 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.91 -148.24 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.09 154.15 48.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 111.96 12.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.37 124.38 15.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.33 7.43 32.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -103.04 -47.81 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.9 p -113.59 -45.18 3.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.59 60.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -124.39 124.8 43.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -88.62 118.58 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 35.2 m -139.88 146.32 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.546 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.8 m80 -50.93 -178.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 258' ' ' GLN . 64.2 m-70 -75.75 -38.82 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -88.19 -43.51 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.1 m -50.25 -24.11 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 12.2 pt20 -61.15 -33.73 73.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 43.2 p -78.98 11.16 2.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -33.08 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 277' ' ' VAL . 1.8 t -63.82 156.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.471 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -77.08 150.08 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.46 ' C ' HD22 ' A' ' 280' ' ' LEU . 4.4 m-20 -86.64 30.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -103.34 67.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.2 t -92.76 106.42 18.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.52 -27.24 6.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.33 -26.56 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 22.1 mmt -126.32 97.04 35.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.834 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.9 Cg_endo -69.79 158.47 56.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.297 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.45 116.08 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.28 62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 269' ' ' VAL . 31.1 m-85 -61.01 136.11 57.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -138.48 123.85 19.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.474 ' HA ' HD23 ' A' ' 260' ' ' LEU . 3.2 t -51.93 127.9 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.82 162.93 38.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.564 ' ND2' ' HB1' ' A' ' 256' ' ' ALA . 2.4 m120 -87.39 113.39 23.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -63.33 153.02 36.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -134.82 10.08 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 4.1 m -167.64 154.26 7.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.64 0.733 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 122.92 9.6 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.36 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.611 ' OG1' HD21 ' A' ' 252' ' ' LEU . 1.0 OUTLIER -118.57 163.55 16.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.36 104.06 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.69 128.91 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -86.57 8.67 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 73.5 t60 -113.75 -71.22 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.5 p -75.45 -35.96 60.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.65 42.7 6.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 35.1 p -139.47 159.51 42.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.6 mp -63.9 -179.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.611 HD21 ' OG1' ' A' ' 243' ' ' THR . 1.7 pt? -171.04 124.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -172.46 153.02 2.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 161.73 -117.91 0.79 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.484 ' N ' ' HG3' ' A' ' 258' ' ' GLN . 2.7 mm? -68.14 160.2 29.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.564 ' HB1' ' ND2' ' A' ' 238' ' ' ASN . . . -50.85 -50.08 57.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.61 47.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 255' ' ' LEU . 23.2 mm-40 -99.88 146.47 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 51.7 179.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 236' ' ' VAL . 34.4 mt -142.96 152.81 42.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.6 117.36 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.95 141.16 28.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.09 7.73 41.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -110.74 -68.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 24.1 p -84.0 -46.05 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.57 61.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.9 ttp -122.86 145.74 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -111.41 123.48 50.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.528 HG22 ' CE1' ' A' ' 234' ' ' PHE . 12.1 m -146.18 165.6 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -64.52 -178.71 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -75.3 -38.42 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.732 ' O ' HG22 ' A' ' 275' ' ' THR . 13.5 mtm-85 -89.2 -39.9 13.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.4 m -54.93 -21.2 10.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.485 ' CG ' ' N ' ' A' ' 275' ' ' THR . 11.3 pt20 -64.68 -47.81 77.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.9 t -70.32 -0.69 8.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 61.8 mttt -101.52 -26.94 13.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 273' ' ' CYS . 3.2 t -69.08 148.79 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.55 153.28 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.09 53.58 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 66.1 mt -121.74 73.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.7 t -83.32 112.23 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.27 23.54 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 283' ' ' ILE . 19.7 mm -70.44 -24.43 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 28.1 mtm -103.47 96.99 9.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 157.28 61.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.619 2.213 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.23 121.66 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -76.01 52.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.408 ' HB3' ' CB ' ' A' ' 260' ' ' LEU . 23.7 m-85 -51.75 132.33 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -139.03 134.27 32.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.29 125.47 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 7.0 t80 -142.1 140.67 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.403 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 7.8 p-10 -101.46 111.24 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 158.9 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -94.51 -58.06 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.1 p -44.22 151.08 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 116.21 4.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.1 m -116.2 132.27 56.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -110.21 153.24 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.3 t -71.15 137.07 48.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.52 9.19 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -120.93 -68.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.3 p -77.67 -14.34 59.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.05 52.67 49.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.496 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 10.6 p -138.06 157.72 45.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.96 166.6 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.508 ' C ' ' CE3' ' A' ' 253' ' ' TRP . 3.2 mt -113.59 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.508 ' CE3' ' C ' ' A' ' 252' ' ' LEU . 6.6 m-90 -151.14 -175.89 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 98.1 172.06 32.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 255' ' ' LEU . 7.2 tt -111.68 -51.27 2.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -105.15 -64.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -75.69 70.69 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -93.28 99.13 11.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 50.35 -165.41 0.6 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.501 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.408 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 8.6 mt -126.6 163.14 24.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.372 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -139.37 123.6 18.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.6 t -62.43 131.76 50.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.41 15.87 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.521 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.88 -66.61 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -88.52 -47.02 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 111.67 65.16 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.9 ttp -125.97 152.95 45.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -117.3 115.18 24.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 20.7 m -136.03 159.61 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.466 ' NE2' HD23 ' A' ' 252' ' ' LEU . 11.1 m80 -65.87 -175.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -76.09 -39.29 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -89.82 -47.06 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 86.4 m -44.91 -25.04 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.427 ' CG ' ' N ' ' A' ' 275' ' ' THR . 15.3 pt20 -57.45 -44.88 85.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 27.5 p -64.5 -6.94 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -94.7 -30.89 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.9 126.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -47.84 173.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -99.9 46.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 53.9 mt -124.88 93.37 3.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.4 t -93.82 115.07 27.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.64 -29.15 3.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.5 mt -75.7 -28.56 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 12.1 mtm -107.52 97.03 17.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.528 0.68 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 127.05 13.98 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.233 . . . . 0.0 112.348 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -48.37 115.59 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -74.62 61.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.545 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 43.4 m-85 -52.68 139.87 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 127.23 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.443 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 54.0 t -54.94 124.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -134.27 138.56 45.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.39 97.66 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 258' ' ' GLN . 2.1 p90 -125.04 120.45 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -83.15 67.89 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.8 m -142.07 145.14 34.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.707 0.765 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 77.87 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.681 ' O ' HD13 ' A' ' 252' ' ' LEU . 18.6 m -95.09 142.55 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -111.5 128.34 55.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 9.4 t -46.92 139.77 5.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.61 3.15 56.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.447 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 53.8 t-80 -110.94 -73.02 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.66 -31.33 59.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 53.1 6.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.41 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 251' ' ' LEU . 55.3 p -137.03 131.85 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 252' ' ' LEU . 1.0 OUTLIER -34.58 126.16 0.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 243' ' ' THR . 9.9 mp -67.46 135.41 53.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.449 ' C ' ' O ' ' A' ' 252' ' ' LEU . 70.4 m95 -34.64 -74.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 118.96 56.43 0.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 258' ' ' GLN . 4.6 mp -129.69 165.97 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.66 -25.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.504 ' CD ' ' NE2' ' A' ' 271' ' ' HIS . 13.3 ttp180 -100.49 34.81 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 239' ' ' TYR . 6.6 mm-40 -36.04 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 34.8 -148.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.6 141.87 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.26 104.84 10.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -47.99 118.55 2.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.79 4.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.9 -74.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.088 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.2 p -80.7 -46.0 16.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.6 ttp -104.88 145.17 30.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -106.08 116.14 31.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.545 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 2.6 m -139.55 149.67 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -54.92 -174.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.504 ' NE2' ' CD ' ' A' ' 257' ' ' ARG . 1.5 m-70 -82.1 -34.24 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -94.0 -25.61 17.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.0 m -71.69 -25.98 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 2.8 pt20 -63.23 -38.45 91.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -74.68 -5.34 42.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.447 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 41.4 mttm -98.5 -10.48 23.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.6 t -83.42 165.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.418 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -88.32 156.14 19.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.554 ' O ' HD23 ' A' ' 280' ' ' LEU . 23.4 p30 -84.89 56.66 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 279' ' ' ASN . 56.2 mt -131.19 81.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 111.31 22.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.11 -26.27 21.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.523 HG13 HD22 ' A' ' 280' ' ' LEU . 6.6 mm -45.81 -28.33 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.117 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 97.01 44.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.49 18.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.699 2.266 . . . . 0.0 112.373 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -85.69 118.17 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -78.97 59.38 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 39.5 m-85 -55.99 126.24 25.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt -131.54 133.7 45.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.535 ' CG1' ' NE ' ' A' ' 257' ' ' ARG . 2.2 t -51.58 134.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -144.27 157.09 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.15 109.5 18.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -49.17 130.81 19.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.02 11.62 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.944 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 32.5 m -167.73 149.29 5.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 78.82 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' ' 268' ' ' ASN . 1.2 m -98.33 143.68 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.532 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 5.4 m-85 -102.24 151.34 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 4.3 t -61.56 137.81 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.91 -3.45 54.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 81.4 t60 -101.56 -70.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.0 p -77.2 -19.38 56.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.2 43.59 63.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.45 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.1 p -140.0 150.68 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 244' ' ' PHE . 15.8 mt -62.18 154.55 26.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -124.68 54.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -39.12 94.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 252' ' ' LEU . . . -177.36 140.4 4.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 3.9 mt -135.04 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 255' ' ' LEU . . . 71.81 47.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 236' ' ' VAL . 4.7 mmm180 74.89 50.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -102.57 -4.35 25.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -140.18 -164.49 9.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.437 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.85 158.7 43.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.12 114.56 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 10.3 t -58.57 119.1 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -83.76 2.39 38.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.465 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -95.3 -57.57 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.3 p -104.35 -34.61 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.0 73.87 1.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.446 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.0 ttp -138.44 140.56 39.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.435 ' HB2' HG21 ' A' ' 243' ' ' THR . 0.5 OUTLIER -105.33 122.35 45.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.81 164.85 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.858 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.8 m80 -60.07 177.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.37 -32.04 64.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -93.96 -46.89 6.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.557 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.5 m -45.84 -24.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.575 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 11.6 pt20 -60.11 -47.88 84.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 1.6 p -70.09 -13.23 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.585 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 26.0 mtpp -85.44 -33.96 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.9 t -62.12 142.4 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.51 173.65 6.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.42 50.67 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.56 73.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.3 t -93.77 116.08 28.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.14 -4.89 85.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 283' ' ' ILE . 10.4 mm -58.25 -20.51 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.349 . . . . 0.0 111.108 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.926 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.825 0.345 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.404 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 37.8 mtp -107.79 97.05 18.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 153.45 69.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.358 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.5 m-70 -66.09 116.19 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.406 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 73.1 mtt85 -73.46 64.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 35.3 m-85 -67.89 125.85 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -127.18 139.61 52.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 260' ' ' LEU . 91.4 t -60.63 132.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -148.49 154.75 40.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.29 128.42 34.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 258' ' ' GLN . 55.5 m-85 -107.09 116.85 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -92.45 26.01 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.2 m -170.69 156.38 5.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 139.2 39.73 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.405 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.492 ' OG1' HD12 ' A' ' 252' ' ' LEU . 4.7 p -139.14 159.64 41.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -106.37 144.75 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.5 t -76.0 121.49 22.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.38 5.79 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 277' ' ' VAL . 21.5 t-80 -110.03 -73.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.1 p -75.56 -33.88 60.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 43.29 5.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 251' ' ' LEU . 43.0 p -139.99 138.13 35.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.788 0.327 . . . . 0.0 111.164 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 250' ' ' THR . 10.0 mt -34.78 146.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 270' ' ' HIS . 70.1 mt -94.01 121.42 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -102.63 148.6 25.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 147.49 157.32 7.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.87 -69.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.6 -41.66 4.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 259' ' ' GLY . 0.2 OUTLIER -80.07 12.36 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.466 ' O ' ' CE1' ' A' ' 239' ' ' TYR . 22.7 tt0 -37.84 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 59.16 -171.7 4.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 236' ' ' VAL . 8.7 mt -130.78 160.98 32.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -122.32 126.49 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 266' ' ' GLY . 11.5 t -77.27 104.38 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.45 -5.71 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.14 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.97 -29.5 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 262' ' ' CYS . . . 91.23 83.88 1.43 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 11.5 ttp -144.45 130.05 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.14 119.13 30.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.78 154.67 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 252' ' ' LEU . 23.0 m80 -59.04 -175.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -75.43 -32.59 60.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -92.91 -41.44 10.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 277' ' ' VAL . 78.4 m -57.06 -12.58 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -63.79 -41.03 98.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.949 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 11.77 37.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.576 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 34.2 mtmt -100.85 -24.93 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -73.69 -179.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -83.69 150.0 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -84.78 27.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.9 79.48 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.88 129.31 34.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.38 -21.82 19.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 36.7 mm -61.44 -28.19 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.814 0.34 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.43 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 32.9 mtm -116.15 97.09 48.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.553 0.692 . . . . 0.0 110.856 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 127.51 14.71 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 97.2 m-70 -44.86 117.78 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -72.99 65.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 43.1 m-85 -60.87 139.81 57.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -143.54 132.87 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.506 HG11 ' HD2' ' A' ' 257' ' ' ARG . 19.6 t -60.38 122.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.6 163.96 33.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.12 128.32 36.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -80.15 123.73 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -102.64 -5.62 23.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.959 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 65.1 m -142.83 153.3 60.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 88.57 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.259 . . . . 0.0 112.371 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 244' ' ' PHE . 15.5 m -93.88 161.47 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.5 ' N ' HG22 ' A' ' 243' ' ' THR . 39.8 m-85 -122.91 124.42 43.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.46 146.81 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.23 -0.66 57.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -115.94 -67.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 14.6 p -78.18 -15.95 58.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 54.04 62.6 5.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 38.1 p -139.43 179.41 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.3 OUTLIER -94.57 113.13 24.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.917 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -88.71 112.08 22.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -45.6 141.24 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -111.54 47.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.6 -64.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -172.8 144.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.506 ' HD2' HG11 ' A' ' 236' ' ' VAL . 12.5 mmt85 44.7 50.25 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -116.45 147.09 42.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 47.59 -170.41 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 3.0 mt -146.46 161.17 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -126.87 138.76 53.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.2 t -86.72 122.76 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.59 8.74 18.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -106.54 -67.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.5 p -88.58 -44.69 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 115.22 22.87 4.72 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.1 ttp -86.97 156.34 19.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -130.33 115.59 17.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 274' ' ' GLN . 6.2 m -131.27 166.08 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.917 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.4 m80 -70.12 -176.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -37.43 12.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.21 -25.1 65.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.582 ' HA ' HG21 ' A' ' 269' ' ' VAL . 13.4 pt20 -60.87 -43.33 98.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 7.6 p -69.82 -6.63 33.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.439 ' HA ' ' CE ' ' A' ' 276' ' ' LYS . 1.4 mmpt? -96.09 -13.07 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.84 158.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.558 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -79.75 141.62 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.453 ' C ' HD22 ' A' ' 280' ' ' LEU . 9.7 p30 -80.06 52.08 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.558 HD23 ' HB1' ' A' ' 278' ' ' ALA . 2.8 mm? -127.75 70.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 52.9 t -90.7 155.96 18.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 60.68 18.19 51.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.2 mm -101.57 -25.41 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.841 0.353 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 283' ' ' ILE . 3.9 ptp -126.69 97.0 34.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.0 Cg_endo -69.75 163.58 37.73 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.324 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 47.5 m80 -86.66 115.4 24.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.468 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 26.5 mtt-85 -72.23 66.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.752 ' CE1' HG22 ' A' ' 269' ' ' VAL . 53.9 m-85 -62.28 149.9 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 234' ' ' PHE . 68.3 mttt -158.61 137.97 11.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.48 137.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -148.23 146.52 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -97.94 96.86 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.28 141.86 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 94.96 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.1 t -176.1 146.71 0.81 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.648 0.737 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 87.04 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.711 2.274 . . . . 0.0 112.377 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 m -106.71 138.21 43.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 244' ' ' PHE . 4.5 m-85 -106.36 140.21 39.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.1 t -56.56 129.55 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -86.93 5.8 35.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.615 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t-80 -110.64 -70.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.61 -33.11 60.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.1 39.31 6.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 28.4 p -138.08 150.13 46.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' CZ2' ' A' ' 253' ' ' TRP . 16.8 mt -64.33 175.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 253' ' ' TRP . 1.7 pt? -155.39 152.1 28.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -154.8 158.54 39.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 155.78 -172.05 33.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.37 179.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.851 0.358 . . . . 0.0 110.869 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -70.39 69.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 259' ' ' GLY . 8.0 mm100 -85.13 114.97 22.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 34.96 -146.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 3.0 mt -147.35 131.01 16.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -102.08 118.26 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 8.4 t -64.59 104.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -57.87 -18.68 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -76.29 -73.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.08 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.1 p -86.19 -42.05 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.0 60.76 0.75 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 9.4 ttp -125.33 119.86 29.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -90.09 120.19 31.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.752 HG22 ' CE1' ' A' ' 234' ' ' PHE . 31.6 m -137.53 179.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -70.32 165.2 22.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -62.46 -31.77 72.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -91.81 -47.75 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.553 ' O ' HG23 ' A' ' 277' ' ' VAL . 84.4 m -50.71 -32.18 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.674 ' NE2' HG23 ' A' ' 275' ' ' THR . 0.9 OUTLIER -53.12 -37.44 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.674 HG23 ' NE2' ' A' ' 274' ' ' GLN . 2.2 p -85.77 -11.83 52.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.615 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -87.03 -23.36 25.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.2 t -70.47 143.3 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.754 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -50.09 150.49 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -83.22 41.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 2.8 mp -127.94 104.63 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.4 t -93.65 140.77 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.85 -33.94 3.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.451 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 280' ' ' LEU . 3.8 mp -63.79 -17.63 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.423 ' C ' ' OD1' ' A' ' 279' ' ' ASN . 55.3 mtm -107.16 96.99 16.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.555 0.693 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.437 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.74 164.65 33.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.8 m-70 -78.24 121.04 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -73.95 64.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 30.8 m-85 -63.79 131.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -141.74 130.86 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -45.82 132.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 238' ' ' ASN . 82.1 t80 -148.22 161.04 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.591 ' O ' ' CE2' ' A' ' 237' ' ' TYR . 0.6 OUTLIER -92.12 144.76 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -106.35 133.76 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.57 4.49 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 35.3 m -139.36 154.55 71.92 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.687 0.756 . . . . 0.0 110.818 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 251' ' ' LEU . 53.8 m -113.76 149.97 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.94 128.61 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.35 140.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.01 9.05 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 71.1 t60 -123.56 -66.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.7 p -78.87 -17.42 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.31 48.06 78.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.3 p -137.71 152.65 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.594 ' O ' ' CZ3' ' A' ' 253' ' ' TRP . 11.4 mt -64.73 159.66 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.578 HD13 ' NE2' ' A' ' 270' ' ' HIS . 3.5 mm? -87.46 174.37 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' TRP . . . . . 0.594 ' CZ3' ' O ' ' A' ' 251' ' ' LEU . 2.8 p90 -173.52 129.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' GLY . . . . . 0.889 ' C ' HD23 ' A' ' 255' ' ' LEU . . . 151.07 -124.98 1.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.536 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -135.35 179.76 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 238' ' ' ASN . . . -39.08 -35.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -93.56 57.61 2.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 253' ' ' TRP . 30.2 tp60 -113.74 157.21 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 260' ' ' LEU . . . 41.05 -159.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 259' ' ' GLY . 18.2 mt -153.98 161.34 42.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.22 139.53 51.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 5.5 t -91.88 114.75 27.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -78.19 7.03 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.4 -65.1 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.6 p -93.69 -40.4 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.81 33.85 3.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 17.0 ttp -106.52 119.04 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -87.56 139.95 30.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.34 164.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.578 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.0 m80 -67.54 -176.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.22 -36.57 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.778 ' O ' HG22 ' A' ' 275' ' ' THR . 0.0 OUTLIER -94.07 -42.05 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 67.9 m -48.71 -22.37 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.553 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 10.1 pt20 -64.01 -41.08 97.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 272' ' ' ARG . 10.6 t -74.46 -6.03 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 35.4 mttt -95.21 -12.41 26.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.5 171.27 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.55 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -92.9 171.73 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.649 ' C ' HD22 ' A' ' 280' ' ' LEU . 35.2 t-20 -104.12 50.95 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.649 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.0 mm? -128.12 59.43 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.45 128.93 34.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.77 -17.86 50.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.69 -28.23 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 28.7 p30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.784 0.326 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.413 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 11.0 mmt -112.78 97.04 39.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.1 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.693 2.262 . . . . 0.0 112.344 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -83.44 115.74 22.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 233' ' ' ARG . 14.3 mtp-105 -74.72 62.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 36.9 m-85 -60.58 135.84 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -141.49 132.45 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.3 129.67 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.61 115.6 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.411 ' OD1' ' C ' ' A' ' 238' ' ' ASN . 36.0 t-20 -88.61 108.27 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -126.93 173.62 9.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' SER . 0.3 OUTLIER -109.81 -53.16 2.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' LYS . 84.5 p -36.34 150.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 116.56 4.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.421 HG21 ' CB ' ' A' ' 268' ' ' ASN . 3.8 m -121.32 141.79 50.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -119.85 145.01 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.78 125.03 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.8 9.25 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 84.5 t60 -119.13 -73.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 250' ' ' THR . 15.3 p -75.48 -22.82 56.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 66.76 46.19 77.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' THR . . . . . 0.462 HG23 ' SG ' ' A' ' 248' ' ' CYS . 5.8 p -133.23 153.72 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.135 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 251' ' ' LEU . 13.0 mt -65.21 160.72 20.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 0.537 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.8 mm? -87.47 179.53 6.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -141.15 151.44 43.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 92.69 -156.57 23.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 255' ' ' LEU . 5.4 mp -125.75 -70.09 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -88.02 -178.0 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.466 ' N ' ' HD3' ' A' ' 257' ' ' ARG . 4.7 mpt_? 44.88 26.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -54.2 108.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 37.95 -151.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.82 170.46 15.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -142.84 128.29 18.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.4 t -72.06 114.36 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.88 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -83.86 -71.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 26.7 p -86.39 -46.5 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.88 60.37 0.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 10.5 ttp -118.83 146.85 44.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.338 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.421 ' CB ' HG21 ' A' ' 243' ' ' THR . 0.9 OUTLIER -106.96 122.33 46.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 15.3 m -143.19 179.89 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 0.537 ' NE2' HD13 ' A' ' 252' ' ' LEU . 11.1 m80 -86.24 -176.01 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.402 ' O ' ' NE2' ' A' ' 274' ' ' GLN . 67.8 m-70 -77.55 -35.28 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -94.09 -38.53 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 95.0 m -55.61 -27.32 48.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 24.6 pt20 -61.53 -35.16 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 31.8 p -80.01 7.04 9.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 49.8 mttt -114.31 -8.19 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -84.09 174.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.651 ' HB1' HD12 ' A' ' 280' ' ' LEU . . . -84.57 -178.64 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.09 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -117.57 30.88 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.651 HD12 ' HB1' ' A' ' 278' ' ' ALA . 3.9 mp -106.83 65.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 44.5 t -83.6 122.84 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.58 -38.34 3.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.53 -19.65 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.924 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.869 0.366 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.435 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -111.52 97.08 35.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.56 0.695 . . . . 0.0 110.847 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.8 153.51 68.65 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.335 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 47.0 m80 -70.05 116.94 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -70.96 70.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 232' ' ' HIS . 51.0 m-85 -62.21 139.16 58.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -146.2 135.13 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' HD23 ' A' ' 260' ' ' LEU . 2.5 t -52.67 126.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.85 145.19 28.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -85.2 108.45 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -79.62 82.13 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.14 -33.29 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.4 149.75 41.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.94 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' THR . . . . . 0.447 HG21 ' OD1' ' A' ' 268' ' ' ASN . 93.7 m -115.58 126.26 53.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' PHE . . . . . 0.63 ' CE2' HD11 ' A' ' 251' ' ' LEU . 37.8 m-85 -70.04 122.31 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 12.9 t -47.93 124.7 7.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.95 7.29 7.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' HIS . . . . . 0.517 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 28.5 t-80 -110.89 -70.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.09 -15.41 53.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 -20.09 28.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.13 152.51 29.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.139 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.63 HD11 ' CE2' ' A' ' 244' ' ' PHE . 6.4 mt -76.44 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' LEU . . . . . 1.091 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -136.57 160.83 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -143.68 155.53 44.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 157.6 -177.71 34.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.41 -40.02 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 0.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' ARG . . . -144.51 159.24 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ARG . . . . . 0.531 ' CB ' HG13 ' A' ' 236' ' ' VAL . 24.9 ptt180 36.15 44.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -54.45 -39.66 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.82 -168.07 13.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 236' ' ' VAL . 4.8 mt -126.13 131.07 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -103.49 144.57 31.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.7 t -85.13 119.7 25.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -84.34 3.65 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.507 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -97.63 -48.65 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.3 p -113.12 -39.82 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.79 65.11 0.72 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' A' ' 268' ' ' ASN . 7.0 ttp -121.66 159.44 26.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.447 ' OD1' HG21 ' A' ' 243' ' ' THR . 4.0 m120 -122.81 122.68 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 171.38 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' HIS . . . . . 1.091 ' CD2' HD23 ' A' ' 252' ' ' LEU . 12.8 m80 -71.77 -177.95 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' HIS . . . . . 0.406 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 46.7 m-70 -72.19 -36.38 69.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -93.95 -44.06 8.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 277' ' ' VAL . 81.5 m -47.36 -31.84 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 275' ' ' THR . 9.8 pt20 -52.66 -50.54 63.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' THR . . . . . 0.536 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 24.8 p -76.5 -5.36 47.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -94.69 -17.82 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -74.49 176.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.094 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -84.54 162.58 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -98.25 50.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.82 75.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 48.9 t -82.0 140.97 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.2 -36.01 2.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 283' ' ' ILE . 2.1 mp -65.03 -24.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 31.3 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.9 t -168.22 171.88 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.9 t -110.09 105.82 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.25 -145.89 14.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.495 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.5 t -149.88 147.12 27.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.4 m -125.14 163.97 21.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -127.46 -101.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.474 ' N ' ' HD3' ' A' ' 227' ' ' LYS . 5.8 mmtp -87.08 139.61 30.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.78 145.77 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.513 ' HB3' HD23 ' A' ' 280' ' ' LEU . 12.6 m-20 -136.07 134.66 38.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 32.5 mtm -124.4 143.73 43.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.587 0.708 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 173.24 11.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 0.0 112.283 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.479 ' CB ' ' CE2' ' A' ' 234' ' ' PHE . 90.0 m-70 -92.29 116.51 29.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -69.99 69.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.479 ' CE2' ' CB ' ' A' ' 232' ' ' HIS . 43.9 m-85 -78.63 120.19 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -124.42 137.49 54.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 257' ' ' ARG . 59.7 t -55.4 146.76 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.78 ' CD1' ' CD2' ' A' ' 239' ' ' TYR . 1.9 t80 -142.8 131.16 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -101.82 98.11 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.78 ' CD2' ' CD1' ' A' ' 237' ' ' TYR . 0.1 OUTLIER -140.3 173.85 11.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 83.83 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 28.9 p -161.07 149.33 12.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.1 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.547 ' OG1' HD13 ' A' ' 252' ' ' LEU . 1.1 p -92.86 148.49 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -122.26 135.9 54.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -77.53 141.43 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.67 6.81 44.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.49 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 54.7 t60 -119.36 -68.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 17.3 p -77.76 -14.08 59.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.33 54.45 34.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.0 p -138.75 -179.35 5.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.62 163.31 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 252' ' ' LEU . 0.2 OUTLIER -123.32 124.04 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -109.95 105.47 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -141.9 -176.18 15.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.529 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 255' ' ' LEU . 3.2 tm? -124.19 -56.82 1.62 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.07 -28.56 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' GLY . 80.0 mtt180 -109.02 43.36 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.44 86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 52.61 -154.63 5.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 236' ' ' VAL . 14.9 mt -138.87 156.88 46.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.927 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 tmmm? -136.65 124.17 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.25 121.05 14.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.89 -0.67 49.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.672 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -96.57 -74.14 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -79.71 -38.57 33.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.95 65.28 0.82 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -131.06 147.71 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -110.63 116.73 31.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 274' ' ' GLN . 2.9 m -142.29 157.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -64.54 173.67 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.67 -38.95 92.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -89.01 -40.68 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 72.9 m -61.14 -12.8 13.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HA ' HG21 ' A' ' 269' ' ' VAL . 5.9 pt20 -75.35 -45.38 39.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 3.1 p -72.75 2.71 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.49 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 25.6 mtpp -101.87 -17.36 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.48 157.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.08 154.73 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -94.43 41.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 229' ' ' ASP . 39.4 mt -121.78 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 7.2 t -94.6 116.12 28.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.25 -35.57 4.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 283' ' ' ILE . 5.3 mp -71.8 -27.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 111.123 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.8 t -166.33 165.68 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 43.2 t -153.34 -176.99 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.72 84.51 0.1 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.9 p -113.05 171.58 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.879 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.8 p -149.6 160.53 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.21 -109.27 2.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -105.47 64.18 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 283' ' ' ILE . 8.6 mm -106.75 100.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -119.81 135.7 54.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.0 mtm -130.17 143.98 51.33 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.15 15.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.659 2.239 . . . . 0.0 112.314 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -93.65 122.85 36.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.412 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 84.8 mtt-85 -69.96 72.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.31 132.46 37.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -144.57 129.67 18.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.81 117.89 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -144.58 153.68 42.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -91.89 121.07 33.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 241' ' ' SER . 0.7 OUTLIER -118.67 178.78 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -123.48 168.95 11.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 1.5 t 62.22 147.15 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.691 0.757 . . . . 0.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.74 54.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.692 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.0 OUTLIER -139.53 136.74 34.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 38.7 m-85 -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 250' ' ' THR . 9.4 t -53.32 109.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.1 -2.83 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 66.0 t60 -93.14 -67.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.0 p -89.3 -13.5 37.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.15 -22.05 28.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -79.93 156.36 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 243' ' ' THR . 3.8 mt -68.92 175.11 3.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.495 HD11 ' CG2' ' A' ' 243' ' ' THR . 12.4 mt -96.43 178.08 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.578 ' CE2' ' CD2' ' A' ' 270' ' ' HIS . 0.3 OUTLIER -144.28 130.95 20.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 255' ' ' LEU . . . 137.57 -170.26 23.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 254' ' ' GLY . 9.9 mp -125.57 -72.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.17 -36.12 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 271' ' ' HIS . 38.7 ttp180 -104.3 41.89 1.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 254' ' ' GLY . 8.0 tt0 -70.13 84.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 76.55 -154.27 43.69 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.429 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 4.8 mt -147.02 130.02 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 237' ' ' TYR . 11.1 tptm -102.87 122.49 44.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 6.3 t -65.98 131.82 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -99.39 11.95 37.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -109.05 -31.89 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -129.93 -45.59 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.69 79.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 5.9 ttp -150.19 139.53 21.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.9 OUTLIER -105.73 132.62 51.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.66 155.89 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.578 ' CD2' ' CE2' ' A' ' 253' ' ' TRP . 12.5 m80 -52.63 -175.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 257' ' ' ARG . 20.0 m-70 -76.65 -36.5 57.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.735 ' O ' HG22 ' A' ' 275' ' ' THR . 0.3 OUTLIER -93.43 -42.83 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 66.7 m -47.03 -26.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 8.4 pt20 -62.68 -45.52 92.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.735 HG22 ' O ' ' A' ' 272' ' ' ARG . 13.7 t -75.08 5.32 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 26.1 mtpt -108.64 -19.06 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 277' ' ' VAL . 1.7 t -73.75 158.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.091 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 160.83 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.066 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.63 45.74 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.74 86.08 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 22.3 t -93.45 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 73.02 35.35 57.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 228' ' ' ILE . 8.5 mm -105.87 -20.92 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.134 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.419 ' C ' ' OD1' ' A' ' 284' ' ' ASN . 15.5 p30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 222' ' ' SER . 8.7 t -139.68 175.73 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.857 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.419 ' N ' ' OG ' ' A' ' 221' ' ' SER . 27.4 t -140.27 167.91 21.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -82.07 -174.76 49.98 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.447 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.2 t -159.52 162.94 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.9 p -39.62 114.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.37 17.7 52.78 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -112.74 83.87 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.302 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.33 108.59 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.426 ' CB ' HD23 ' A' ' 280' ' ' LEU . 1.2 p30 -68.57 113.19 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.1 mmt -117.97 143.16 32.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.605 0.717 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 173.22 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 93.1 m-70 -88.67 123.13 32.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -69.39 70.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 269' ' ' VAL . 48.3 m-85 -71.8 138.85 48.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -155.29 122.81 5.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 257' ' ' ARG . 89.2 t -55.37 133.66 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 72.1 t80 -143.32 164.12 31.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 237' ' ' TYR . 4.5 t30 -92.0 124.81 36.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.501 ' CG ' ' HG2' ' A' ' 258' ' ' GLN . 3.6 m-30 -102.29 176.34 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 7.43 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.6 m -161.39 150.1 13.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 113.78 3.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.541 HG21 HD22 ' A' ' 268' ' ' ASN . 13.6 m -100.01 164.14 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.54 ' N ' HG22 ' A' ' 243' ' ' THR . 36.2 m-85 -111.45 126.44 54.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.9 t -52.18 133.68 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -85.58 9.36 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.5 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 74.7 t60 -119.33 -71.64 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.9 p -75.5 -28.9 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.15 49.93 9.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 30.8 p -136.82 142.71 42.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.192 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.76 157.8 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.9 mp -108.72 97.72 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.515 ' O ' HD22 ' A' ' 255' ' ' LEU . 20.9 m95 -51.31 -69.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -42.86 138.42 3.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.515 HD22 ' O ' ' A' ' 253' ' ' TRP . 2.2 mm? -102.63 -74.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -48.26 -23.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.547 ' O ' ' NE2' ' A' ' 258' ' ' GLN . 36.4 ttm180 -103.71 -39.49 6.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 4.0 pp0? 34.32 43.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.432 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 70.52 -119.91 8.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 6.8 mt -148.75 154.01 38.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -133.65 102.62 5.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 132.85 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.23 1.46 57.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.686 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -101.65 -71.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.063 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.62 -42.19 22.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.97 40.17 2.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.51 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.439 ' HE1' HG11 ' A' ' 277' ' ' VAL . 0.6 OUTLIER -102.37 149.96 23.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.541 HD22 HG21 ' A' ' 243' ' ' THR . 0.5 OUTLIER -117.86 123.22 45.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 234' ' ' PHE . 11.5 m -149.89 148.66 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -52.19 -174.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -79.33 -30.27 42.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.829 ' O ' HG22 ' A' ' 275' ' ' THR . 79.8 mtm180 -93.14 -36.41 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 75.8 m -64.51 -14.79 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.2 pt20 -71.01 -35.05 71.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.8 t -79.52 8.46 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.5 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 60.0 mttt -115.47 -14.19 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.943 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -77.03 170.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -67.29 156.1 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.09 30.93 3.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -129.35 93.0 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 18.3 t -90.17 112.05 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.33 -41.39 2.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.41 -27.63 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.7 p -163.17 165.36 24.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.89 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.3 m -153.94 -178.74 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 161.73 115.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.8 m -78.11 161.53 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.369 . . . . 0.0 110.889 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 85.3 p -122.41 94.67 4.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -104.62 166.56 15.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.29 99.51 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.319 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.525 HD12 ' C ' ' A' ' 228' ' ' ILE . 2.3 pp -133.25 161.65 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.442 ' HB3' HD23 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -40.84 102.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.18 142.73 87.58 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.557 0.694 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 173.19 11.33 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.375 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 97.0 m-70 -95.65 120.07 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 72.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.18 114.11 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.7 132.16 45.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.96 138.64 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -146.31 154.31 41.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -99.86 105.68 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.418 ' OH ' ' ND2' ' A' ' 268' ' ' ASN . 30.0 m-85 -90.79 137.3 32.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -95.76 29.8 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.2 p -170.28 150.62 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.627 0.727 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 100.53 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.297 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.508 ' O ' HD12 ' A' ' 252' ' ' LEU . 6.7 m -93.72 149.68 21.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -95.16 146.07 24.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 7.9 t -71.67 130.86 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.14 7.83 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 50.2 t60 -116.52 -69.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 p -80.05 -26.74 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.83 50.68 10.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 29.8 p -138.51 148.76 44.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 14.2 mt -44.7 168.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 243' ' ' THR . 13.8 mt -108.14 178.2 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -168.59 129.28 1.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 159.04 131.06 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.449 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.37 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.8 0.333 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -113.45 -33.59 5.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -84.99 68.51 10.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -73.55 78.49 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 65.67 -148.79 51.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 11.9 mt -148.8 131.14 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 0.1 OUTLIER -113.41 142.86 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.38 132.98 38.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -93.71 10.73 31.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -112.67 -71.39 0.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -82.06 -45.31 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.08 65.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.03 139.55 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -106.17 125.4 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 274' ' ' GLN . 29.3 m -144.17 146.78 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -51.58 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -35.95 66.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.826 ' O ' HG22 ' A' ' 275' ' ' THR . 9.5 mpt_? -93.95 -37.4 11.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.49 -21.08 14.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 3.3 pt20 -65.49 -40.88 93.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.826 HG22 ' O ' ' A' ' 272' ' ' ARG . 15.3 t -75.2 -3.61 34.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 43.7 mttp -97.43 -14.86 20.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -81.37 166.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -80.21 155.43 27.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -88.35 34.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 229' ' ' ASP . 8.2 mt -116.15 88.46 2.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.0 t -93.14 125.29 37.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.04 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 280' ' ' LEU . 50.7 mm -44.58 -25.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.8 p -159.58 154.41 24.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 t -149.42 152.81 36.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -127.31 -157.38 9.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.6 p -148.91 155.03 40.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.861 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.8 m -124.13 141.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -86.07 153.54 26.85 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 48.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 229' ' ' ASP . 1.2 pt -123.15 151.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 228' ' ' ILE . 13.9 p-10 -37.47 114.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.441 ' O ' ' C ' ' A' ' 279' ' ' ASN . 17.5 mtm -124.61 143.77 44.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.858 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 171.54 14.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.259 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -91.75 129.4 37.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.402 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 55.7 mtp85 -69.69 69.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 34.9 m-85 -68.83 143.42 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -162.59 121.07 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.41 142.93 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 16.5 t80 -147.24 154.95 41.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.415 ' CG ' ' O ' ' A' ' 238' ' ' ASN . 18.2 p-10 -91.95 96.9 10.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD2' ' OE1' ' A' ' 258' ' ' GLN . 0.1 OUTLIER -91.79 163.6 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 -27.29 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 239' ' ' TYR . 2.3 m -99.26 156.77 35.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.681 0.753 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 149.95 67.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.797 ' OG1' HD23 ' A' ' 252' ' ' LEU . 1.1 p -135.21 155.61 50.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -117.95 108.51 15.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 6.9 t -56.81 101.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.8 -6.09 19.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 31.4 t60 -82.67 -70.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 28.7 p -79.87 -36.36 36.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 106.86 20.5 8.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 73.0 p -131.94 139.94 48.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.28 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.797 HD23 ' OG1' ' A' ' 243' ' ' THR . 2.6 mm? -93.3 149.37 21.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -119.3 12.84 12.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.541 ' C ' HD22 ' A' ' 255' ' ' LEU . . . -79.68 -176.15 48.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.444 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.663 HD22 ' N ' ' A' ' 255' ' ' LEU . 1.4 mm? -108.41 -64.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.908 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.71 26.55 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.453 ' N ' ' HD3' ' A' ' 257' ' ' ARG . 0.2 OUTLIER -127.15 -30.61 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.575 ' OE1' ' CD2' ' A' ' 239' ' ' TYR . 5.8 pt20 35.84 38.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 271' ' ' HIS . . . 79.86 -107.16 2.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.458 ' CD1' ' CD ' ' A' ' 274' ' ' GLN . 44.8 mt -154.54 146.22 23.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.486 ' HE3' ' ND2' ' A' ' 268' ' ' ASN . 3.0 tppp? -125.45 117.38 23.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 4.3 t -64.45 134.87 55.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.09 -2.7 27.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -91.81 -34.36 14.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.5 p -126.43 -40.17 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.73 83.25 1.72 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.0 ttp -145.82 135.92 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.486 ' ND2' ' HE3' ' A' ' 261' ' ' LYS . 0.6 OUTLIER -99.27 127.53 45.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.52 156.03 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.169 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.512 ' CD2' ' CD1' ' A' ' 252' ' ' LEU . 16.5 m80 -58.77 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.442 ' CD2' ' HA2' ' A' ' 259' ' ' GLY . 20.7 m170 -74.95 -35.37 62.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 275' ' ' THR . 11.6 ptp180 -93.31 -38.71 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.7 m -52.66 -16.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.484 ' CG ' ' N ' ' A' ' 275' ' ' THR . 10.0 pt20 -68.91 -47.05 66.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 272' ' ' ARG . 2.0 t -73.01 1.96 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 44.6 mttm -102.56 -23.58 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.7 t -68.01 172.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.613 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -93.83 150.86 20.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.798 ' C ' HD22 ' A' ' 280' ' ' LEU . 25.8 m-80 -79.9 52.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.798 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.1 mm? -127.78 73.85 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.4 t -92.0 121.13 33.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 61.49 11.72 29.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.705 HG21 HD12 ' A' ' 280' ' ' LEU . 10.0 mm -72.66 -89.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ASN . . . . . 0.637 ' N ' HG22 ' A' ' 283' ' ' ILE . 2.1 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.0 t -155.48 130.71 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.908 0.385 . . . . 0.0 110.799 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.2 p -70.03 160.11 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.823 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -129.47 -146.74 6.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.5 m -148.44 120.94 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.5 m -154.44 174.24 15.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.95 179.18 29.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -115.91 113.6 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 9.7 mt -129.03 140.23 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -126.6 -175.02 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 42.4 mtm -122.97 142.26 37.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 173.18 11.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.361 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 69.8 m-70 -90.59 116.11 28.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 264' ' ' ALA . 23.0 mtp180 -63.63 74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 24.8 m-85 -84.64 140.7 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.93 120.07 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 257' ' ' ARG . 42.8 t -44.59 127.08 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.498 ' CE1' ' O ' ' A' ' 238' ' ' ASN . 42.6 t80 -145.38 141.43 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.498 ' O ' ' CE1' ' A' ' 237' ' ' TYR . 31.0 t-20 -86.97 122.2 30.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.586 ' CD1' ' C ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -126.28 179.38 5.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -130.81 -62.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 13.6 m -43.34 144.45 1.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.66 0.743 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.48 28.02 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 252' ' ' LEU . 4.3 t -136.35 153.54 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.23 140.86 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.85 143.71 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.63 9.1 38.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.631 ' CE1' ' HG2' ' A' ' 276' ' ' LYS . 5.5 t-80 -121.76 -67.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.0 p -75.45 -29.41 59.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 38.2 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.459 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.0 p -138.99 141.8 38.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 111.157 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 173.37 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.897 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -121.78 163.33 19.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -153.16 126.32 8.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -168.4 151.67 18.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.6 -65.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.92 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.77 -55.96 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.439 ' HA ' HG13 ' A' ' 236' ' ' VAL . 51.1 mtm180 -70.45 73.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 88.91 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 57.25 -147.71 34.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 259' ' ' GLY . 8.1 mt -147.09 119.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -100.17 110.65 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -55.42 130.52 42.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.5 1.6 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -98.21 -50.82 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.02 -35.62 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.37 73.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.0 ttp -145.25 135.5 24.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -95.11 115.83 27.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 277' ' ' VAL . 4.3 m -134.96 150.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.897 ' CD2' HD23 ' A' ' 252' ' ' LEU . 28.4 m80 -64.25 167.13 7.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -61.32 -26.9 68.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.415 ' HG3' ' NZ ' ' A' ' 276' ' ' LYS . 4.8 tpt180 -93.87 -63.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 277' ' ' VAL . 4.6 m -46.47 -20.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.542 ' CG ' ' N ' ' A' ' 275' ' ' THR . 4.3 pt20 -46.94 -50.66 18.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.9 OUTLIER -67.54 -41.42 84.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.631 ' HG2' ' CE1' ' A' ' 247' ' ' HIS . 0.7 OUTLIER -50.24 -26.21 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 269' ' ' VAL . 1.8 t -76.03 126.76 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.111 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.869 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -44.59 136.62 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.088 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -75.93 51.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.869 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 4.9 mp -125.37 78.63 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.94 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 6.9 t -88.69 142.57 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.55 -7.46 76.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 280' ' ' LEU . 3.9 mm -73.71 -28.87 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.4 m -106.59 176.29 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.6 m -152.6 178.03 10.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -71.21 121.08 8.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.2 p -76.47 149.09 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.89 179.9 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.54 -97.24 1.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -130.81 -175.65 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.67 76.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.082 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.92 140.25 51.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 35.4 mtm -128.58 143.76 49.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.608 0.718 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 164.24 35.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.571 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 86.0 m-70 -87.45 120.41 28.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.487 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 15.0 mmt85 -70.94 68.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 51.7 m-85 -71.59 138.1 48.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.49 128.71 18.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.09 127.15 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.81 148.87 32.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.553 ' CE2' ' CB ' ' A' ' 258' ' ' GLN . 7.1 p90 -113.23 120.79 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.468 ' N ' ' HE2' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -86.39 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 52.6 p -39.0 144.35 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.7 0.762 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 138.03 36.75 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.831 ' O ' HD23 ' A' ' 251' ' ' LEU . 2.8 t -145.83 146.9 31.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 251' ' ' LEU . 7.4 m-85 -106.02 132.61 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 250' ' ' THR . 7.5 t -63.35 103.85 0.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.74 -7.41 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 52.3 t60 -87.23 -70.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.86 -9.82 56.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 245' ' ' CYS . . . 85.21 -19.77 20.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -81.19 157.14 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 243' ' ' THR . 7.3 mt -76.83 -176.87 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.545 HD12 ' CZ ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -145.94 145.31 30.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -173.23 130.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -177.21 -134.32 1.98 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 258' ' ' GLN . 2.5 mm? -83.98 178.07 8.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . . . -37.61 -34.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -86.65 36.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.553 ' CB ' ' CE2' ' A' ' 239' ' ' TYR . 73.4 mt-30 -41.28 -74.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.72 -162.9 10.83 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 26.5 mt -131.72 126.36 34.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -106.59 114.37 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 3.7 t -62.45 125.78 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.61 18.13 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.22 -40.52 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -119.78 -44.95 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 108.4 78.82 1.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.2 ttp -146.17 141.17 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -106.03 122.59 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.6 m -142.4 154.95 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 251' ' ' LEU . 13.7 m80 -51.64 179.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -69.13 -36.5 77.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.654 ' O ' HG22 ' A' ' 275' ' ' THR . 27.4 mtt-85 -93.89 -49.13 5.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 277' ' ' VAL . 61.3 m -39.29 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 275' ' ' THR . 12.6 pt20 -52.46 -49.77 63.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 272' ' ' ARG . 0.7 OUTLIER -70.55 -37.35 74.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.604 ' CE ' HG23 ' A' ' 275' ' ' THR . 0.4 OUTLIER -54.82 -31.82 59.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 273' ' ' CYS . 2.2 t -65.31 172.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -94.28 155.61 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 280' ' ' LEU . 5.8 m-20 -79.22 52.84 1.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 280' ' ' LEU . 4.2 mm? -123.02 78.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 13.1 t -89.16 116.52 27.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.46 -30.14 11.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 283' ' ' ILE . 4.4 mp -83.45 -77.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.847 0.356 . . . . 0.0 111.103 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 62.1 p -144.19 -175.47 4.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.4 t -130.1 132.96 46.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -103.29 110.2 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 31.8 m -85.69 110.8 19.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.849 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 226' ' ' GLY . 13.2 t -114.62 178.75 4.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . 0.424 ' N ' ' OG ' ' A' ' 225' ' ' SER . . . 167.1 -145.35 9.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -104.45 160.23 15.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 110.947 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 8.1 mt -144.24 117.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.105 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.42 148.98 51.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 230' ' ' MET . 4.7 mpp? -125.29 143.61 44.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.64 ' HB3' HD22 ' A' ' 279' ' ' ASN . 52.9 Cg_endo -69.82 173.19 11.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 82.6 m-70 -95.7 122.89 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' A' ' 264' ' ' ALA . 59.4 mtt180 -71.23 67.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 34.5 m-85 -80.28 124.34 28.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -126.77 121.44 31.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 257' ' ' ARG . 2.3 t -51.21 113.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 14.5 t80 -120.87 159.24 25.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.541 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.5 t30 -118.37 97.3 5.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.43 167.32 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.432 ' CD ' ' C ' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.41 -52.26 2.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 21.7 m -39.09 153.23 0.18 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.65 13.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.613 ' HB ' HD12 ' A' ' 252' ' ' LEU . 2.7 m -130.51 108.53 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -89.87 141.68 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.66 112.69 11.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -76.96 3.32 12.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t60 -97.65 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.3 p -82.56 -18.4 41.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.81 -12.68 68.79 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.4 159.88 19.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.5 OUTLIER -82.85 134.89 35.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 1.09 ' N ' HD12 ' A' ' 251' ' ' LEU . 29.8 mt -46.24 172.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -173.74 133.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.7 43.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.5 mp -90.67 -74.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -121.11 -31.06 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.489 ' HB2' HG13 ' A' ' 236' ' ' VAL . 14.0 ptt180 -89.93 29.66 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 257' ' ' ARG . 30.6 mt-30 -36.48 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 42.14 -150.96 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 271' ' ' HIS . 17.2 mt -147.46 148.01 30.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.48 ' HD3' ' ND2' ' A' ' 268' ' ' ASN . 12.7 tptm -122.97 117.03 24.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 1.8 t -65.06 128.47 35.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -93.1 -3.14 54.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.703 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -93.93 -60.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.2 p -96.03 -34.86 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.57 73.26 1.19 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.5 ttp -143.81 130.17 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -94.23 128.22 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 22.8 m -152.53 152.49 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 252' ' ' LEU . 14.1 m80 -48.56 172.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 2.2 t60 -69.05 -32.31 71.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -94.14 -47.17 6.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 276' ' ' LYS . 63.6 m -44.72 -31.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.56 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 9.8 pt20 -51.6 -50.4 60.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.535 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 11.9 p -66.88 -10.44 48.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -85.92 -29.82 23.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.27 150.11 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.47 143.68 52.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.64 HD22 ' HB3' ' A' ' 231' ' ' PRO . 4.9 t-20 -78.82 54.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 11.7 mt -129.63 82.55 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 11.0 t -92.56 128.44 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.47 -10.96 60.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.7 mt -90.66 -79.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.85 45.08 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.1 p -67.82 155.33 39.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -149.6 -170.95 17.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 14.8 m -126.88 -176.35 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.844 0.354 . . . . 0.0 110.879 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.0 t -153.08 142.68 21.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 165.33 -161.23 34.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -141.28 161.22 38.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pt -122.4 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.143 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.68 109.8 21.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 7.8 mtt -103.07 97.03 8.86 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.595 0.712 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.6 Cg_endo -69.75 165.1 32.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 0.0 112.345 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.5 115.59 20.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.16 63.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 38.4 m-85 -59.52 152.18 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.403 ' NZ ' ' HA ' ' A' ' 235' ' ' LYS . 0.0 OUTLIER -148.19 118.43 7.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -46.49 126.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.63 148.81 39.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.44 134.25 34.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.84 115.71 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -86.39 -12.19 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.52 152.42 46.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 108.61 2.14 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.537 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.3 m -104.55 147.26 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -103.52 129.42 50.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.61 124.99 23.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -78.25 8.99 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -117.8 -72.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.1 p -75.51 -25.93 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.95 43.09 18.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.9 p -139.73 159.16 42.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 243' ' ' THR . 29.2 mt -74.03 175.94 6.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.576 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -132.17 113.37 13.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -100.38 151.97 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 139.45 -9.72 3.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 19.6 mt 40.32 31.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -167.92 145.8 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 45.22 26.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -42.03 104.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 40.4 -149.83 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.428 HD21 ' CE1' ' A' ' 271' ' ' HIS . 0.5 OUTLIER -142.37 170.58 15.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -137.58 131.68 32.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.0 t -75.7 140.55 42.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -97.56 6.28 48.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.62 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -107.42 -60.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.89 -44.42 9.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.24 52.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 21.4 ttp -115.39 163.74 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -124.47 128.39 48.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.69 150.98 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.576 ' CD2' HD23 ' A' ' 252' ' ' LEU . 14.1 m80 -51.28 -175.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.428 ' CE1' HD21 ' A' ' 260' ' ' LEU . 41.1 m-70 -76.54 -35.67 58.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -93.94 -38.45 11.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 46.2 m -50.07 -19.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.488 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 7.6 pt20 -71.15 -36.9 72.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.4 p -77.81 2.78 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.157 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -109.74 -8.82 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.03 175.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -89.18 159.93 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.13 48.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.34 84.34 2.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.7 t -94.01 114.15 26.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.8 -5.58 38.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.25 -23.22 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -150.09 142.68 24.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -160.68 178.34 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.34 172.76 37.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.9 t -107.46 76.48 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.9 p -103.62 76.33 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -126.77 -138.36 4.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 133.65 55.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.19 134.62 44.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -148.32 172.65 14.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 1.6 mpt? -125.67 97.01 37.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.532 0.682 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.79 139.71 40.79 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.65 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 99.3 m-70 -55.75 116.68 3.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -74.35 67.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 62.3 m-85 -59.28 146.0 41.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -153.65 137.2 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 ' HD2' ' A' ' 257' ' ' ARG . 42.1 t -59.31 119.52 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -136.07 161.28 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.08 147.83 24.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.23 153.45 33.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -8.35 8.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.8 m -133.21 160.08 70.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.752 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 118.85 5.93 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -127.37 147.24 50.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.61 134.42 50.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -48.87 144.38 4.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.29 8.83 25.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -127.98 -68.13 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.88 -16.94 59.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 59.57 52.94 50.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.1 p -139.97 150.55 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.108 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.6 mp -56.56 167.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.546 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.7 mm? -96.76 -178.84 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -158.66 145.4 17.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.44 -164.79 19.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.4 mt -116.79 -70.42 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.92 -64.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HD2' HG21 ' A' ' 236' ' ' VAL . 6.3 ttp-105 -83.48 69.39 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.421 ' O ' ' NE2' ' A' ' 271' ' ' HIS . 35.2 mt-30 -78.48 -53.5 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.91 -148.24 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.09 154.15 48.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 111.96 12.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.37 124.38 15.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.33 7.43 32.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -103.04 -47.81 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.9 p -113.59 -45.18 3.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.59 60.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -124.39 124.8 43.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -88.62 118.58 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 35.2 m -139.88 146.32 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.546 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.8 m80 -50.93 -178.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 258' ' ' GLN . 64.2 m-70 -75.75 -38.82 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -88.19 -43.51 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.1 m -50.25 -24.11 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 12.2 pt20 -61.15 -33.73 73.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 43.2 p -78.98 11.16 2.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -33.08 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 277' ' ' VAL . 1.8 t -63.82 156.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.471 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -77.08 150.08 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.46 ' C ' HD22 ' A' ' 280' ' ' LEU . 4.4 m-20 -86.64 30.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -103.34 67.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.2 t -92.76 106.42 18.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.52 -27.24 6.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.33 -26.56 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m -119.38 143.09 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 110.84 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.6 t -165.53 156.46 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 146.41 -148.6 20.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 36.6 t -135.76 149.28 49.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 m -79.47 121.96 25.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 168.02 -52.26 0.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -155.31 118.71 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 50.4 mt -98.07 142.85 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.66 129.99 14.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 22.1 mmt -126.32 97.04 35.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.834 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.9 Cg_endo -69.79 158.47 56.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.297 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.45 116.08 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.28 62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 269' ' ' VAL . 31.1 m-85 -61.01 136.11 57.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -138.48 123.85 19.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.474 ' HA ' HD23 ' A' ' 260' ' ' LEU . 3.2 t -51.93 127.9 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.82 162.93 38.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.564 ' ND2' ' HB1' ' A' ' 256' ' ' ALA . 2.4 m120 -87.39 113.39 23.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -63.33 153.02 36.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -134.82 10.08 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 4.1 m -167.64 154.26 7.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.64 0.733 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 122.92 9.6 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.36 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.611 ' OG1' HD21 ' A' ' 252' ' ' LEU . 1.0 OUTLIER -118.57 163.55 16.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.36 104.06 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.69 128.91 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -86.57 8.67 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 73.5 t60 -113.75 -71.22 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.5 p -75.45 -35.96 60.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.65 42.7 6.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 35.1 p -139.47 159.51 42.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.6 mp -63.9 -179.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.611 HD21 ' OG1' ' A' ' 243' ' ' THR . 1.7 pt? -171.04 124.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -172.46 153.02 2.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 161.73 -117.91 0.79 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.484 ' N ' ' HG3' ' A' ' 258' ' ' GLN . 2.7 mm? -68.14 160.2 29.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.564 ' HB1' ' ND2' ' A' ' 238' ' ' ASN . . . -50.85 -50.08 57.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.61 47.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 255' ' ' LEU . 23.2 mm-40 -99.88 146.47 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 51.7 179.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 236' ' ' VAL . 34.4 mt -142.96 152.81 42.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.6 117.36 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.95 141.16 28.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.09 7.73 41.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -110.74 -68.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 24.1 p -84.0 -46.05 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.57 61.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.9 ttp -122.86 145.74 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -111.41 123.48 50.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.528 HG22 ' CE1' ' A' ' 234' ' ' PHE . 12.1 m -146.18 165.6 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -64.52 -178.71 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -75.3 -38.42 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.732 ' O ' HG22 ' A' ' 275' ' ' THR . 13.5 mtm-85 -89.2 -39.9 13.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.4 m -54.93 -21.2 10.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.485 ' CG ' ' N ' ' A' ' 275' ' ' THR . 11.3 pt20 -64.68 -47.81 77.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.9 t -70.32 -0.69 8.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 61.8 mttt -101.52 -26.94 13.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 273' ' ' CYS . 3.2 t -69.08 148.79 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.55 153.28 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.09 53.58 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 66.1 mt -121.74 73.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.7 t -83.32 112.23 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.27 23.54 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 283' ' ' ILE . 19.7 mm -70.44 -24.43 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.927 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.9 p -118.4 165.42 13.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.7 p -87.33 159.81 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -163.17 120.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 109.55 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.2 m -94.72 85.81 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -151.57 -172.73 20.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.502 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.96 136.94 36.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.4 pt -106.87 165.63 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -162.66 114.32 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 28.1 mtm -103.47 96.99 9.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 157.28 61.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.619 2.213 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.23 121.66 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -76.01 52.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.408 ' HB3' ' CB ' ' A' ' 260' ' ' LEU . 23.7 m-85 -51.75 132.33 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -139.03 134.27 32.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.29 125.47 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 7.0 t80 -142.1 140.67 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.403 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 7.8 p-10 -101.46 111.24 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 158.9 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -94.51 -58.06 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.1 p -44.22 151.08 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 116.21 4.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.1 m -116.2 132.27 56.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -110.21 153.24 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.3 t -71.15 137.07 48.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.52 9.19 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -120.93 -68.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.3 p -77.67 -14.34 59.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.05 52.67 49.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.496 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 10.6 p -138.06 157.72 45.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.96 166.6 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.508 ' C ' ' CE3' ' A' ' 253' ' ' TRP . 3.2 mt -113.59 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.508 ' CE3' ' C ' ' A' ' 252' ' ' LEU . 6.6 m-90 -151.14 -175.89 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 98.1 172.06 32.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 255' ' ' LEU . 7.2 tt -111.68 -51.27 2.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -105.15 -64.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -75.69 70.69 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -93.28 99.13 11.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 50.35 -165.41 0.6 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.501 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.408 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 8.6 mt -126.6 163.14 24.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.372 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -139.37 123.6 18.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.6 t -62.43 131.76 50.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.41 15.87 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.521 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.88 -66.61 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -88.52 -47.02 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 111.67 65.16 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.9 ttp -125.97 152.95 45.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -117.3 115.18 24.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 20.7 m -136.03 159.61 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.466 ' NE2' HD23 ' A' ' 252' ' ' LEU . 11.1 m80 -65.87 -175.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -76.09 -39.29 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -89.82 -47.06 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 86.4 m -44.91 -25.04 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.427 ' CG ' ' N ' ' A' ' 275' ' ' THR . 15.3 pt20 -57.45 -44.88 85.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 27.5 p -64.5 -6.94 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -94.7 -30.89 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.9 126.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -47.84 173.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -99.9 46.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 53.9 mt -124.88 93.37 3.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.4 t -93.82 115.07 27.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.64 -29.15 3.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.5 mt -75.7 -28.56 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.64 129.55 1.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.9 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.7 t -109.03 89.89 3.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -65.34 138.63 38.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.468 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.0 t -78.42 145.41 35.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 110.87 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.3 p -160.64 125.73 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.803 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -137.74 124.25 2.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -72.56 142.45 48.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.92 144.11 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -120.07 133.87 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 12.1 mtm -107.52 97.03 17.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.528 0.68 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 127.05 13.98 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.233 . . . . 0.0 112.348 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -48.37 115.59 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -74.62 61.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.545 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 43.4 m-85 -52.68 139.87 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 127.23 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.443 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 54.0 t -54.94 124.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -134.27 138.56 45.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -100.39 97.66 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 258' ' ' GLN . 2.1 p90 -125.04 120.45 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -83.15 67.89 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.8 m -142.07 145.14 34.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.707 0.765 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 77.87 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.681 ' O ' HD13 ' A' ' 252' ' ' LEU . 18.6 m -95.09 142.55 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -111.5 128.34 55.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 9.4 t -46.92 139.77 5.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.61 3.15 56.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.447 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 53.8 t-80 -110.94 -73.02 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.66 -31.33 59.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 53.1 6.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.41 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 251' ' ' LEU . 55.3 p -137.03 131.85 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 252' ' ' LEU . 1.0 OUTLIER -34.58 126.16 0.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 243' ' ' THR . 9.9 mp -67.46 135.41 53.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.449 ' C ' ' O ' ' A' ' 252' ' ' LEU . 70.4 m95 -34.64 -74.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 118.96 56.43 0.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 258' ' ' GLN . 4.6 mp -129.69 165.97 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.66 -25.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.504 ' CD ' ' NE2' ' A' ' 271' ' ' HIS . 13.3 ttp180 -100.49 34.81 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 239' ' ' TYR . 6.6 mm-40 -36.04 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 34.8 -148.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.6 141.87 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.26 104.84 10.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -47.99 118.55 2.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.79 4.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.9 -74.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.088 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.2 p -80.7 -46.0 16.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.6 ttp -104.88 145.17 30.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -106.08 116.14 31.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.545 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 2.6 m -139.55 149.67 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -54.92 -174.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.504 ' NE2' ' CD ' ' A' ' 257' ' ' ARG . 1.5 m-70 -82.1 -34.24 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -94.0 -25.61 17.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.0 m -71.69 -25.98 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 2.8 pt20 -63.23 -38.45 91.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -74.68 -5.34 42.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.447 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 41.4 mttm -98.5 -10.48 23.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.6 t -83.42 165.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.418 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -88.32 156.14 19.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.554 ' O ' HD23 ' A' ' 280' ' ' LEU . 23.4 p30 -84.89 56.66 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 279' ' ' ASN . 56.2 mt -131.19 81.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 111.31 22.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.11 -26.27 21.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.523 HG13 HD22 ' A' ' 280' ' ' LEU . 6.6 mm -45.81 -28.33 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.117 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.1 t -148.4 161.99 40.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.0 t -68.17 122.96 19.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -127.63 88.61 0.33 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.516 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.2 m -149.26 131.37 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.1 t -157.14 148.53 22.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 148.67 121.17 1.14 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.514 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -103.21 143.91 32.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.658 ' H ' HD12 ' A' ' 228' ' ' ILE . 1.1 mp -101.58 131.11 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.72 -179.16 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 97.01 44.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.49 18.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.699 2.266 . . . . 0.0 112.373 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -85.69 118.17 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -78.97 59.38 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 39.5 m-85 -55.99 126.24 25.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt -131.54 133.7 45.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.535 ' CG1' ' NE ' ' A' ' 257' ' ' ARG . 2.2 t -51.58 134.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -144.27 157.09 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -85.15 109.5 18.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -49.17 130.81 19.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.02 11.62 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.944 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 32.5 m -167.73 149.29 5.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 78.82 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' ' 268' ' ' ASN . 1.2 m -98.33 143.68 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.532 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 5.4 m-85 -102.24 151.34 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 4.3 t -61.56 137.81 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.91 -3.45 54.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 81.4 t60 -101.56 -70.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.0 p -77.2 -19.38 56.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.2 43.59 63.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.45 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.1 p -140.0 150.68 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 244' ' ' PHE . 15.8 mt -62.18 154.55 26.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -124.68 54.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -39.12 94.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 252' ' ' LEU . . . -177.36 140.4 4.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 3.9 mt -135.04 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 255' ' ' LEU . . . 71.81 47.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 236' ' ' VAL . 4.7 mmm180 74.89 50.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -102.57 -4.35 25.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -140.18 -164.49 9.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.437 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.85 158.7 43.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.12 114.56 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 10.3 t -58.57 119.1 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -83.76 2.39 38.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.465 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -95.3 -57.57 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.3 p -104.35 -34.61 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.0 73.87 1.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.446 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.0 ttp -138.44 140.56 39.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.435 ' HB2' HG21 ' A' ' 243' ' ' THR . 0.5 OUTLIER -105.33 122.35 45.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.81 164.85 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.858 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.8 m80 -60.07 177.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.37 -32.04 64.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -93.96 -46.89 6.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.557 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.5 m -45.84 -24.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.575 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 11.6 pt20 -60.11 -47.88 84.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 1.6 p -70.09 -13.23 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.585 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 26.0 mtpp -85.44 -33.96 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.9 t -62.12 142.4 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.51 173.65 6.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.42 50.67 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.56 73.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.3 t -93.77 116.08 28.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.14 -4.89 85.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 283' ' ' ILE . 10.4 mm -58.25 -20.51 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.349 . . . . 0.0 111.108 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.4 p -119.82 179.1 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 63.0 p -140.44 173.94 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.825 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.4 22.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.0 m -132.42 137.69 47.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 35.6 p -143.04 120.05 11.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -135.21 148.09 19.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.81 123.6 28.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.766 0.317 . . . . 0.0 110.931 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.9 pt -69.41 179.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.19 115.27 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.404 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 37.8 mtp -107.79 97.05 18.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 153.45 69.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.358 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.5 m-70 -66.09 116.19 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.406 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 73.1 mtt85 -73.46 64.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 35.3 m-85 -67.89 125.85 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -127.18 139.61 52.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 260' ' ' LEU . 91.4 t -60.63 132.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -148.49 154.75 40.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.29 128.42 34.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 258' ' ' GLN . 55.5 m-85 -107.09 116.85 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -92.45 26.01 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.2 m -170.69 156.38 5.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 139.2 39.73 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.405 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.492 ' OG1' HD12 ' A' ' 252' ' ' LEU . 4.7 p -139.14 159.64 41.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -106.37 144.75 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.5 t -76.0 121.49 22.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.38 5.79 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.598 ' CD2' HG22 ' A' ' 277' ' ' VAL . 21.5 t-80 -110.03 -73.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.1 p -75.56 -33.88 60.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 43.29 5.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 251' ' ' LEU . 43.0 p -139.99 138.13 35.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.788 0.327 . . . . 0.0 111.164 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 250' ' ' THR . 10.0 mt -34.78 146.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 270' ' ' HIS . 70.1 mt -94.01 121.42 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -102.63 148.6 25.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 147.49 157.32 7.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.87 -69.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.6 -41.66 4.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 259' ' ' GLY . 0.2 OUTLIER -80.07 12.36 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.466 ' O ' ' CE1' ' A' ' 239' ' ' TYR . 22.7 tt0 -37.84 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 59.16 -171.7 4.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 236' ' ' VAL . 8.7 mt -130.78 160.98 32.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -122.32 126.49 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 266' ' ' GLY . 11.5 t -77.27 104.38 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.45 -5.71 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.14 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.97 -29.5 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 262' ' ' CYS . . . 91.23 83.88 1.43 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 11.5 ttp -144.45 130.05 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.14 119.13 30.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.78 154.67 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 252' ' ' LEU . 23.0 m80 -59.04 -175.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -75.43 -32.59 60.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -92.91 -41.44 10.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 277' ' ' VAL . 78.4 m -57.06 -12.58 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -63.79 -41.03 98.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.949 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 11.77 37.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.576 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 34.2 mtmt -100.85 -24.93 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -73.69 -179.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -83.69 150.0 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -84.78 27.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.9 79.48 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.88 129.31 34.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.38 -21.82 19.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 36.7 mm -61.44 -28.19 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.2 t -171.94 161.47 5.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.875 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.0 m -112.37 104.06 12.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.39 39.2 3.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.545 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.7 t -64.86 125.33 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.2 m -140.79 159.34 42.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.834 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.75 174.1 15.05 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.458 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -100.01 153.51 19.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -114.47 106.47 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.07 126.32 8.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.43 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 32.9 mtm -116.15 97.09 48.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.553 0.692 . . . . 0.0 110.856 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 127.51 14.71 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 97.2 m-70 -44.86 117.78 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -72.99 65.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 43.1 m-85 -60.87 139.81 57.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -143.54 132.87 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.506 HG11 ' HD2' ' A' ' 257' ' ' ARG . 19.6 t -60.38 122.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.6 163.96 33.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.12 128.32 36.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -80.15 123.73 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -102.64 -5.62 23.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.959 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 65.1 m -142.83 153.3 60.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 88.57 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.259 . . . . 0.0 112.371 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 244' ' ' PHE . 15.5 m -93.88 161.47 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.5 ' N ' HG22 ' A' ' 243' ' ' THR . 39.8 m-85 -122.91 124.42 43.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.46 146.81 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.23 -0.66 57.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -115.94 -67.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 14.6 p -78.18 -15.95 58.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 54.04 62.6 5.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 38.1 p -139.43 179.41 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.3 OUTLIER -94.57 113.13 24.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.917 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -88.71 112.08 22.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -45.6 141.24 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -111.54 47.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.6 -64.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -172.8 144.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.506 ' HD2' HG11 ' A' ' 236' ' ' VAL . 12.5 mmt85 44.7 50.25 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -116.45 147.09 42.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 47.59 -170.41 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 3.0 mt -146.46 161.17 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -126.87 138.76 53.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.2 t -86.72 122.76 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.59 8.74 18.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -106.54 -67.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.5 p -88.58 -44.69 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 115.22 22.87 4.72 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.1 ttp -86.97 156.34 19.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -130.33 115.59 17.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 274' ' ' GLN . 6.2 m -131.27 166.08 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.917 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.4 m80 -70.12 -176.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -37.43 12.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.21 -25.1 65.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.582 ' HA ' HG21 ' A' ' 269' ' ' VAL . 13.4 pt20 -60.87 -43.33 98.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 7.6 p -69.82 -6.63 33.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.439 ' HA ' ' CE ' ' A' ' 276' ' ' LYS . 1.4 mmpt? -96.09 -13.07 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.84 158.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.558 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -79.75 141.62 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.453 ' C ' HD22 ' A' ' 280' ' ' LEU . 9.7 p30 -80.06 52.08 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.558 HD23 ' HB1' ' A' ' 278' ' ' ALA . 2.8 mm? -127.75 70.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 52.9 t -90.7 155.96 18.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 60.68 18.19 51.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.2 mm -101.57 -25.41 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.7 m -136.8 136.88 39.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.857 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.5 m -106.91 136.07 47.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 169.21 61.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -151.17 131.04 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.84 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 89.9 p -55.48 117.05 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.8 -82.17 1.32 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.54 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -123.74 107.45 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.82 120.09 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -162.09 137.53 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 283' ' ' ILE . 3.9 ptp -126.69 97.0 34.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.0 Cg_endo -69.75 163.58 37.73 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.324 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 95.0 m-70 -86.66 115.4 24.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.468 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 26.5 mtt-85 -72.23 66.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.752 ' CE1' HG22 ' A' ' 269' ' ' VAL . 53.9 m-85 -62.28 149.9 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 234' ' ' PHE . 68.3 mttt -158.61 137.97 11.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.48 137.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -148.23 146.52 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -97.94 96.86 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.28 141.86 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 94.96 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.1 t -176.1 146.71 0.81 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.648 0.737 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 87.04 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.711 2.274 . . . . 0.0 112.377 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 m -106.71 138.21 43.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 244' ' ' PHE . 4.5 m-85 -106.36 140.21 39.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.1 t -56.56 129.55 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -86.93 5.8 35.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.615 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t-80 -110.64 -70.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.61 -33.11 60.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.1 39.31 6.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 28.4 p -138.08 150.13 46.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' CZ2' ' A' ' 253' ' ' TRP . 16.8 mt -64.33 175.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 253' ' ' TRP . 1.7 pt? -155.39 152.1 28.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -154.8 158.54 39.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 155.78 -172.05 33.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.37 179.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.851 0.358 . . . . 0.0 110.869 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -70.39 69.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 259' ' ' GLY . 8.0 mm100 -85.13 114.97 22.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 34.96 -146.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 3.0 mt -147.35 131.01 16.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -102.08 118.26 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 8.4 t -64.59 104.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -57.87 -18.68 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -76.29 -73.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.08 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.1 p -86.19 -42.05 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.0 60.76 0.75 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 9.4 ttp -125.33 119.86 29.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -90.09 120.19 31.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.752 HG22 ' CE1' ' A' ' 234' ' ' PHE . 31.6 m -137.53 179.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -70.32 165.2 22.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -62.46 -31.77 72.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -91.81 -47.75 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.553 ' O ' HG23 ' A' ' 277' ' ' VAL . 84.4 m -50.71 -32.18 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.674 ' NE2' HG23 ' A' ' 275' ' ' THR . 0.9 OUTLIER -53.12 -37.44 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.674 HG23 ' NE2' ' A' ' 274' ' ' GLN . 2.2 p -85.77 -11.83 52.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.615 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -87.03 -23.36 25.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.2 t -70.47 143.3 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.754 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -50.09 150.49 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -83.22 41.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 2.8 mp -127.94 104.63 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.4 t -93.65 140.77 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.85 -33.94 3.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.451 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 280' ' ' LEU . 3.8 mp -63.79 -17.63 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.5 t -83.26 -72.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.82 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.6 t -145.7 145.88 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.93 124.32 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.6 p -86.46 107.96 18.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 73.5 m -60.73 131.19 49.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -69.24 148.96 48.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.504 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -73.84 94.77 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 7.9 pt -115.82 164.75 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -140.24 130.48 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.423 ' C ' ' OD1' ' A' ' 279' ' ' ASN . 55.3 mtm -107.16 96.99 16.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.555 0.693 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.437 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.74 164.65 33.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.8 m-70 -78.24 121.04 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -73.95 64.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 30.8 m-85 -63.79 131.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -141.74 130.86 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -45.82 132.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 238' ' ' ASN . 82.1 t80 -148.22 161.04 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.591 ' O ' ' CE2' ' A' ' 237' ' ' TYR . 0.6 OUTLIER -92.12 144.76 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -106.35 133.76 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.57 4.49 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 35.3 m -139.36 154.55 71.92 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.687 0.756 . . . . 0.0 110.818 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 251' ' ' LEU . 53.8 m -113.76 149.97 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.94 128.61 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.35 140.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.01 9.05 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 71.1 t60 -123.56 -66.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.7 p -78.87 -17.42 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.31 48.06 78.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.3 p -137.71 152.65 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.594 ' O ' ' CZ3' ' A' ' 253' ' ' TRP . 11.4 mt -64.73 159.66 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.578 HD13 ' NE2' ' A' ' 270' ' ' HIS . 3.5 mm? -87.46 174.37 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' TRP . . . . . 0.594 ' CZ3' ' O ' ' A' ' 251' ' ' LEU . 2.8 p90 -173.52 129.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' GLY . . . . . 0.889 ' C ' HD23 ' A' ' 255' ' ' LEU . . . 151.07 -124.98 1.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.536 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -135.35 179.76 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 238' ' ' ASN . . . -39.08 -35.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -93.56 57.61 2.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 253' ' ' TRP . 30.2 tp60 -113.74 157.21 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 260' ' ' LEU . . . 41.05 -159.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.467 HD23 ' O ' ' A' ' 259' ' ' GLY . 18.2 mt -153.98 161.34 42.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.22 139.53 51.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 5.5 t -91.88 114.75 27.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -78.19 7.03 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.4 -65.1 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.6 p -93.69 -40.4 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.81 33.85 3.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 17.0 ttp -106.52 119.04 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -87.56 139.95 30.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.34 164.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.578 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.0 m80 -67.54 -176.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.22 -36.57 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.778 ' O ' HG22 ' A' ' 275' ' ' THR . 0.0 OUTLIER -94.07 -42.05 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 67.9 m -48.71 -22.37 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.553 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 10.1 pt20 -64.01 -41.08 97.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 272' ' ' ARG . 10.6 t -74.46 -6.03 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 35.4 mttt -95.21 -12.41 26.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.5 171.27 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.55 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -92.9 171.73 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.649 ' C ' HD22 ' A' ' 280' ' ' LEU . 35.2 t-20 -104.12 50.95 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.649 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.0 mm? -128.12 59.43 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.45 128.93 34.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.77 -17.86 50.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.69 -28.23 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 28.7 p30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.2 m -166.11 147.06 6.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.8 t -121.67 132.24 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 148.8 117.52 0.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.6 t -110.17 117.59 34.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.806 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.6 p -60.55 167.84 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -150.55 -168.27 15.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.54 109.36 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.37 124.23 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -151.79 159.67 43.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.413 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 11.0 mmt -112.78 97.04 39.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.1 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.693 2.262 . . . . 0.0 112.344 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -83.44 115.74 22.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 233' ' ' ARG . 14.3 mtp-105 -74.72 62.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 36.9 m-85 -60.58 135.84 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -141.49 132.45 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.3 129.67 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.61 115.6 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.411 ' OD1' ' C ' ' A' ' 238' ' ' ASN . 36.0 t-20 -88.61 108.27 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -126.93 173.62 9.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' SER . 0.3 OUTLIER -109.81 -53.16 2.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' LYS . 84.5 p -36.34 150.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 116.56 4.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.421 HG21 ' CB ' ' A' ' 268' ' ' ASN . 3.8 m -121.32 141.79 50.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -119.85 145.01 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.78 125.03 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.8 9.25 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 84.5 t60 -119.13 -73.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 250' ' ' THR . 15.3 p -75.48 -22.82 56.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 66.76 46.19 77.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' THR . . . . . 0.462 HG23 ' SG ' ' A' ' 248' ' ' CYS . 5.8 p -133.23 153.72 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.135 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 251' ' ' LEU . 13.0 mt -65.21 160.72 20.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 0.537 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.8 mm? -87.47 179.53 6.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -141.15 151.44 43.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 92.69 -156.57 23.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 255' ' ' LEU . 5.4 mp -125.75 -70.09 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -88.02 -178.0 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.466 ' N ' ' HD3' ' A' ' 257' ' ' ARG . 4.7 mpt_? 44.88 26.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -54.2 108.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 37.95 -151.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.82 170.46 15.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -142.84 128.29 18.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.4 t -72.06 114.36 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.88 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -83.86 -71.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 26.7 p -86.39 -46.5 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.88 60.37 0.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 10.5 ttp -118.83 146.85 44.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.338 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.421 ' CB ' HG21 ' A' ' 243' ' ' THR . 0.9 OUTLIER -106.96 122.33 46.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 15.3 m -143.19 179.89 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 0.537 ' NE2' HD13 ' A' ' 252' ' ' LEU . 11.1 m80 -86.24 -176.01 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.402 ' O ' ' NE2' ' A' ' 274' ' ' GLN . 67.8 m-70 -77.55 -35.28 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -94.09 -38.53 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 95.0 m -55.61 -27.32 48.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 24.6 pt20 -61.53 -35.16 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 31.8 p -80.01 7.04 9.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 49.8 mttt -114.31 -8.19 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -84.09 174.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.651 ' HB1' HD12 ' A' ' 280' ' ' LEU . . . -84.57 -178.64 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.09 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -117.57 30.88 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.651 HD12 ' HB1' ' A' ' 278' ' ' ALA . 3.9 mp -106.83 65.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 44.5 t -83.6 122.84 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.58 -38.34 3.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.53 -19.65 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -110.33 153.4 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.846 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 28.0 m -144.62 123.69 12.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -145.52 175.97 24.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 38.9 m -78.84 140.43 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.904 0.383 . . . . 0.0 110.851 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 61.7 m -63.42 171.35 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -125.52 155.8 19.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -70.25 122.9 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.5 pt -122.45 72.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.66 140.99 52.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.435 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -111.52 97.08 35.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.56 0.695 . . . . 0.0 110.847 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.8 153.51 68.65 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.335 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 99.0 m-70 -70.05 116.94 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -70.96 70.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 232' ' ' HIS . 51.0 m-85 -62.21 139.16 58.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -146.2 135.13 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' HD23 ' A' ' 260' ' ' LEU . 2.5 t -52.67 126.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.85 145.19 28.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -85.2 108.45 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -79.62 82.13 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.14 -33.29 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.4 149.75 41.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.94 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' THR . . . . . 0.447 HG21 ' OD1' ' A' ' 268' ' ' ASN . 93.7 m -115.58 126.26 53.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' PHE . . . . . 0.63 ' CE2' HD11 ' A' ' 251' ' ' LEU . 37.8 m-85 -70.04 122.31 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 12.9 t -47.93 124.7 7.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.95 7.29 7.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' HIS . . . . . 0.517 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 28.5 t-80 -110.89 -70.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.09 -15.41 53.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 -20.09 28.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.13 152.51 29.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.139 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.63 HD11 ' CE2' ' A' ' 244' ' ' PHE . 6.4 mt -76.44 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' LEU . . . . . 1.091 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -136.57 160.83 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -143.68 155.53 44.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 157.6 -177.71 34.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.41 -40.02 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 0.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' ARG . . . -144.51 159.24 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ARG . . . . . 0.531 ' CB ' HG13 ' A' ' 236' ' ' VAL . 24.9 ptt180 36.15 44.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -54.45 -39.66 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.82 -168.07 13.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 236' ' ' VAL . 4.8 mt -126.13 131.07 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -103.49 144.57 31.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.7 t -85.13 119.7 25.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -84.34 3.65 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.507 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -97.63 -48.65 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.3 p -113.12 -39.82 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.79 65.11 0.72 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' A' ' 268' ' ' ASN . 7.0 ttp -121.66 159.44 26.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.447 ' OD1' HG21 ' A' ' 243' ' ' THR . 4.0 m120 -122.81 122.68 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 171.38 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' HIS . . . . . 1.091 ' CD2' HD23 ' A' ' 252' ' ' LEU . 12.8 m80 -71.77 -177.95 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' HIS . . . . . 0.406 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 46.7 m-70 -72.19 -36.38 69.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -93.95 -44.06 8.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 277' ' ' VAL . 81.5 m -47.36 -31.84 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 275' ' ' THR . 9.8 pt20 -52.66 -50.54 63.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' THR . . . . . 0.536 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 24.8 p -76.5 -5.36 47.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.517 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -94.69 -17.82 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -74.49 176.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.094 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -84.54 162.58 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -98.25 50.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.82 75.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 48.9 t -82.0 140.97 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.2 -36.01 2.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 283' ' ' ILE . 2.1 mp -65.03 -24.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 31.3 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.513 ' HB3' HD23 ' A' ' 280' ' ' LEU . 12.6 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.812 0.339 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 32.5 mtm -124.4 143.73 43.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.587 0.708 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 173.24 11.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 0.0 112.283 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.479 ' CB ' ' CE2' ' A' ' 234' ' ' PHE . 90.0 m-70 -92.29 116.51 29.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -69.99 69.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.479 ' CE2' ' CB ' ' A' ' 232' ' ' HIS . 43.9 m-85 -78.63 120.19 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -124.42 137.49 54.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 257' ' ' ARG . 59.7 t -55.4 146.76 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.78 ' CD1' ' CD2' ' A' ' 239' ' ' TYR . 1.9 t80 -142.8 131.16 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -101.82 98.11 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.78 ' CD2' ' CD1' ' A' ' 237' ' ' TYR . 0.1 OUTLIER -140.3 173.85 11.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 83.83 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 28.9 p -161.07 149.33 12.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.1 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.547 ' OG1' HD13 ' A' ' 252' ' ' LEU . 1.1 p -92.86 148.49 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -122.26 135.9 54.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -77.53 141.43 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.67 6.81 44.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.49 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 54.7 t60 -119.36 -68.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 17.3 p -77.76 -14.08 59.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.33 54.45 34.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.0 p -138.75 -179.35 5.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.62 163.31 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 252' ' ' LEU . 0.2 OUTLIER -123.32 124.04 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -109.95 105.47 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -141.9 -176.18 15.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.529 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 255' ' ' LEU . 3.2 tm? -124.19 -56.82 1.62 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.07 -28.56 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' GLY . 80.0 mtt180 -109.02 43.36 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.44 86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 52.61 -154.63 5.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 236' ' ' VAL . 14.9 mt -138.87 156.88 46.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.927 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 6.1 tmmm? -136.65 124.17 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.25 121.05 14.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.89 -0.67 49.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.672 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -96.57 -74.14 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -79.71 -38.57 33.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.95 65.28 0.82 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -131.06 147.71 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -110.63 116.73 31.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 274' ' ' GLN . 2.9 m -142.29 157.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -64.54 173.67 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.67 -38.95 92.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -89.01 -40.68 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 72.9 m -61.14 -12.8 13.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HA ' HG21 ' A' ' 269' ' ' VAL . 7.2 pt20 -75.35 -45.38 39.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 3.1 p -72.75 2.71 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.49 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 25.6 mtpp -101.87 -17.36 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.48 157.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.08 154.73 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -94.43 41.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 229' ' ' ASP . 39.4 mt -121.78 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 7.2 t -94.6 116.12 28.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.25 -35.57 4.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.541 HD12 ' H ' ' A' ' 283' ' ' ILE . 5.3 mp -71.8 -27.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 111.123 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.791 0.329 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.0 mtm -130.17 143.98 51.33 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.15 15.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.659 2.239 . . . . 0.0 112.314 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -93.65 122.85 36.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.412 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 84.8 mtt-85 -69.96 72.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.31 132.46 37.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -144.57 129.67 18.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.81 117.89 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -144.58 153.68 42.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -91.89 121.07 33.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 241' ' ' SER . 0.7 OUTLIER -118.67 178.78 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -123.48 168.95 11.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 1.5 t 62.22 147.15 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.691 0.757 . . . . 0.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.74 54.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.692 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.0 OUTLIER -139.53 136.74 34.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 38.7 m-85 -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 250' ' ' THR . 9.4 t -53.32 109.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.1 -2.83 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 66.0 t60 -93.14 -67.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.0 p -89.3 -13.5 37.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.15 -22.05 28.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -79.93 156.36 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 243' ' ' THR . 3.8 mt -68.92 175.11 3.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.495 HD11 ' CG2' ' A' ' 243' ' ' THR . 12.4 mt -96.43 178.08 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.578 ' CE2' ' CD2' ' A' ' 270' ' ' HIS . 0.3 OUTLIER -144.28 130.95 20.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 255' ' ' LEU . . . 137.57 -170.26 23.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 254' ' ' GLY . 9.9 mp -125.57 -72.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.17 -36.12 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 271' ' ' HIS . 38.7 ttp180 -104.3 41.89 1.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 254' ' ' GLY . 8.0 tt0 -70.13 84.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 76.55 -154.27 43.69 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.58 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 4.8 mt -147.02 130.02 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 237' ' ' TYR . 11.1 tptm -102.87 122.49 44.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 6.3 t -65.98 131.82 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -99.39 11.95 37.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -109.05 -31.89 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -129.93 -45.59 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.69 79.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 5.9 ttp -150.19 139.53 21.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.9 OUTLIER -105.73 132.62 51.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.66 155.89 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.578 ' CD2' ' CE2' ' A' ' 253' ' ' TRP . 12.5 m80 -52.63 -175.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 257' ' ' ARG . 20.0 m-70 -76.65 -36.5 57.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.735 ' O ' HG22 ' A' ' 275' ' ' THR . 0.3 OUTLIER -93.43 -42.83 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 66.7 m -47.03 -26.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.58 ' NE2' ' CD1' ' A' ' 260' ' ' LEU . 6.3 pt20 -62.68 -45.52 92.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.735 HG22 ' O ' ' A' ' 272' ' ' ARG . 13.7 t -75.08 5.32 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 26.1 mtpt -108.64 -19.06 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 277' ' ' VAL . 1.7 t -73.75 158.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.091 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 160.83 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.066 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.63 45.74 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.74 86.08 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 22.3 t -93.45 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 73.02 35.35 57.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.5 mm -105.87 -20.92 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.134 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.419 ' C ' ' OD1' ' A' ' 284' ' ' ASN . 15.5 p30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.426 ' CB ' HD23 ' A' ' 280' ' ' LEU . 1.2 p30 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.1 mmt -117.97 143.16 32.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.605 0.717 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 173.22 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 93.1 m-70 -88.67 123.13 32.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -69.39 70.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 269' ' ' VAL . 48.3 m-85 -71.8 138.85 48.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -155.29 122.81 5.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 257' ' ' ARG . 89.2 t -55.37 133.66 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 72.1 t80 -143.32 164.12 31.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 237' ' ' TYR . 4.5 t30 -92.0 124.81 36.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.516 ' CZ ' ' NE2' ' A' ' 258' ' ' GLN . 3.6 m-30 -102.29 176.34 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 7.43 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.6 m -161.39 150.1 13.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 113.78 3.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.541 HG21 HD22 ' A' ' 268' ' ' ASN . 13.6 m -100.01 164.14 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.54 ' N ' HG22 ' A' ' 243' ' ' THR . 36.2 m-85 -111.45 126.44 54.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.9 t -52.18 133.68 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -85.58 9.36 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.5 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 74.7 t60 -119.33 -71.64 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.9 p -75.5 -28.9 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.15 49.93 9.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 30.8 p -136.82 142.71 42.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.192 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.76 157.8 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.9 mp -108.72 97.72 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.515 ' O ' HD22 ' A' ' 255' ' ' LEU . 20.9 m95 -51.31 -69.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -42.86 138.42 3.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.515 HD22 ' O ' ' A' ' 253' ' ' TRP . 2.2 mm? -102.63 -74.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -48.26 -23.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 258' ' ' GLN . 36.4 ttm180 -103.71 -39.49 6.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.516 ' NE2' ' CZ ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER 34.32 43.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.432 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 70.52 -119.91 8.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 6.8 mt -148.75 154.01 38.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -133.65 102.62 5.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 132.85 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.23 1.46 57.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.686 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -101.65 -71.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.063 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.62 -42.19 22.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.97 40.17 2.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.51 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.439 ' HE1' HG11 ' A' ' 277' ' ' VAL . 0.6 OUTLIER -102.37 149.96 23.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.541 HD22 HG21 ' A' ' 243' ' ' THR . 0.5 OUTLIER -117.86 123.22 45.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 234' ' ' PHE . 11.5 m -149.89 148.66 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -52.19 -174.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -30.27 42.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.829 ' O ' HG22 ' A' ' 275' ' ' THR . 79.8 mtm180 -93.14 -36.41 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 75.8 m -64.51 -14.79 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.2 pt20 -71.01 -35.05 71.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.8 t -79.52 8.46 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.5 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 60.0 mttt -115.47 -14.19 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.943 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -77.03 170.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -67.29 156.1 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.09 30.93 3.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -129.35 93.0 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 18.3 t -90.17 112.05 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.33 -41.39 2.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.41 -27.63 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.442 ' HB3' HD23 ' A' ' 280' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.758 0.313 . . . . 0.0 110.867 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.18 142.73 87.58 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.557 0.694 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 173.19 11.33 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.375 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 97.0 m-70 -95.65 120.07 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 72.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.18 114.11 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.7 132.16 45.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.96 138.64 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -146.31 154.31 41.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -99.86 105.68 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.418 ' OH ' ' ND2' ' A' ' 268' ' ' ASN . 30.0 m-85 -90.79 137.3 32.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -95.76 29.8 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.2 p -170.28 150.62 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.627 0.727 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 100.53 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.297 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.508 ' O ' HD12 ' A' ' 252' ' ' LEU . 6.7 m -93.72 149.68 21.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -95.16 146.07 24.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 7.9 t -71.67 130.86 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.14 7.83 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 50.2 t60 -116.52 -69.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 p -80.05 -26.74 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.83 50.68 10.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 29.8 p -138.51 148.76 44.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 14.2 mt -44.7 168.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 243' ' ' THR . 13.8 mt -108.14 178.2 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -168.59 129.28 1.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 159.04 131.06 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.449 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.37 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.8 0.333 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -113.45 -33.59 5.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -84.99 68.51 10.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -73.55 78.49 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 65.67 -148.79 51.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 11.9 mt -148.8 131.14 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 261' ' ' LYS . 0.1 OUTLIER -113.41 142.86 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.38 132.98 38.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -93.71 10.73 31.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -112.67 -71.39 0.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -82.06 -45.31 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.08 65.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.03 139.55 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.495 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -106.17 125.4 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 274' ' ' GLN . 29.3 m -144.17 146.78 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -51.58 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -35.95 66.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.826 ' O ' HG22 ' A' ' 275' ' ' THR . 9.5 mpt_? -93.95 -37.4 11.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.49 -21.08 14.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 3.3 pt20 -65.49 -40.88 93.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.826 HG22 ' O ' ' A' ' 272' ' ' ARG . 15.3 t -75.2 -3.61 34.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 43.7 mttp -97.43 -14.86 20.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -81.37 166.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -80.21 155.43 27.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -88.35 34.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 229' ' ' ASP . 8.2 mt -116.15 88.46 2.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.0 t -93.14 125.29 37.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.04 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 280' ' ' LEU . 50.7 mm -44.58 -25.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.858 0.361 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.441 ' O ' ' C ' ' A' ' 279' ' ' ASN . 17.5 mtm -124.61 143.77 44.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.858 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 171.54 14.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.259 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -91.75 129.4 37.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.402 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 55.7 mtp85 -69.69 69.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 34.9 m-85 -68.83 143.42 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -162.59 121.07 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.41 142.93 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 16.5 t80 -147.24 154.95 41.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 238' ' ' ASN . 18.2 p-10 -91.95 96.9 10.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD2' ' OE1' ' A' ' 258' ' ' GLN . 0.1 OUTLIER -91.79 163.6 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 -27.29 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 239' ' ' TYR . 2.3 m -99.26 156.77 35.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.681 0.753 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 149.95 67.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.797 ' OG1' HD23 ' A' ' 252' ' ' LEU . 1.1 p -135.21 155.61 50.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -117.95 108.51 15.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 6.9 t -56.81 101.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.8 -6.09 19.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 31.4 t60 -82.67 -70.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 28.7 p -79.87 -36.36 36.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 106.86 20.5 8.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 73.0 p -131.94 139.94 48.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.28 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.797 HD23 ' OG1' ' A' ' 243' ' ' THR . 2.6 mm? -93.3 149.37 21.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -119.3 12.84 12.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.541 ' C ' HD22 ' A' ' 255' ' ' LEU . . . -79.68 -176.15 48.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.444 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.663 ' N ' HD22 ' A' ' 255' ' ' LEU . 1.4 mm? -108.41 -64.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.908 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.71 26.55 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.453 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 0.2 OUTLIER -127.15 -30.61 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.575 ' OE1' ' CD2' ' A' ' 239' ' ' TYR . 5.8 pt20 35.84 38.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.471 ' O ' ' CE1' ' A' ' 271' ' ' HIS . . . 79.86 -107.16 2.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.458 ' CD1' ' CD ' ' A' ' 274' ' ' GLN . 44.8 mt -154.54 146.22 23.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.486 ' HE3' ' ND2' ' A' ' 268' ' ' ASN . 3.0 tppp? -125.45 117.38 23.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 4.3 t -64.45 134.87 55.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.09 -2.7 27.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -91.81 -34.36 14.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.5 p -126.43 -40.17 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.73 83.25 1.72 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.0 ttp -145.82 135.92 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.486 ' ND2' ' HE3' ' A' ' 261' ' ' LYS . 0.6 OUTLIER -99.27 127.53 45.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.52 156.03 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.169 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.512 ' CD2' ' CD1' ' A' ' 252' ' ' LEU . 16.5 m80 -58.77 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.471 ' CE1' ' O ' ' A' ' 259' ' ' GLY . 42.1 m-70 -74.95 -35.37 62.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 275' ' ' THR . 11.6 ptp180 -93.31 -38.71 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.7 m -52.66 -16.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.484 ' CG ' ' N ' ' A' ' 275' ' ' THR . 10.0 pt20 -68.91 -47.05 66.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 272' ' ' ARG . 2.0 t -73.01 1.96 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 44.6 mttm -102.56 -23.58 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.7 t -68.01 172.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.613 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -93.83 150.86 20.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.798 ' C ' HD22 ' A' ' 280' ' ' LEU . 25.8 m-80 -79.9 52.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.798 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.1 mm? -127.78 73.85 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.4 t -92.0 121.13 33.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 61.49 11.72 29.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.705 HG21 HD12 ' A' ' 280' ' ' LEU . 10.0 mm -72.66 -89.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . 0.637 ' N ' HG22 ' A' ' 283' ' ' ILE . 2.1 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.775 0.322 . . . . 0.0 110.922 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 42.4 mtm -122.97 142.26 37.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 173.18 11.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.361 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 69.8 m-70 -90.59 116.11 28.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 264' ' ' ALA . 23.0 mtp180 -63.63 74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 24.8 m-85 -84.64 140.7 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.93 120.07 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 257' ' ' ARG . 42.8 t -44.59 127.08 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.498 ' CE1' ' O ' ' A' ' 238' ' ' ASN . 42.6 t80 -145.38 141.43 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.498 ' O ' ' CE1' ' A' ' 237' ' ' TYR . 31.0 t-20 -86.97 122.2 30.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -126.28 179.38 5.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -130.81 -62.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 13.6 m -43.34 144.45 1.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.66 0.743 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.48 28.02 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 252' ' ' LEU . 4.3 t -136.35 153.54 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.23 140.86 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.85 143.71 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.63 9.1 38.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 26.1 t60 -121.76 -67.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.0 p -75.45 -29.41 59.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 38.2 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.459 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.0 p -138.99 141.8 38.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 111.157 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 173.37 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.897 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -121.78 163.33 19.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -153.16 126.32 8.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -168.4 151.67 18.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.6 -65.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.92 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.77 -55.96 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.439 ' HA ' HG13 ' A' ' 236' ' ' VAL . 51.1 mtm180 -70.45 73.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 88.91 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 57.25 -147.71 34.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 259' ' ' GLY . 8.1 mt -147.09 119.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -100.17 110.65 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -55.42 130.52 42.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.5 1.6 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -98.21 -50.82 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.02 -35.62 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.37 73.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.0 ttp -145.25 135.5 24.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -95.11 115.83 27.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 277' ' ' VAL . 4.3 m -134.96 150.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.897 ' CD2' HD23 ' A' ' 252' ' ' LEU . 28.4 m80 -64.25 167.13 7.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -61.32 -26.9 68.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.415 ' HG3' ' NZ ' ' A' ' 276' ' ' LYS . 4.8 tpt180 -93.87 -63.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 277' ' ' VAL . 4.6 m -46.47 -20.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.542 ' CG ' ' N ' ' A' ' 275' ' ' THR . 0.6 OUTLIER -46.94 -50.66 18.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.9 OUTLIER -67.54 -41.42 84.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.557 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 0.7 OUTLIER -50.24 -26.21 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 269' ' ' VAL . 1.8 t -76.03 126.76 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.111 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.869 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -44.59 136.62 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.088 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -75.93 51.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.869 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 4.9 mp -125.37 78.63 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.94 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 6.9 t -88.69 142.57 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.55 -7.46 76.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 280' ' ' LEU . 3.9 mm -73.71 -28.87 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.874 0.369 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 35.4 mtm -128.58 143.76 49.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.608 0.718 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 164.24 35.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.571 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 86.0 m-70 -87.45 120.41 28.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.487 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 15.0 mmt85 -70.94 68.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 51.7 m-85 -71.59 138.1 48.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.49 128.71 18.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.09 127.15 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.81 148.87 32.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.553 ' CE2' ' CB ' ' A' ' 258' ' ' GLN . 7.1 p90 -113.23 120.79 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.468 ' HE2' ' N ' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -86.39 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 52.6 p -39.0 144.35 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.7 0.762 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 138.03 36.75 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.831 ' O ' HD23 ' A' ' 251' ' ' LEU . 2.8 t -145.83 146.9 31.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 251' ' ' LEU . 7.4 m-85 -106.02 132.61 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 250' ' ' THR . 7.5 t -63.35 103.85 0.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.74 -7.41 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 52.3 t60 -87.23 -70.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.86 -9.82 56.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 245' ' ' CYS . . . 85.21 -19.77 20.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -81.19 157.14 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 243' ' ' THR . 7.3 mt -76.83 -176.87 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.545 HD12 ' CZ ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -145.94 145.31 30.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -173.23 130.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -177.21 -134.32 1.98 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 258' ' ' GLN . 2.5 mm? -83.98 178.07 8.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . . . -37.61 -34.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -86.65 36.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.553 ' CB ' ' CE2' ' A' ' 239' ' ' TYR . 73.4 mt-30 -41.28 -74.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.72 -162.9 10.83 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 26.5 mt -131.72 126.36 34.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -106.59 114.37 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 3.7 t -62.45 125.78 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.61 18.13 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.22 -40.52 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -119.78 -44.95 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 108.4 78.82 1.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.2 ttp -146.17 141.17 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -106.03 122.59 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.6 m -142.4 154.95 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 251' ' ' LEU . 13.7 m80 -51.64 179.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -69.13 -36.5 77.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.654 ' O ' HG22 ' A' ' 275' ' ' THR . 27.4 mtt-85 -93.89 -49.13 5.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 277' ' ' VAL . 61.3 m -39.29 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 275' ' ' THR . 12.6 pt20 -52.46 -49.77 63.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 272' ' ' ARG . 0.7 OUTLIER -70.55 -37.35 74.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.604 ' CE ' HG23 ' A' ' 275' ' ' THR . 0.4 OUTLIER -54.82 -31.82 59.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 278' ' ' ALA . 2.2 t -65.31 172.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -94.28 155.61 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 280' ' ' LEU . 5.8 m-20 -79.22 52.84 1.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 280' ' ' LEU . 4.2 mm? -123.02 78.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 13.1 t -89.16 116.52 27.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.46 -30.14 11.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 283' ' ' ILE . 4.4 mp -83.45 -77.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.847 0.356 . . . . 0.0 111.103 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.934 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.857 0.361 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 230' ' ' MET . 4.7 mpp? -125.29 143.61 44.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.496 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 52.9 Cg_endo -69.82 173.19 11.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 82.6 m-70 -95.7 122.89 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' A' ' 264' ' ' ALA . 59.4 mtt180 -71.23 67.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 34.5 m-85 -80.28 124.34 28.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -126.77 121.44 31.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 257' ' ' ARG . 2.3 t -51.21 113.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 14.5 t80 -120.87 159.24 25.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.541 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.5 t30 -118.37 97.3 5.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.43 167.32 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.432 ' CD ' ' C ' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.41 -52.26 2.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 21.7 m -39.09 153.23 0.18 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.65 13.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.613 ' HB ' HD12 ' A' ' 252' ' ' LEU . 2.7 m -130.51 108.53 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -89.87 141.68 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.66 112.69 11.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -76.96 3.32 12.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t60 -97.65 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.3 p -82.56 -18.4 41.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.81 -12.68 68.79 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.4 159.88 19.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.5 OUTLIER -82.85 134.89 35.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 1.09 ' N ' HD12 ' A' ' 251' ' ' LEU . 29.8 mt -46.24 172.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -173.74 133.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.7 43.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.5 mp -90.67 -74.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -121.11 -31.06 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.489 ' HB2' HG13 ' A' ' 236' ' ' VAL . 14.0 ptt180 -89.93 29.66 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 257' ' ' ARG . 30.6 mt-30 -36.48 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 42.14 -150.96 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 271' ' ' HIS . 17.2 mt -147.46 148.01 30.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.48 ' HD3' ' ND2' ' A' ' 268' ' ' ASN . 12.7 tptm -122.97 117.03 24.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 1.8 t -65.06 128.47 35.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -93.1 -3.14 54.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.703 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -93.93 -60.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.2 p -96.03 -34.86 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.57 73.26 1.19 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.5 ttp -143.81 130.17 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -94.23 128.22 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 22.8 m -152.53 152.49 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 252' ' ' LEU . 14.1 m80 -48.56 172.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 2.2 t60 -69.05 -32.31 71.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -94.14 -47.17 6.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 276' ' ' LYS . 63.6 m -44.72 -31.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.56 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 9.8 pt20 -51.6 -50.4 60.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.535 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 11.9 p -66.88 -10.44 48.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -85.92 -29.82 23.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.27 150.11 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.47 143.68 52.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.496 ' ND2' ' N ' ' A' ' 231' ' ' PRO . 2.4 t30 -78.82 54.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 11.7 mt -129.63 82.55 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 11.0 t -92.56 128.44 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.47 -10.96 60.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.7 mt -90.66 -79.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.771 0.32 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 7.8 mtt -103.07 97.03 8.86 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.595 0.712 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.6 Cg_endo -69.75 165.1 32.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 0.0 112.345 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.5 115.59 20.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.16 63.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 38.4 m-85 -59.52 152.18 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.403 ' NZ ' ' HA ' ' A' ' 235' ' ' LYS . 0.0 OUTLIER -148.19 118.43 7.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -46.49 126.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.63 148.81 39.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.44 134.25 34.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.84 115.71 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -86.39 -12.19 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.52 152.42 46.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 108.61 2.14 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.537 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.3 m -104.55 147.26 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -103.52 129.42 50.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.61 124.99 23.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -78.25 8.99 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -117.8 -72.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.1 p -75.51 -25.93 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.95 43.09 18.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.9 p -139.73 159.16 42.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 243' ' ' THR . 29.2 mt -74.03 175.94 6.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.576 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -132.17 113.37 13.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -100.38 151.97 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 139.45 -9.72 3.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 19.6 mt 40.32 31.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -167.92 145.8 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 45.22 26.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -42.03 104.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 40.4 -149.83 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.428 HD21 ' CE1' ' A' ' 271' ' ' HIS . 0.5 OUTLIER -142.37 170.58 15.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -137.58 131.68 32.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.0 t -75.7 140.55 42.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -97.56 6.28 48.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.62 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -107.42 -60.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.89 -44.42 9.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.24 52.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 21.4 ttp -115.39 163.74 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -124.47 128.39 48.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.69 150.98 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.576 ' CD2' HD23 ' A' ' 252' ' ' LEU . 14.1 m80 -51.28 -175.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.428 ' CE1' HD21 ' A' ' 260' ' ' LEU . 41.1 m-70 -76.54 -35.67 58.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -93.94 -38.45 11.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 46.2 m -50.07 -19.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.488 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 7.6 pt20 -71.15 -36.9 72.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.4 p -77.81 2.78 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.157 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -109.74 -8.82 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.03 175.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -89.18 159.93 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.13 48.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.34 84.34 2.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.7 t -94.01 114.15 26.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.8 -5.58 38.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.25 -23.22 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.913 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.804 0.335 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 1.6 mpt? -125.67 97.01 37.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.532 0.682 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.79 139.71 40.79 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.65 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 99.3 m-70 -55.75 116.68 3.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -74.35 67.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 62.3 m-85 -59.28 146.0 41.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -153.65 137.2 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 ' HD2' ' A' ' 257' ' ' ARG . 42.1 t -59.31 119.52 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -136.07 161.28 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.08 147.83 24.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.23 153.45 33.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -8.35 8.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.8 m -133.21 160.08 70.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.752 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 118.85 5.93 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -127.37 147.24 50.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.61 134.42 50.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -48.87 144.38 4.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.29 8.83 25.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.497 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 53.4 t60 -127.98 -68.13 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.88 -16.94 59.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 59.57 52.94 50.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.1 p -139.97 150.55 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.108 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.6 mp -56.56 167.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.546 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.7 mm? -96.76 -178.84 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -158.66 145.4 17.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.44 -164.79 19.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.4 mt -116.79 -70.42 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.92 -64.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HD2' HG21 ' A' ' 236' ' ' VAL . 6.3 ttp-105 -83.48 69.39 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.421 ' O ' ' NE2' ' A' ' 271' ' ' HIS . 26.1 mt-30 -78.48 -53.5 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.91 -148.24 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.09 154.15 48.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 111.96 12.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.37 124.38 15.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.33 7.43 32.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -103.04 -47.81 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.9 p -113.59 -45.18 3.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.59 60.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -124.39 124.8 43.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -88.62 118.58 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 35.2 m -139.88 146.32 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.546 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.8 m80 -50.93 -178.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 258' ' ' GLN . 64.2 m-70 -75.75 -38.82 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -88.19 -43.51 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.1 m -50.25 -24.11 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 12.2 pt20 -61.15 -33.73 73.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 43.2 p -78.98 11.16 2.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.497 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -114.63 -33.08 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 277' ' ' VAL . 1.8 t -63.82 156.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.471 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -77.08 150.08 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.46 ' C ' HD22 ' A' ' 280' ' ' LEU . 1.0 OUTLIER -86.64 30.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -103.34 67.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.2 t -92.76 106.42 18.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.52 -27.24 6.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.33 -26.56 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.794 0.33 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 22.1 mmt -126.32 97.04 35.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.834 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.9 Cg_endo -69.79 158.47 56.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.297 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.45 116.08 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.28 62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 269' ' ' VAL . 31.1 m-85 -61.01 136.11 57.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -138.48 123.85 19.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.474 ' HA ' HD23 ' A' ' 260' ' ' LEU . 3.2 t -51.93 127.9 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.82 162.93 38.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 238' ' ' ASN . 0.9 OUTLIER -87.39 113.39 23.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -63.33 153.02 36.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -134.82 10.08 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 4.1 m -167.64 154.26 7.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.64 0.733 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 122.92 9.6 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.36 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.611 ' OG1' HD21 ' A' ' 252' ' ' LEU . 1.0 OUTLIER -118.57 163.55 16.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.36 104.06 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.69 128.91 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -86.57 8.67 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 73.5 t60 -113.75 -71.22 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.5 p -75.45 -35.96 60.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.65 42.7 6.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 35.1 p -139.47 159.51 42.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.6 mp -63.9 -179.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.611 HD21 ' OG1' ' A' ' 243' ' ' THR . 1.7 pt? -171.04 124.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -172.46 153.02 2.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 161.73 -117.91 0.79 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.484 ' N ' ' HG3' ' A' ' 258' ' ' GLN . 2.7 mm? -68.14 160.2 29.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.417 ' HB1' ' OD1' ' A' ' 238' ' ' ASN . . . -50.85 -50.08 57.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.61 47.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 255' ' ' LEU . 6.5 mm100 -99.88 146.47 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 51.7 179.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 236' ' ' VAL . 34.4 mt -142.96 152.81 42.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.6 117.36 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.95 141.16 28.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.09 7.73 41.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -110.74 -68.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 24.1 p -84.0 -46.05 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.57 61.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.9 ttp -122.86 145.74 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -111.41 123.48 50.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.528 HG22 ' CE1' ' A' ' 234' ' ' PHE . 12.1 m -146.18 165.6 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -64.52 -178.71 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -75.3 -38.42 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.732 ' O ' HG22 ' A' ' 275' ' ' THR . 13.5 mtm-85 -89.2 -39.9 13.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.4 m -54.93 -21.2 10.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.485 ' CG ' ' N ' ' A' ' 275' ' ' THR . 4.7 pt20 -64.68 -47.81 77.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.9 t -70.32 -0.69 8.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 61.8 mttt -101.52 -26.94 13.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 273' ' ' CYS . 3.2 t -69.08 148.79 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.55 153.28 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -81.09 53.58 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 66.1 mt -121.74 73.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.7 t -83.32 112.23 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.27 23.54 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 283' ' ' ILE . 19.7 mm -70.44 -24.43 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.927 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.762 0.315 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 28.1 mtm -103.47 96.99 9.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 157.28 61.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.619 2.213 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.23 121.66 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -76.01 52.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.408 ' HB3' ' CB ' ' A' ' 260' ' ' LEU . 23.7 m-85 -51.75 132.33 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -139.03 134.27 32.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.29 125.47 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 7.0 t80 -142.1 140.67 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.403 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.1 p30 -101.46 111.24 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 158.9 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -94.51 -58.06 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.1 p -44.22 151.08 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 116.21 4.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.1 m -116.2 132.27 56.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -110.21 153.24 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.3 t -71.15 137.07 48.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.52 9.19 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -120.93 -68.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.3 p -77.67 -14.34 59.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.05 52.67 49.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.496 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 10.6 p -138.06 157.72 45.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.96 166.6 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.508 ' C ' ' CE3' ' A' ' 253' ' ' TRP . 3.2 mt -113.59 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.508 ' CE3' ' C ' ' A' ' 252' ' ' LEU . 6.6 m-90 -151.14 -175.89 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 98.1 172.06 32.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 255' ' ' LEU . 7.2 tt -111.68 -51.27 2.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -105.15 -64.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -75.69 70.69 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -93.28 99.13 11.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 50.35 -165.41 0.6 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.501 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.408 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 8.6 mt -126.6 163.14 24.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.372 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -139.37 123.6 18.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.6 t -62.43 131.76 50.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.41 15.87 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.521 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.88 -66.61 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -88.52 -47.02 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 111.67 65.16 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.9 ttp -125.97 152.95 45.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -117.3 115.18 24.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 20.7 m -136.03 159.61 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.466 ' NE2' HD23 ' A' ' 252' ' ' LEU . 11.1 m80 -65.87 -175.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -76.09 -39.29 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -89.82 -47.06 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 86.4 m -44.91 -25.04 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.427 ' CG ' ' N ' ' A' ' 275' ' ' THR . 1.2 pt20 -57.45 -44.88 85.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 27.5 p -64.5 -6.94 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -94.7 -30.89 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.9 126.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -47.84 173.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -99.9 46.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 53.9 mt -124.88 93.37 3.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.4 t -93.82 115.07 27.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.64 -29.15 3.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.5 mt -75.7 -28.56 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.795 0.331 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 12.1 mtm -107.52 97.03 17.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.528 0.68 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 127.05 13.98 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.233 . . . . 0.0 112.348 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -48.37 115.59 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -74.62 61.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.545 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 43.4 m-85 -52.68 139.87 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 127.23 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.443 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 54.0 t -54.94 124.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -134.27 138.56 45.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.441 ' ND2' ' H ' ' A' ' 238' ' ' ASN . 0.5 OUTLIER -100.39 97.66 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 258' ' ' GLN . 2.1 p90 -125.04 120.45 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -83.15 67.89 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.8 m -142.07 145.14 34.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.707 0.765 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 77.87 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.681 ' O ' HD13 ' A' ' 252' ' ' LEU . 18.6 m -95.09 142.55 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -111.5 128.34 55.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 9.4 t -46.92 139.77 5.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.61 3.15 56.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 43.5 t60 -110.94 -73.02 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.66 -31.33 59.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 53.1 6.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.41 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 251' ' ' LEU . 55.3 p -137.03 131.85 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 252' ' ' LEU . 1.0 OUTLIER -34.58 126.16 0.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 243' ' ' THR . 9.9 mp -67.46 135.41 53.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.449 ' C ' ' O ' ' A' ' 252' ' ' LEU . 70.4 m95 -34.64 -74.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 118.96 56.43 0.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 258' ' ' GLN . 4.6 mp -129.69 165.97 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.66 -25.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.504 ' CD ' ' NE2' ' A' ' 271' ' ' HIS . 13.3 ttp180 -100.49 34.81 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 239' ' ' TYR . 6.6 mm-40 -36.04 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 34.8 -148.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.6 141.87 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.26 104.84 10.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -47.99 118.55 2.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.79 4.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.9 -74.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.088 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.2 p -80.7 -46.0 16.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.6 ttp -104.88 145.17 30.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -106.08 116.14 31.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.545 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 2.6 m -139.55 149.67 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -54.92 -174.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.504 ' NE2' ' CD ' ' A' ' 257' ' ' ARG . 1.5 m-70 -82.1 -34.24 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -94.0 -25.61 17.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.0 m -71.69 -25.98 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 2.8 pt20 -63.23 -38.45 91.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -74.68 -5.34 42.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 41.4 mttm -98.5 -10.48 23.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.6 t -83.42 165.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.418 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -88.32 156.14 19.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.554 ' O ' HD23 ' A' ' 280' ' ' LEU . 23.4 p30 -84.89 56.66 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 279' ' ' ASN . 56.2 mt -131.19 81.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 111.31 22.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.11 -26.27 21.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.523 HG13 HD22 ' A' ' 280' ' ' LEU . 6.6 mm -45.81 -28.33 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.117 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.968 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 97.01 44.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.49 18.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.699 2.266 . . . . 0.0 112.373 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -85.69 118.17 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -78.97 59.38 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 39.5 m-85 -55.99 126.24 25.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt -131.54 133.7 45.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.535 ' CG1' ' NE ' ' A' ' 257' ' ' ARG . 2.2 t -51.58 134.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -144.27 157.09 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.15 109.5 18.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -49.17 130.81 19.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.02 11.62 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.944 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 32.5 m -167.73 149.29 5.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 78.82 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' ' 268' ' ' ASN . 1.2 m -98.33 143.68 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.532 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 5.4 m-85 -102.24 151.34 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 4.3 t -61.56 137.81 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.91 -3.45 54.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 81.4 t60 -101.56 -70.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.0 p -77.2 -19.38 56.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.2 43.59 63.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.45 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.1 p -140.0 150.68 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 244' ' ' PHE . 15.8 mt -62.18 154.55 26.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -124.68 54.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -39.12 94.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 252' ' ' LEU . . . -177.36 140.4 4.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 3.9 mt -135.04 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 255' ' ' LEU . . . 71.81 47.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 236' ' ' VAL . 4.7 mmm180 74.89 50.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -102.57 -4.35 25.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -140.18 -164.49 9.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.437 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.85 158.7 43.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.12 114.56 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 10.3 t -58.57 119.1 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -83.76 2.39 38.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.465 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -95.3 -57.57 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.3 p -104.35 -34.61 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.0 73.87 1.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.446 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.0 ttp -138.44 140.56 39.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.435 ' HB2' HG21 ' A' ' 243' ' ' THR . 0.2 OUTLIER -105.33 122.35 45.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.81 164.85 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.858 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.8 m80 -60.07 177.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.37 -32.04 64.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -93.96 -46.89 6.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.557 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.5 m -45.84 -24.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.575 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 11.6 pt20 -60.11 -47.88 84.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 1.6 p -70.09 -13.23 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.585 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 26.0 mtpp -85.44 -33.96 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.9 t -62.12 142.4 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.51 173.65 6.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.42 50.67 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.56 73.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.3 t -93.77 116.08 28.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.14 -4.89 85.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 283' ' ' ILE . 10.4 mm -58.25 -20.51 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.349 . . . . 0.0 111.108 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.926 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.825 0.345 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.404 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 37.8 mtp -107.79 97.05 18.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 153.45 69.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.358 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.5 m-70 -66.09 116.19 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.406 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 73.1 mtt85 -73.46 64.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 35.3 m-85 -67.89 125.85 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -127.18 139.61 52.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 260' ' ' LEU . 91.4 t -60.63 132.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -148.49 154.75 40.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.29 128.42 34.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 258' ' ' GLN . 55.5 m-85 -107.09 116.85 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -92.45 26.01 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.2 m -170.69 156.38 5.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 139.2 39.73 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.405 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.492 ' OG1' HD12 ' A' ' 252' ' ' LEU . 4.7 p -139.14 159.64 41.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -106.37 144.75 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.5 t -76.0 121.49 22.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.38 5.79 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.495 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 58.7 t60 -110.03 -73.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.1 p -75.56 -33.88 60.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 43.29 5.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 251' ' ' LEU . 43.0 p -139.99 138.13 35.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.788 0.327 . . . . 0.0 111.164 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 250' ' ' THR . 10.0 mt -34.78 146.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 270' ' ' HIS . 70.1 mt -94.01 121.42 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -102.63 148.6 25.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 147.49 157.32 7.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.87 -69.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.6 -41.66 4.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 259' ' ' GLY . 0.2 OUTLIER -80.07 12.36 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.466 ' O ' ' CE1' ' A' ' 239' ' ' TYR . 22.7 tt0 -37.84 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 59.16 -171.7 4.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 236' ' ' VAL . 8.7 mt -130.78 160.98 32.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -122.32 126.49 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 266' ' ' GLY . 11.5 t -77.27 104.38 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.45 -5.71 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.14 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.97 -29.5 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 262' ' ' CYS . . . 91.23 83.88 1.43 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 11.5 ttp -144.45 130.05 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.14 119.13 30.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.78 154.67 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 252' ' ' LEU . 23.0 m80 -59.04 -175.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -75.43 -32.59 60.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -92.91 -41.44 10.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 277' ' ' VAL . 78.4 m -57.06 -12.58 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -63.79 -41.03 98.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.949 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 11.77 37.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.495 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 34.2 mtmt -100.85 -24.93 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -73.69 -179.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -83.69 150.0 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -84.78 27.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.9 79.48 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.88 129.31 34.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.38 -21.82 19.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 36.7 mm -61.44 -28.19 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.814 0.34 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.43 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 32.9 mtm -116.15 97.09 48.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.553 0.692 . . . . 0.0 110.856 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 127.51 14.71 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 97.2 m-70 -44.86 117.78 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -72.99 65.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 43.1 m-85 -60.87 139.81 57.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -143.54 132.87 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.506 HG11 ' HD2' ' A' ' 257' ' ' ARG . 19.6 t -60.38 122.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.6 163.96 33.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.12 128.32 36.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -80.15 123.73 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -102.64 -5.62 23.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.959 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 65.1 m -142.83 153.3 60.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 88.57 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.259 . . . . 0.0 112.371 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 244' ' ' PHE . 15.5 m -93.88 161.47 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.5 ' N ' HG22 ' A' ' 243' ' ' THR . 39.8 m-85 -122.91 124.42 43.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.46 146.81 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.23 -0.66 57.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 78.1 t60 -115.94 -67.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 14.6 p -78.18 -15.95 58.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 54.04 62.6 5.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 38.1 p -139.43 179.41 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.3 OUTLIER -94.57 113.13 24.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.917 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -88.71 112.08 22.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -45.6 141.24 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -111.54 47.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.6 -64.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -172.8 144.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.506 ' HD2' HG11 ' A' ' 236' ' ' VAL . 12.5 mmt85 44.7 50.25 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -116.45 147.09 42.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 47.59 -170.41 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 3.0 mt -146.46 161.17 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -126.87 138.76 53.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.2 t -86.72 122.76 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.59 8.74 18.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -106.54 -67.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.5 p -88.58 -44.69 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 115.22 22.87 4.72 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.1 ttp -86.97 156.34 19.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -130.33 115.59 17.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 274' ' ' GLN . 6.2 m -131.27 166.08 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.917 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.4 m80 -70.12 -176.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -37.43 12.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.21 -25.1 65.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.582 ' HA ' HG21 ' A' ' 269' ' ' VAL . 13.4 pt20 -60.87 -43.33 98.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 7.6 p -69.82 -6.63 33.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.55 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 1.4 mmpt? -96.09 -13.07 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.84 158.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.558 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -79.75 141.62 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.453 ' C ' HD22 ' A' ' 280' ' ' LEU . 9.7 p30 -80.06 52.08 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.558 HD23 ' HB1' ' A' ' 278' ' ' ALA . 2.8 mm? -127.75 70.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 52.9 t -90.7 155.96 18.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 60.68 18.19 51.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.2 mm -101.57 -25.41 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.841 0.353 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 283' ' ' ILE . 3.9 ptp -126.69 97.0 34.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.0 Cg_endo -69.75 163.58 37.73 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.324 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 95.0 m-70 -86.66 115.4 24.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.468 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 26.5 mtt-85 -72.23 66.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.752 ' CE1' HG22 ' A' ' 269' ' ' VAL . 53.9 m-85 -62.28 149.9 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 234' ' ' PHE . 68.3 mttt -158.61 137.97 11.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.48 137.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -148.23 146.52 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -97.94 96.86 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.28 141.86 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 94.96 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.1 t -176.1 146.71 0.81 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.648 0.737 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 87.04 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.711 2.274 . . . . 0.0 112.377 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 m -106.71 138.21 43.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 244' ' ' PHE . 4.5 m-85 -106.36 140.21 39.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.1 t -56.56 129.55 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -86.93 5.8 35.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.581 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 37.3 t60 -110.64 -70.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.61 -33.11 60.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.1 39.31 6.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 28.4 p -138.08 150.13 46.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' CZ2' ' A' ' 253' ' ' TRP . 16.8 mt -64.33 175.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 253' ' ' TRP . 1.7 pt? -155.39 152.1 28.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -154.8 158.54 39.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 155.78 -172.05 33.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.37 179.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.851 0.358 . . . . 0.0 110.869 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -70.39 69.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 259' ' ' GLY . 8.0 mm100 -85.13 114.97 22.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 34.96 -146.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 3.0 mt -147.35 131.01 16.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -102.08 118.26 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 8.4 t -64.59 104.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -57.87 -18.68 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -76.29 -73.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.08 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.1 p -86.19 -42.05 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.0 60.76 0.75 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 9.4 ttp -125.33 119.86 29.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -90.09 120.19 31.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.752 HG22 ' CE1' ' A' ' 234' ' ' PHE . 31.6 m -137.53 179.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -70.32 165.2 22.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -62.46 -31.77 72.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -91.81 -47.75 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.553 ' O ' HG23 ' A' ' 277' ' ' VAL . 84.4 m -50.71 -32.18 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.674 ' NE2' HG23 ' A' ' 275' ' ' THR . 0.9 OUTLIER -53.12 -37.44 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.674 HG23 ' NE2' ' A' ' 274' ' ' GLN . 2.2 p -85.77 -11.83 52.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.581 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -87.03 -23.36 25.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.2 t -70.47 143.3 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.754 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -50.09 150.49 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -83.22 41.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 2.8 mp -127.94 104.63 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.4 t -93.65 140.77 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.85 -33.94 3.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.451 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 280' ' ' LEU . 3.8 mp -63.79 -17.63 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.423 ' C ' ' OD1' ' A' ' 279' ' ' ASN . 55.3 mtm -107.16 96.99 16.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.555 0.693 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.437 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.74 164.65 33.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.8 m-70 -78.24 121.04 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -73.95 64.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 30.8 m-85 -63.79 131.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -141.74 130.86 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -45.82 132.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 238' ' ' ASN . 82.1 t80 -148.22 161.04 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.591 ' O ' ' CE2' ' A' ' 237' ' ' TYR . 0.6 OUTLIER -92.12 144.76 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -106.35 133.76 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.57 4.49 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 35.3 m -139.36 154.55 71.92 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.687 0.756 . . . . 0.0 110.818 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 251' ' ' LEU . 53.8 m -113.76 149.97 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.94 128.61 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.35 140.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.01 9.05 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 71.1 t60 -123.56 -66.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.7 p -78.87 -17.42 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.31 48.06 78.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.3 p -137.71 152.65 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.594 ' O ' ' CZ3' ' A' ' 253' ' ' TRP . 11.4 mt -64.73 159.66 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.578 HD13 ' NE2' ' A' ' 270' ' ' HIS . 3.5 mm? -87.46 174.37 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . 0.594 ' CZ3' ' O ' ' A' ' 251' ' ' LEU . 2.8 p90 -173.52 129.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . 0.889 ' C ' HD23 ' A' ' 255' ' ' LEU . . . 151.07 -124.98 1.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.536 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -135.35 179.76 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 238' ' ' ASN . . . -39.08 -35.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -93.56 57.61 2.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 253' ' ' TRP . 30.2 tp60 -113.74 157.21 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 260' ' ' LEU . . . 41.05 -159.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.518 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 18.2 mt -153.98 161.34 42.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.22 139.53 51.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 5.5 t -91.88 114.75 27.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -78.19 7.03 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.4 -65.1 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.6 p -93.69 -40.4 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.81 33.85 3.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 17.0 ttp -106.52 119.04 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -87.56 139.95 30.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.34 164.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.578 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.0 m80 -67.54 -176.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.22 -36.57 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.778 ' O ' HG22 ' A' ' 275' ' ' THR . 0.0 OUTLIER -94.07 -42.05 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 67.9 m -48.71 -22.37 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.553 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 3.0 pt20 -64.01 -41.08 97.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 272' ' ' ARG . 10.6 t -74.46 -6.03 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 35.4 mttt -95.21 -12.41 26.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.5 171.27 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.55 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -92.9 171.73 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.649 ' C ' HD22 ' A' ' 280' ' ' LEU . 35.2 t-20 -104.12 50.95 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.649 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.0 mm? -128.12 59.43 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.45 128.93 34.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.77 -17.86 50.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.69 -28.23 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 28.7 p30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.784 0.326 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.413 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 11.0 mmt -112.78 97.04 39.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.1 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.693 2.262 . . . . 0.0 112.344 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -83.44 115.74 22.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 233' ' ' ARG . 14.3 mtp-105 -74.72 62.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 36.9 m-85 -60.58 135.84 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -141.49 132.45 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.3 129.67 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.61 115.6 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.411 ' OD1' ' C ' ' A' ' 238' ' ' ASN . 36.0 t-20 -88.61 108.27 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -126.93 173.62 9.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' SER . 0.3 OUTLIER -109.81 -53.16 2.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' LYS . 84.5 p -36.34 150.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 116.56 4.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.421 HG21 ' CB ' ' A' ' 268' ' ' ASN . 3.8 m -121.32 141.79 50.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -119.85 145.01 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.78 125.03 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.8 9.25 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 84.5 t60 -119.13 -73.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 250' ' ' THR . 15.3 p -75.48 -22.82 56.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 66.76 46.19 77.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . 0.462 HG23 ' SG ' ' A' ' 248' ' ' CYS . 5.8 p -133.23 153.72 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.135 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 251' ' ' LEU . 13.0 mt -65.21 160.72 20.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 0.537 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.8 mm? -87.47 179.53 6.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -141.15 151.44 43.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 92.69 -156.57 23.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 255' ' ' LEU . 5.4 mp -125.75 -70.09 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -88.02 -178.0 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.466 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 4.7 mpt_? 44.88 26.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -54.2 108.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 37.95 -151.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.82 170.46 15.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -142.84 128.29 18.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.4 t -72.06 114.36 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.88 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -83.86 -71.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 26.7 p -86.39 -46.5 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.88 60.37 0.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 10.5 ttp -118.83 146.85 44.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.338 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.421 ' CB ' HG21 ' A' ' 243' ' ' THR . 0.9 OUTLIER -106.96 122.33 46.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 15.3 m -143.19 179.89 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 0.537 ' NE2' HD13 ' A' ' 252' ' ' LEU . 11.1 m80 -86.24 -176.01 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.402 ' O ' ' NE2' ' A' ' 274' ' ' GLN . 67.8 m-70 -77.55 -35.28 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -94.09 -38.53 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 95.0 m -55.61 -27.32 48.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 24.6 pt20 -61.53 -35.16 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 31.8 p -80.01 7.04 9.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 49.8 mttt -114.31 -8.19 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -84.09 174.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.651 ' HB1' HD12 ' A' ' 280' ' ' LEU . . . -84.57 -178.64 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.09 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -117.57 30.88 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.651 HD12 ' HB1' ' A' ' 278' ' ' ALA . 3.9 mp -106.83 65.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 44.5 t -83.6 122.84 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.58 -38.34 3.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.53 -19.65 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.924 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.869 0.366 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.435 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -111.52 97.08 35.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.56 0.695 . . . . 0.0 110.847 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.8 153.51 68.65 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.335 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 99.0 m-70 -70.05 116.94 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -70.96 70.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 232' ' ' HIS . 51.0 m-85 -62.21 139.16 58.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.443 ' HA ' ' CE ' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -146.2 135.13 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' HD23 ' A' ' 260' ' ' LEU . 2.5 t -52.67 126.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.85 145.19 28.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -85.2 108.45 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -79.62 82.13 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.14 -33.29 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.4 149.75 41.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.94 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' THR . . . . . 0.747 HG21 HD22 ' A' ' 268' ' ' ASN . 93.7 m -115.58 126.26 53.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' PHE . . . . . 0.63 ' CE2' HD11 ' A' ' 251' ' ' LEU . 37.8 m-85 -70.04 122.31 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 12.9 t -47.93 124.7 7.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.95 7.29 7.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 52.3 t60 -110.89 -70.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.09 -15.41 53.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 -20.09 28.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.13 152.51 29.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.139 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.63 HD11 ' CE2' ' A' ' 244' ' ' PHE . 6.4 mt -76.44 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' LEU . . . . . 1.091 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -136.57 160.83 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -143.68 155.53 44.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 157.6 -177.71 34.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.41 -40.02 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 0.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' ARG . . . -144.51 159.24 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ARG . . . . . 0.531 ' CB ' HG13 ' A' ' 236' ' ' VAL . 24.9 ptt180 36.15 44.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -54.45 -39.66 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.82 -168.07 13.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 236' ' ' VAL . 4.8 mt -126.13 131.07 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -103.49 144.57 31.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.7 t -85.13 119.7 25.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -84.34 3.65 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.507 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -97.63 -48.65 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.3 p -113.12 -39.82 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.79 65.11 0.72 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' A' ' 268' ' ' ASN . 7.0 ttp -121.66 159.44 26.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.747 HD22 HG21 ' A' ' 243' ' ' THR . 10.7 m-20 -122.81 122.68 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 171.38 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' HIS . . . . . 1.091 ' CD2' HD23 ' A' ' 252' ' ' LEU . 12.8 m80 -71.77 -177.95 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' HIS . . . . . 0.406 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 46.7 m-70 -72.19 -36.38 69.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -93.95 -44.06 8.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 277' ' ' VAL . 81.5 m -47.36 -31.84 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 275' ' ' THR . 9.8 pt20 -52.66 -50.54 63.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' THR . . . . . 0.536 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 24.8 p -76.5 -5.36 47.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' LYS . . . . . 0.553 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -94.69 -17.82 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -74.49 176.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.094 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -84.54 162.58 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -98.25 50.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.82 75.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 48.9 t -82.0 140.97 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.2 -36.01 2.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 283' ' ' ILE . 2.1 mp -65.03 -24.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 31.3 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.952 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 42.9 t -168.22 171.88 9.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.893 0.378 . . . . 0.0 110.864 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.9 t -110.09 105.82 15.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.882 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 151.25 -145.89 14.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.495 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.5 t -149.88 147.12 27.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 110.835 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.4 m -125.14 163.97 21.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -127.46 -101.18 1.11 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.473 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 227' ' ' LYS . 5.8 mmtp -87.08 139.61 30.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.78 145.77 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.513 ' HB3' HD23 ' A' ' 280' ' ' LEU . 12.6 m-20 -136.07 134.66 38.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 32.5 mtm -124.4 143.73 43.89 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.587 0.708 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 173.24 11.28 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.667 2.244 . . . . 0.0 112.283 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.479 ' CB ' ' CE2' ' A' ' 234' ' ' PHE . 90.0 m-70 -92.29 116.51 29.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -69.99 69.27 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.479 ' CE2' ' CB ' ' A' ' 232' ' ' HIS . 43.9 m-85 -78.63 120.19 22.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.892 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -124.42 137.49 54.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 257' ' ' ARG . 59.7 t -55.4 146.76 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.145 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.78 ' CD1' ' CD2' ' A' ' 239' ' ' TYR . 1.9 t80 -142.8 131.16 22.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -101.82 98.11 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.78 ' CD2' ' CD1' ' A' ' 237' ' ' TYR . 0.1 OUTLIER -140.3 173.85 11.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.26 83.83 2.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 28.9 p -161.07 149.33 12.82 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.651 0.739 . . . . 0.0 110.86 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 100.1 0.8 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.359 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.547 ' OG1' HD13 ' A' ' 252' ' ' LEU . 1.1 p -92.86 148.49 21.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.151 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -122.26 135.9 54.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.868 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -77.53 141.43 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -91.67 6.81 44.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.49 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 54.7 t60 -119.36 -68.96 0.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 17.3 p -77.76 -14.08 59.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.875 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 55.33 54.45 34.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.475 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.0 p -138.75 -179.35 5.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.809 0.338 . . . . 0.0 111.164 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 6.5 mp -89.62 163.31 15.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.705 ' N ' HD12 ' A' ' 252' ' ' LEU . 0.2 OUTLIER -123.32 124.04 42.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.907 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.9 t-105 -109.95 105.47 14.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.914 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -141.9 -176.18 15.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.529 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.431 ' C ' HD13 ' A' ' 255' ' ' LEU . 3.2 tm? -124.19 -56.82 1.62 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.07 -28.56 6.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' GLY . 80.0 mtt180 -109.02 43.36 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -52.44 86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 52.61 -154.63 5.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.466 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.448 ' CD2' HG22 ' A' ' 236' ' ' VAL . 14.9 mt -138.87 156.88 46.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.893 0.378 . . . . 0.0 110.927 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.415 ' HD2' ' C ' ' A' ' 261' ' ' LYS . 6.1 tmmm? -136.65 124.17 22.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -66.25 121.05 14.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -82.89 -0.67 49.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.844 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.672 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -96.57 -74.14 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.107 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -79.71 -38.57 33.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.95 65.28 0.82 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.476 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -131.06 147.71 52.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -110.63 116.73 31.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.596 HG21 ' HA ' ' A' ' 274' ' ' GLN . 2.9 m -142.29 157.03 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.138 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -64.54 173.67 2.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -64.67 -38.95 92.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.838 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -89.01 -40.68 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 72.9 m -61.14 -12.8 13.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.596 ' HA ' HG21 ' A' ' 269' ' ' VAL . 7.2 pt20 -75.35 -45.38 39.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.451 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 3.1 p -72.75 2.71 6.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.154 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.49 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 25.6 mtpp -101.87 -17.36 16.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.48 157.11 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.143 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -59.08 154.73 15.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -94.43 41.56 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 229' ' ' ASP . 39.4 mt -121.78 86.99 2.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 7.2 t -94.6 116.12 28.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.25 -35.57 4.8 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.501 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.541 ' H ' HD12 ' A' ' 283' ' ' ILE . 5.3 mp -71.8 -27.21 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.817 0.342 . . . . 0.0 111.123 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.921 179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 28.8 t -166.33 165.68 17.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 0.0 110.847 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 43.2 t -153.34 -176.99 6.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -165.72 84.51 0.1 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 6.9 p -113.05 171.58 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.834 0.35 . . . . 0.0 110.879 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 3.8 p -149.6 160.53 43.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 110.21 -109.27 2.62 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.514 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -105.47 64.18 0.7 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.764 0.316 . . . . 0.0 110.89 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.415 ' O ' HD12 ' A' ' 283' ' ' ILE . 8.6 mm -106.75 100.35 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.144 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -119.81 135.7 54.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 24.0 mtm -130.17 143.98 51.33 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 0.0 110.853 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 171.15 15.01 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.659 2.239 . . . . 0.0 112.314 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -93.65 122.85 36.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.412 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 84.8 mtt-85 -69.96 72.46 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.84 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.49 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.31 132.46 37.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -144.57 129.67 18.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.81 117.89 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.089 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.579 ' CE1' ' HB3' ' A' ' 261' ' ' LYS . 0.2 OUTLIER -144.58 153.68 42.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -91.89 121.07 33.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.58 ' CE2' ' O ' ' A' ' 241' ' ' SER . 0.7 OUTLIER -118.67 178.78 4.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -123.48 168.95 11.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.58 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 1.5 t 62.22 147.15 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.691 0.757 . . . . 0.0 110.852 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 144.74 54.92 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.686 2.257 . . . . 0.0 112.346 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.692 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.0 OUTLIER -139.53 136.74 34.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.11 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.423 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 38.7 m-85 -94.33 127.15 40.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . 0.49 ' CB ' ' O ' ' A' ' 250' ' ' THR . 9.4 t -53.32 109.06 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -68.1 -2.83 8.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.921 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 66.0 t60 -93.14 -67.05 0.88 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.873 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.0 p -89.3 -13.5 37.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.916 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 90.15 -22.05 28.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.49 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -79.93 156.36 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.84 0.352 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 243' ' ' THR . 3.8 mt -68.92 175.11 3.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.495 HD11 ' CG2' ' A' ' 243' ' ' THR . 12.4 mt -96.43 178.08 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.578 ' CE2' ' CD2' ' A' ' 270' ' ' HIS . 0.3 OUTLIER -144.28 130.95 20.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.561 ' O ' HD12 ' A' ' 255' ' ' LEU . . . 137.57 -170.26 23.73 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.561 HD12 ' O ' ' A' ' 254' ' ' GLY . 9.9 mp -125.57 -72.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.902 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -86.17 -36.12 19.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.426 ' HG2' ' NE2' ' A' ' 271' ' ' HIS . 38.7 ttp180 -104.3 41.89 1.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 254' ' ' GLY . 8.0 tt0 -70.13 84.93 0.54 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.429 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 76.55 -154.27 43.69 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.58 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 4.8 mt -147.02 130.02 16.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 237' ' ' TYR . 11.1 tptm -102.87 122.49 44.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 6.3 t -65.98 131.82 47.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.896 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -99.39 11.95 37.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -109.05 -31.89 7.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -129.93 -45.59 1.15 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.877 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 110.69 79.42 1.04 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 5.9 ttp -150.19 139.53 21.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.792 0.33 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.416 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.9 OUTLIER -105.73 132.62 51.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -150.66 155.89 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.578 ' CD2' ' CE2' ' A' ' 253' ' ' TRP . 12.5 m80 -52.63 -175.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.882 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.426 ' NE2' ' HG2' ' A' ' 257' ' ' ARG . 20.0 m-70 -76.65 -36.5 57.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.813 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.735 ' O ' HG22 ' A' ' 275' ' ' THR . 0.3 OUTLIER -93.43 -42.83 9.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 66.7 m -47.03 -26.21 0.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.58 ' NE2' ' CD1' ' A' ' 260' ' ' LEU . 6.3 pt20 -62.68 -45.52 92.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.735 HG22 ' O ' ' A' ' 272' ' ' ARG . 13.7 t -75.08 5.32 5.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 26.1 mtpt -108.64 -19.06 13.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 277' ' ' VAL . 1.7 t -73.75 158.55 5.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.091 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -66.28 160.83 23.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.066 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.63 45.74 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.74 86.08 2.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 22.3 t -93.45 110.82 22.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 73.02 35.35 57.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.517 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 228' ' ' ILE . 8.5 mm -105.87 -20.92 5.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.857 0.36 . . . . 0.0 111.134 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.419 ' C ' ' OD1' ' A' ' 284' ' ' ASN . 15.5 p30 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 222' ' ' SER . 8.7 t -139.68 175.73 9.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.903 0.382 . . . . 0.0 110.857 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.419 ' N ' ' OG ' ' A' ' 221' ' ' SER . 27.4 t -140.27 167.91 21.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.918 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -82.07 -174.76 49.98 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.447 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 8.2 t -159.52 162.94 35.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 9.9 p -39.62 114.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -90.37 17.7 52.78 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.478 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -112.74 83.87 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.735 0.302 . . . . 0.0 110.895 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 19.3 mt -104.33 108.59 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.113 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.426 ' CB ' HD23 ' A' ' 280' ' ' LEU . 1.2 p30 -68.57 113.19 5.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.845 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 20.1 mmt -117.97 143.16 32.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.605 0.717 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 173.22 11.34 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.663 2.242 . . . . 0.0 112.352 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.582 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 93.1 m-70 -88.67 123.13 32.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -69.39 70.12 0.26 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' HG22 ' A' ' 269' ' ' VAL . 48.3 m-85 -71.8 138.85 48.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -155.29 122.81 5.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 257' ' ' ARG . 89.2 t -55.37 133.66 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.115 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 72.1 t80 -143.32 164.12 31.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.405 ' N ' ' CG ' ' A' ' 237' ' ' TYR . 4.5 t30 -92.0 124.81 36.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.879 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.516 ' CZ ' ' NE2' ' A' ' 258' ' ' GLN . 3.6 m-30 -102.29 176.34 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.41 7.43 4.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 34.6 m -161.39 150.1 13.07 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.651 0.739 . . . . 0.0 110.878 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 113.78 3.49 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.639 2.226 . . . . 0.0 112.386 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.541 HG21 HD22 ' A' ' 268' ' ' ASN . 13.6 m -100.01 164.14 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.157 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.54 ' N ' HG22 ' A' ' 243' ' ' THR . 36.2 m-85 -111.45 126.44 54.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.9 t -52.18 133.68 33.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -85.58 9.36 16.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.835 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.5 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 74.7 t60 -119.33 -71.64 0.73 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.9 p -75.5 -28.9 59.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.877 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.15 49.93 9.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.515 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 30.8 p -136.82 142.71 42.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.816 0.341 . . . . 0.0 111.192 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.76 157.8 0.24 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . . . . . . . . . 10.9 mp -108.72 97.72 7.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.515 ' O ' HD22 ' A' ' 255' ' ' LEU . 20.9 m95 -51.31 -69.72 0.1 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -42.86 138.42 3.12 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.493 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.515 HD22 ' O ' ' A' ' 253' ' ' TRP . 2.2 mm? -102.63 -74.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -48.26 -23.46 0.9 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.438 ' O ' ' C ' ' A' ' 258' ' ' GLN . 36.4 ttm180 -103.71 -39.49 6.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.516 ' NE2' ' CZ ' ' A' ' 239' ' ' TYR . 0.0 OUTLIER 34.32 43.3 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.432 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 70.52 -119.91 8.76 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.432 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 6.8 mt -148.75 154.01 38.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.918 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -133.65 102.62 5.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.3 t -43.52 132.85 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.891 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.23 1.46 57.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.686 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -101.65 -71.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.063 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.1 p -80.62 -42.19 22.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.97 40.17 2.18 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.51 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.439 ' HE1' HG11 ' A' ' 277' ' ' VAL . 0.6 OUTLIER -102.37 149.96 23.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.541 HD22 HG21 ' A' ' 243' ' ' THR . 0.5 OUTLIER -117.86 123.22 45.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.586 HG22 ' CE1' ' A' ' 234' ' ' PHE . 11.5 m -149.89 148.66 15.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -52.19 -174.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.85 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -79.33 -30.27 42.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.829 ' O ' HG22 ' A' ' 275' ' ' THR . 79.8 mtm180 -93.14 -36.41 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 75.8 m -64.51 -14.79 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.533 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 13.2 pt20 -71.01 -35.05 71.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.829 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.8 t -79.52 8.46 6.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.5 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 60.0 mttt -115.47 -14.19 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.943 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.556 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -77.03 170.0 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.067 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.556 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -67.29 156.1 37.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -100.09 30.93 3.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.426 HD23 ' CB ' ' A' ' 229' ' ' ASP . 0.5 OUTLIER -129.35 93.0 3.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 18.3 t -90.17 112.05 23.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 101.33 -41.39 2.15 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -48.41 -27.63 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 111.08 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.2 m120 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.873 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.562 -0.215 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 67.7 p -163.17 165.36 24.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.875 0.369 . . . . 0.0 110.89 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.3 m -153.94 -178.74 7.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 161.73 115.21 0.35 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.465 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.8 m -78.11 161.53 27.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.876 0.369 . . . . 0.0 110.889 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 85.3 p -122.41 94.67 4.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.884 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -104.62 166.56 15.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -112.29 99.51 8.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.769 0.319 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 228' ' ' ILE . 2.3 pp -133.25 161.65 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.442 ' HB3' HD23 ' A' ' 280' ' ' LEU . 0.3 OUTLIER -40.84 102.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 179.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -71.18 142.73 87.58 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.557 0.694 . . . . 0.0 110.848 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 173.19 11.33 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.375 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 97.0 m-70 -95.65 120.07 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.846 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.43 72.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.902 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 24.7 m-85 -78.18 114.11 16.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.847 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.7 132.16 45.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 70.7 t -52.96 138.64 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.096 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -146.31 154.31 41.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -99.86 105.68 17.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.418 ' OH ' ' ND2' ' A' ' 268' ' ' ASN . 30.0 m-85 -90.79 137.3 32.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -95.76 29.8 2.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 13.2 p -170.28 150.62 3.55 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.627 0.727 . . . . 0.0 110.849 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 100.53 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.72 2.28 . . . . 0.0 112.297 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.508 ' O ' HD12 ' A' ' 252' ' ' LEU . 6.7 m -93.72 149.68 21.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.143 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -95.16 146.07 24.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 7.9 t -71.67 130.86 42.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.88 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.14 7.83 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 50.2 t60 -116.52 -69.7 0.84 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.4 p -80.05 -26.74 39.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 73.83 50.68 10.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 29.8 p -138.51 148.76 44.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 0.0 111.143 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 14.2 mt -44.7 168.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 243' ' ' THR . 13.8 mt -108.14 178.2 4.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.949 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 13.6 t-105 -168.59 129.28 1.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 159.04 131.06 1.21 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.449 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -52.37 -67.57 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.8 0.333 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -113.45 -33.59 5.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -84.99 68.51 10.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -73.55 78.49 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 65.67 -148.79 51.36 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.494 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 11.9 mt -148.8 131.14 15.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.377 . . . . 0.0 110.963 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.411 ' HD2' ' C ' ' A' ' 261' ' ' LYS . 0.1 OUTLIER -113.41 142.86 45.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.887 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.6 t -77.38 132.98 38.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -93.71 10.73 31.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -112.67 -71.39 0.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.102 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -82.06 -45.31 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.08 65.25 0.56 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 2.6 ttp -134.03 139.55 46.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -106.17 125.4 50.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.879 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' A' ' 274' ' ' GLN . 29.3 m -144.17 146.78 20.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 18.3 m80 -51.58 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -35.95 66.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.826 ' O ' HG22 ' A' ' 275' ' ' THR . 9.5 mpt_? -93.95 -37.4 11.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.49 -21.08 14.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 3.3 pt20 -65.49 -40.88 93.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.89 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.826 HG22 ' O ' ' A' ' 272' ' ' ARG . 15.3 t -75.2 -3.61 34.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 43.7 mttp -97.43 -14.86 20.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -81.37 166.38 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.144 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.403 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -80.21 155.43 27.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -88.35 34.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.896 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.442 HD23 ' HB3' ' A' ' 229' ' ' ASP . 8.2 mt -116.15 88.46 2.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.0 t -93.14 125.29 37.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 86.56 -32.04 4.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.467 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.418 HG13 ' CD2' ' A' ' 280' ' ' LEU . 50.7 mm -44.58 -25.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 111.133 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.8 p -159.58 154.41 24.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.893 0.378 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 t -149.42 152.81 36.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.87 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -127.31 -157.38 9.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 80.6 p -148.91 155.03 40.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.36 . . . . 0.0 110.861 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 5.8 m -124.13 141.46 52.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.851 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -86.07 153.54 26.85 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.08 48.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.408 ' O ' ' C ' ' A' ' 229' ' ' ASP . 1.2 pt -123.15 151.71 27.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 228' ' ' ILE . 13.9 p-10 -37.47 114.68 0.35 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.853 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.441 ' O ' ' C ' ' A' ' 279' ' ' ASN . 17.5 mtm -124.61 143.77 44.36 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.6 0.714 . . . . 0.0 110.858 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 171.54 14.34 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.259 . . . . 0.0 112.311 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -91.75 129.4 37.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.402 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 55.7 mtp85 -69.69 69.58 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 34.9 m-85 -68.83 143.42 54.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -162.59 121.07 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 37.6 t -52.41 142.93 4.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.4 ' CG ' ' N ' ' A' ' 238' ' ' ASN . 16.5 t80 -147.24 154.95 41.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.415 ' O ' ' CG ' ' A' ' 238' ' ' ASN . 18.2 p-10 -91.95 96.9 10.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.575 ' CD2' ' OE1' ' A' ' 258' ' ' GLN . 0.1 OUTLIER -91.79 163.6 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 -27.29 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 239' ' ' TYR . 2.3 m -99.26 156.77 35.07 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.681 0.753 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 149.95 67.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.704 2.269 . . . . 0.0 112.343 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.797 ' OG1' HD23 ' A' ' 252' ' ' LEU . 1.1 p -135.21 155.61 50.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.14 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -117.95 108.51 15.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 6.9 t -56.81 101.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -67.8 -6.09 19.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.542 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 31.4 t60 -82.67 -70.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.865 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 28.7 p -79.87 -36.36 36.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 106.86 20.5 8.8 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.474 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 73.0 p -131.94 139.94 48.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.108 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.28 178.32 0.14 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.797 HD23 ' OG1' ' A' ' 243' ' ' THR . 2.6 mm? -93.3 149.37 21.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 45.3 m95 -119.3 12.84 12.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.935 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.541 ' C ' HD22 ' A' ' 255' ' ' LEU . . . -79.68 -176.15 48.8 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.444 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.663 ' N ' HD22 ' A' ' 255' ' ' LEU . 1.4 mm? -108.41 -64.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.801 0.334 . . . . 0.0 110.908 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -127.71 26.55 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.089 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.453 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 0.2 OUTLIER -127.15 -30.61 2.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.575 ' OE1' ' CD2' ' A' ' 239' ' ' TYR . 5.8 pt20 35.84 38.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.471 ' O ' ' CE1' ' A' ' 271' ' ' HIS . . . 79.86 -107.16 2.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.472 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.458 ' CD1' ' CD ' ' A' ' 274' ' ' GLN . 44.8 mt -154.54 146.22 23.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.848 0.356 . . . . 0.0 110.949 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.486 ' HE3' ' ND2' ' A' ' 268' ' ' ASN . 3.0 tppp? -125.45 117.38 23.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.402 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 4.3 t -64.45 134.87 55.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.09 -2.7 27.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.567 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -91.81 -34.36 14.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.113 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.5 p -126.43 -40.17 1.97 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 101.73 83.25 1.72 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.446 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.0 ttp -145.82 135.92 23.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.486 ' ND2' ' HE3' ' A' ' 261' ' ' LYS . 0.6 OUTLIER -99.27 127.53 45.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.52 156.03 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.169 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.512 ' CD2' ' CD1' ' A' ' 252' ' ' LEU . 16.5 m80 -58.77 -177.91 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.471 ' CE1' ' O ' ' A' ' 259' ' ' GLY . 42.1 m-70 -74.95 -35.37 62.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 275' ' ' THR . 11.6 ptp180 -93.31 -38.71 11.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.884 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 61.7 m -52.66 -16.28 0.91 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.901 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.484 ' CG ' ' N ' ' A' ' 275' ' ' THR . 10.0 pt20 -68.91 -47.05 66.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 272' ' ' ARG . 2.0 t -73.01 1.96 7.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.145 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.542 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 44.6 mttm -102.56 -23.58 13.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.613 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.7 t -68.01 172.97 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.106 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.613 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -93.83 150.86 20.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.12 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.798 ' C ' HD22 ' A' ' 280' ' ' LEU . 25.8 m-80 -79.9 52.6 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.798 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.1 mm? -127.78 73.85 1.49 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.4 t -92.0 121.13 33.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.915 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 61.49 11.72 29.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.705 HG21 HD12 ' A' ' 280' ' ' LEU . 10.0 mm -72.66 -89.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.856 0.36 . . . . 0.0 111.089 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . 0.637 ' N ' HG22 ' A' ' 283' ' ' ILE . 2.1 t30 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 41.0 t -155.48 130.71 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.908 0.385 . . . . 0.0 110.799 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 1.2 p -70.03 160.11 32.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.823 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -129.47 -146.74 6.14 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.5 m -148.44 120.94 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.888 0.375 . . . . 0.0 110.84 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 17.5 m -154.44 174.24 15.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.84 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 154.95 179.18 29.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.507 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -115.91 113.6 23.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.767 0.318 . . . . 0.0 110.877 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 9.7 mt -129.03 140.23 49.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 229' ' ' ASP . 0.3 OUTLIER -126.6 -175.02 3.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 42.4 mtm -122.97 142.26 37.66 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.608 0.718 . . . . 0.0 110.888 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 173.18 11.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.361 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.579 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 69.8 m-70 -90.59 116.11 28.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 264' ' ' ALA . 23.0 mtp180 -63.63 74.39 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.579 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 24.8 m-85 -84.64 140.7 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -156.93 120.07 4.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 257' ' ' ARG . 42.8 t -44.59 127.08 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.136 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.498 ' CE1' ' O ' ' A' ' 238' ' ' ASN . 42.6 t80 -145.38 141.43 28.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.943 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.498 ' O ' ' CE1' ' A' ' 237' ' ' TYR . 31.0 t-20 -86.97 122.2 30.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.586 ' C ' ' CD1' ' A' ' 239' ' ' TYR . 0.0 OUTLIER -126.28 179.38 5.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.91 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -130.81 -62.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.573 ' O ' ' CE2' ' A' ' 239' ' ' TYR . 13.6 m -43.34 144.45 1.22 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.66 0.743 . . . . 0.0 110.845 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.48 28.02 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.691 2.261 . . . . 0.0 112.341 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.456 HG23 ' CD1' ' A' ' 252' ' ' LEU . 4.3 t -136.35 153.54 51.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.137 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -122.23 140.86 52.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -61.85 143.71 55.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -93.63 9.1 38.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.557 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 26.1 t60 -121.76 -67.15 0.98 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.853 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.0 p -75.45 -29.41 59.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 82.82 38.2 12.08 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.459 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 25.0 p -138.99 141.8 38.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 0.0 111.157 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.54 173.37 4.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.897 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.2 OUTLIER -121.78 163.33 19.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.918 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 26.3 p-90 -153.16 126.32 8.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -168.4 151.67 18.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.503 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.9 tp -56.6 -65.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.92 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.77 -55.96 2.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.439 ' HA ' HG13 ' A' ' 236' ' ' VAL . 51.1 mtm180 -70.45 73.03 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.21 88.91 7.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.509 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 57.25 -147.71 34.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.492 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 259' ' ' GLY . 8.1 mt -147.09 119.04 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.901 0.382 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -100.17 110.65 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 1.8 t -55.42 130.52 42.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.889 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.5 1.6 51.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.874 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -98.21 -50.82 4.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.1 p -107.02 -35.62 6.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 96.37 73.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.531 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.0 ttp -145.25 135.5 24.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.755 0.312 . . . . 0.0 110.936 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -95.11 115.83 27.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 277' ' ' VAL . 4.3 m -134.96 150.2 29.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.085 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.897 ' CD2' HD23 ' A' ' 252' ' ' LEU . 28.4 m80 -64.25 167.13 7.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -61.32 -26.9 68.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.856 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.415 ' HG3' ' NZ ' ' A' ' 276' ' ' LYS . 4.8 tpt180 -93.87 -63.29 1.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.497 ' O ' HG23 ' A' ' 277' ' ' VAL . 4.6 m -46.47 -20.82 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.542 ' CG ' ' N ' ' A' ' 275' ' ' THR . 0.6 OUTLIER -46.94 -50.66 18.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.542 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 0.9 OUTLIER -67.54 -41.42 84.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.145 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.557 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 0.7 OUTLIER -50.24 -26.21 4.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.885 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 269' ' ' VAL . 1.8 t -76.03 126.76 37.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.111 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.869 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -44.59 136.62 4.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.088 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -75.93 51.67 0.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.869 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 4.9 mp -125.37 78.63 1.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.94 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 6.9 t -88.69 142.57 27.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.55 -7.46 76.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.511 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.427 ' CG1' ' HB3' ' A' ' 280' ' ' LEU . 3.9 mm -73.71 -28.87 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 5.6 m120 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.4 m -106.59 176.29 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.912 0.387 . . . . 0.0 110.874 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 6.6 m -152.6 178.03 10.03 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.862 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -71.21 121.08 8.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.496 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.2 p -76.47 149.09 36.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.89 179.9 5.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.829 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -96.54 -97.24 1.85 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -130.81 -175.65 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 5.3 pt -107.67 76.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.082 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -128.92 140.25 51.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.843 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 35.4 mtm -128.58 143.76 49.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.608 0.718 . . . . 0.0 110.841 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 164.24 35.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.633 2.222 . . . . 0.0 112.379 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.571 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 86.0 m-70 -87.45 120.41 28.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.487 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 15.0 mmt85 -70.94 68.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.571 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 51.7 m-85 -71.59 138.1 48.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -143.49 128.71 18.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 71.6 t -60.09 127.15 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.13 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.81 148.87 32.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -85.08 105.8 16.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.553 ' CE2' ' CB ' ' A' ' 258' ' ' GLN . 7.1 p90 -113.23 120.79 42.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.906 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.468 ' HE2' ' N ' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -86.39 -62.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.909 179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 52.6 p -39.0 144.35 0.43 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.7 0.762 . . . . 0.0 110.823 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 138.03 36.75 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.643 2.229 . . . . 0.0 112.387 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.831 ' O ' HD23 ' A' ' 251' ' ' LEU . 2.8 t -145.83 146.9 31.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.136 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 251' ' ' LEU . 7.4 m-85 -106.02 132.61 51.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.89 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 250' ' ' THR . 7.5 t -63.35 103.85 0.55 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.74 -7.41 7.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.584 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 52.3 t60 -87.23 -70.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.6 p -85.86 -9.82 56.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 245' ' ' CYS . . . 85.21 -19.77 20.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.468 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.486 ' O ' ' CB ' ' A' ' 245' ' ' CYS . 0.2 OUTLIER -81.19 157.14 25.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.831 HD23 ' O ' ' A' ' 243' ' ' THR . 7.3 mt -76.83 -176.87 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.923 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.545 HD12 ' CZ ' ' A' ' 239' ' ' TYR . 0.2 OUTLIER -145.94 145.31 30.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.951 179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 9.7 t90 -173.23 130.92 0.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.914 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -177.21 -134.32 1.98 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.53 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' A' ' 258' ' ' GLN . 2.5 mm? -83.98 178.07 8.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.796 0.331 . . . . 0.0 110.911 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . . . -37.61 -34.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.074 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 44.8 mtt85 -86.65 36.51 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.553 ' CB ' ' CE2' ' A' ' 239' ' ' TYR . 73.4 mt-30 -41.28 -74.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -130.72 -162.9 10.83 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.476 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 26.5 mt -131.72 126.36 34.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.885 0.374 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -106.59 114.37 28.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.487 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 3.7 t -62.45 125.78 25.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.896 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -94.61 18.13 12.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.628 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.22 -40.52 3.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.1 p -119.78 -44.95 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 108.4 78.82 1.1 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.469 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.2 ttp -146.17 141.17 27.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.787 0.327 . . . . 0.0 110.875 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -106.03 122.59 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.6 m -142.4 154.95 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.151 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 251' ' ' LEU . 13.7 m80 -51.64 179.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -69.13 -36.5 77.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.654 ' O ' HG22 ' A' ' 275' ' ' THR . 27.4 mtt-85 -93.89 -49.13 5.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.642 ' O ' HG23 ' A' ' 277' ' ' VAL . 61.3 m -39.29 -27.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.511 ' CG ' ' N ' ' A' ' 275' ' ' THR . 12.6 pt20 -52.46 -49.77 63.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.654 HG22 ' O ' ' A' ' 272' ' ' ARG . 0.7 OUTLIER -70.55 -37.35 74.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.604 ' CE ' HG23 ' A' ' 275' ' ' THR . 0.4 OUTLIER -54.82 -31.82 59.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 278' ' ' ALA . 2.2 t -65.31 172.76 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.642 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -94.28 155.61 16.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.072 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.411 ' C ' HD22 ' A' ' 280' ' ' LEU . 5.8 m-20 -79.22 52.84 1.38 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 280' ' ' LEU . 4.2 mm? -123.02 78.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.942 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.628 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 13.1 t -89.16 116.52 27.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.849 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 102.46 -30.14 11.03 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.484 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 283' ' ' ILE . 4.4 mp -83.45 -77.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.847 0.356 . . . . 0.0 111.103 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 62.1 p -144.19 -175.47 4.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.4 t -130.1 132.96 46.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -103.29 110.2 3.64 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.48 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 31.8 m -85.69 110.8 19.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.849 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 226' ' ' GLY . 13.2 t -114.62 178.75 4.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . 0.424 ' N ' ' OG ' ' A' ' 225' ' ' SER . . . 167.1 -145.35 9.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.453 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.6 pttp -104.45 160.23 15.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.736 0.303 . . . . 0.0 110.947 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 8.1 mt -144.24 117.26 2.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.105 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.42 148.98 51.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.835 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 230' ' ' MET . 4.7 mpp? -125.29 143.61 44.99 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.604 0.716 . . . . 0.0 110.845 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.496 ' N ' ' ND2' ' A' ' 279' ' ' ASN . 52.9 Cg_endo -69.82 173.19 11.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.701 2.267 . . . . 0.0 112.301 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.491 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 82.6 m-70 -95.7 122.89 38.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.458 ' HG3' ' HB2' ' A' ' 264' ' ' ALA . 59.4 mtt180 -71.23 67.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.56 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 34.5 m-85 -80.28 124.34 28.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.889 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -126.77 121.44 31.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 257' ' ' ARG . 2.3 t -51.21 113.62 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 14.5 t80 -120.87 159.24 25.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.541 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.5 t30 -118.37 97.3 5.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.43 167.32 11.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.432 ' CD ' ' C ' ' A' ' 240' ' ' LYS . 0.1 OUTLIER -108.41 -52.26 2.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.922 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 21.7 m -39.09 153.23 0.18 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.702 0.763 . . . . 0.0 110.828 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 126.65 13.55 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.613 ' HB ' HD12 ' A' ' 252' ' ' LEU . 2.7 m -130.51 108.53 10.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -89.87 141.68 28.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.2 t -74.66 112.69 11.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -76.96 3.32 12.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 20.2 t60 -97.65 -67.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.883 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.3 p -82.56 -18.4 41.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 91.81 -12.68 68.79 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.505 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.4 159.88 19.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.856 0.36 . . . . 0.0 111.135 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 1.09 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.5 OUTLIER -82.85 134.89 35.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.972 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 1.09 ' N ' HD12 ' A' ' 251' ' ' LEU . 29.8 mt -46.24 172.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.867 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 32.9 p-90 -173.74 133.35 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 170.54 -171.7 43.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.47 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.5 mp -90.67 -74.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -121.11 -31.06 4.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.111 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.489 ' HB2' HG13 ' A' ' 236' ' ' VAL . 14.0 ptt180 -89.93 29.66 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.42 ' C ' ' O ' ' A' ' 257' ' ' ARG . 30.6 mt-30 -36.48 114.81 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 252' ' ' LEU . . . 42.14 -150.96 0.28 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 271' ' ' HIS . 17.2 mt -147.46 148.01 30.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.894 0.378 . . . . 0.0 110.916 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.48 ' HD3' ' ND2' ' A' ' 268' ' ' ASN . 12.7 tptm -122.97 117.03 24.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.431 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 1.8 t -65.06 128.47 35.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.925 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -93.1 -3.14 54.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.703 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -93.93 -60.2 1.8 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.049 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 29.2 p -96.03 -34.86 11.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.87 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 94.57 73.26 1.19 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.491 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.5 ttp -143.81 130.17 19.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 0.0 110.861 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -94.23 128.22 40.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.879 -179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 22.8 m -152.53 152.49 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.425 ' NE2' ' HA ' ' A' ' 252' ' ' LEU . 14.1 m80 -48.56 172.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.428 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 2.2 t60 -69.05 -32.31 71.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 50.6 ttp85 -94.14 -47.17 6.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 276' ' ' LYS . 63.6 m -44.72 -31.11 1.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.56 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 9.8 pt20 -51.6 -50.4 60.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.535 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 11.9 p -66.88 -10.44 48.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.144 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -85.92 -29.82 23.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.27 150.11 9.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -60.47 143.68 52.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.496 ' ND2' ' N ' ' A' ' 231' ' ' PRO . 2.4 t30 -78.82 54.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 11.7 mt -129.63 82.55 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.936 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.703 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 11.0 t -92.56 128.44 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 84.47 -10.96 60.13 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.7 mt -90.66 -79.58 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.111 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.85 45.08 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.938 0.399 . . . . 0.0 110.895 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.1 p -67.82 155.33 39.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -149.6 -170.95 17.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 14.8 m -126.88 -176.35 3.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.844 0.354 . . . . 0.0 110.879 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 39.0 t -153.08 142.68 21.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 165.33 -161.23 34.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.506 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.7 mmtm -141.28 161.22 38.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.743 0.306 . . . . 0.0 110.906 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pt -122.4 89.52 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.143 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.68 109.8 21.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 7.8 mtt -103.07 97.03 8.86 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.595 0.712 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.6 Cg_endo -69.75 165.1 32.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.737 2.291 . . . . 0.0 112.345 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -80.5 115.59 20.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -76.16 63.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 38.4 m-85 -59.52 152.18 22.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.908 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.403 ' NZ ' ' HA ' ' A' ' 235' ' ' LYS . 0.0 OUTLIER -148.19 118.43 7.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.1 t -46.49 126.52 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.112 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -141.63 148.81 39.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -85.44 134.25 34.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -121.84 115.71 23.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.947 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -86.39 -12.19 49.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.897 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.52 152.42 46.14 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.674 0.75 . . . . 0.0 110.845 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 108.61 2.14 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.537 ' O ' HD23 ' A' ' 251' ' ' LEU . 1.3 m -104.55 147.26 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -103.52 129.42 50.7 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.7 t -64.61 124.99 23.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.896 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -78.25 8.99 4.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -117.8 -72.07 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.859 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.1 p -75.51 -25.93 57.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 76.95 43.09 18.32 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.496 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 16.9 p -139.73 159.16 42.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.829 0.347 . . . . 0.0 111.118 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 243' ' ' THR . 29.2 mt -74.03 175.94 6.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.576 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -132.17 113.37 13.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -100.38 151.97 20.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 139.45 -9.72 3.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.537 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 19.6 mt 40.32 31.96 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -167.92 145.8 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.102 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.4 mmm180 45.22 26.2 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -42.03 104.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 40.4 -149.83 0.15 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.428 HD21 ' CE1' ' A' ' 271' ' ' HIS . 0.5 OUTLIER -142.37 170.58 15.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -137.58 131.68 32.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.0 t -75.7 140.55 42.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -97.56 6.28 48.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.62 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -107.42 -60.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.061 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.89 -44.42 9.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.933 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.24 52.51 1.0 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.501 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 21.4 ttp -115.39 163.74 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 268' ' ' ASN . 0.4 OUTLIER -124.47 128.39 48.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 16.2 m -149.69 150.98 13.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.133 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.576 ' CD2' HD23 ' A' ' 252' ' ' LEU . 14.1 m80 -51.28 -175.75 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.428 ' CE1' HD21 ' A' ' 260' ' ' LEU . 41.1 m-70 -76.54 -35.67 58.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.871 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 43.6 ttt-85 -93.94 -38.45 11.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 46.2 m -50.07 -19.15 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.893 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.488 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 7.6 pt20 -71.15 -36.9 72.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.953 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 22.4 p -77.81 2.78 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.157 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -109.74 -8.82 14.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.03 175.18 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.122 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.644 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -89.18 159.93 17.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.102 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -95.13 48.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 1.4 mt -132.34 84.34 2.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.62 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 53.7 t -94.01 114.15 26.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 75.8 -5.58 38.33 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 38.0 mm -55.25 -23.22 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 111.157 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.913 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.9 t -150.09 142.68 24.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.867 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -160.68 178.34 9.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -161.34 172.76 37.64 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.9 t -107.46 76.48 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.876 0.37 . . . . 0.0 110.88 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.9 p -103.62 76.33 1.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -126.77 -138.36 4.77 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.463 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.5 133.65 55.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.1 pt -138.19 134.62 44.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.169 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -148.32 172.65 14.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.434 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 1.6 mpt? -125.67 97.01 37.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.532 0.682 . . . . 0.0 110.888 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.79 139.71 40.79 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.65 2.234 . . . . 0.0 112.335 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.444 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 99.3 m-70 -55.75 116.68 3.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -74.35 67.75 1.46 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.586 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 62.3 m-85 -59.28 146.0 41.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -153.65 137.2 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.459 HG21 ' HD2' ' A' ' 257' ' ' ARG . 42.1 t -59.31 119.52 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.168 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -136.07 161.28 36.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -99.08 147.83 24.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.23 153.45 33.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -8.35 8.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.931 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 2.8 m -133.21 160.08 70.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.678 0.752 . . . . 0.0 110.834 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 118.85 5.93 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.679 2.253 . . . . 0.0 112.322 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 1.3 m -127.37 147.24 50.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.174 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -107.61 134.42 50.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.918 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.8 t -48.87 144.38 4.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.29 8.83 25.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.497 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 53.4 t60 -127.98 -68.13 0.79 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.854 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.88 -16.94 59.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 59.57 52.94 50.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.504 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 12.1 p -139.97 150.55 44.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 111.108 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 3.6 mp -56.56 167.98 0.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.546 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.7 mm? -96.76 -178.84 4.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -158.66 145.4 17.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 126.44 -164.79 19.88 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.515 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.4 mt -116.79 -70.42 0.79 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -100.92 -64.17 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.087 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.459 ' HD2' HG21 ' A' ' 236' ' ' VAL . 6.3 ttp-105 -83.48 69.39 10.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.848 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.421 ' O ' ' NE2' ' A' ' 271' ' ' HIS . 26.1 mt-30 -78.48 -53.5 7.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -142.91 -148.24 4.91 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.451 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 5.4 mt -139.09 154.15 48.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.94 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.16 111.96 12.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.869 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.37 124.38 15.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -88.33 7.43 32.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.855 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.481 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -103.04 -47.81 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.118 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.9 p -113.59 -45.18 3.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.59 60.22 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.518 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 3.6 ttm -124.39 124.8 43.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.748 0.309 . . . . 0.0 110.917 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -88.62 118.58 28.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.865 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.586 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 35.2 m -139.88 146.32 25.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.148 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.546 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.8 m80 -50.93 -178.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.421 ' NE2' ' O ' ' A' ' 258' ' ' GLN . 64.2 m-70 -75.75 -38.82 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -88.19 -43.51 11.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.1 m -50.25 -24.11 2.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.859 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 12.2 pt20 -61.15 -33.73 73.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 43.2 p -78.98 11.16 2.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.497 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -114.63 -33.08 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.932 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 277' ' ' VAL . 1.8 t -63.82 156.9 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.121 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.471 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -77.08 150.08 35.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.46 ' C ' HD22 ' A' ' 280' ' ' LEU . 1.0 OUTLIER -86.64 30.79 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.871 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 280' ' ' LEU . 0.9 OUTLIER -103.34 67.56 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.2 t -92.76 106.42 18.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 120.52 -27.24 6.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.471 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 4.1 mm -62.33 -26.56 40.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.809 0.338 . . . . 0.0 111.137 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 5.0 m -119.38 143.09 47.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.878 0.37 . . . . 0.0 110.84 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 29.6 t -165.53 156.46 13.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 146.41 -148.6 20.39 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.456 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 36.6 t -135.76 149.28 49.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.865 0.364 . . . . 0.0 110.873 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 m -79.47 121.96 25.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 168.02 -52.26 0.23 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.478 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -155.31 118.71 4.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 50.4 mt -98.07 142.85 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.159 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -148.66 129.99 14.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.422 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 22.1 mmt -126.32 97.04 35.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.834 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.9 Cg_endo -69.79 158.47 56.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.699 2.266 . . . . 0.0 112.297 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.45 116.08 14.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -76.28 62.22 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.528 ' CE1' HG22 ' A' ' 269' ' ' VAL . 31.1 m-85 -61.01 136.11 57.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -138.48 123.85 19.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.474 ' HA ' HD23 ' A' ' 260' ' ' LEU . 3.2 t -51.93 127.9 9.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.133 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.82 162.93 38.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.957 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 238' ' ' ASN . 0.9 OUTLIER -87.39 113.39 23.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -63.33 153.02 36.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -134.82 10.08 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 4.1 m -167.64 154.26 7.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.64 0.733 . . . . 0.0 110.902 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 122.92 9.6 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.671 2.247 . . . . 0.0 112.36 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.611 ' OG1' HD21 ' A' ' 252' ' ' LEU . 1.0 OUTLIER -118.57 163.55 16.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -120.36 104.06 9.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.69 128.91 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 54.8 mp0 -86.57 8.67 21.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.632 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 73.5 t60 -113.75 -71.22 0.76 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 23.5 p -75.45 -35.96 60.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.892 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.65 42.7 6.01 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.487 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 35.1 p -139.47 159.51 42.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.817 0.341 . . . . 0.0 111.15 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 4.6 mp -63.9 -179.52 0.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.611 HD21 ' OG1' ' A' ' 243' ' ' THR . 1.7 pt? -171.04 124.84 0.64 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -172.46 153.02 2.79 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.941 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 161.73 -117.91 0.79 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.533 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.484 ' N ' ' HG3' ' A' ' 258' ' ' GLN . 2.7 mm? -68.14 160.2 29.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.831 0.348 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.417 ' HB1' ' OD1' ' A' ' 238' ' ' ASN . . . -50.85 -50.08 57.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.106 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -78.61 47.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.484 ' HG3' ' N ' ' A' ' 255' ' ' LEU . 6.5 mm100 -99.88 146.47 26.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.869 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 51.7 179.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.491 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 236' ' ' VAL . 34.4 mt -142.96 152.81 42.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.883 0.373 . . . . 0.0 110.878 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.6 117.36 19.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 4.4 t -53.95 141.16 28.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -102.09 7.73 41.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.581 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -110.74 -68.31 0.94 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 24.1 p -84.0 -46.05 12.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.857 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.57 61.39 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.473 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 8.9 ttp -122.86 145.74 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -111.41 123.48 50.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.528 HG22 ' CE1' ' A' ' 234' ' ' PHE . 12.1 m -146.18 165.6 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -64.52 -178.71 0.41 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -75.3 -38.42 60.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.732 ' O ' HG22 ' A' ' 275' ' ' THR . 13.5 mtm-85 -89.2 -39.9 13.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.565 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.4 m -54.93 -21.2 10.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.485 ' CG ' ' N ' ' A' ' 275' ' ' THR . 4.7 pt20 -64.68 -47.81 77.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 272' ' ' ARG . 9.9 t -70.32 -0.69 8.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.632 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 61.8 mttt -101.52 -26.94 13.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.862 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 273' ' ' CYS . 3.2 t -69.08 148.79 11.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -69.55 153.28 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.555 ' ND2' ' H ' ' A' ' 279' ' ' ASN . 0.1 OUTLIER -81.09 53.58 2.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 66.1 mt -121.74 73.4 1.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.7 t -83.32 112.23 19.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 56.27 23.54 41.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.512 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 283' ' ' ILE . 19.7 mm -70.44 -24.43 25.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.873 0.368 . . . . 0.0 111.145 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.927 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 6.9 p -118.4 165.42 13.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.853 0.359 . . . . 0.0 110.865 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.7 p -87.33 159.81 18.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -163.17 120.38 0.94 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.445 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 32.8 t -65.71 109.55 2.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.2 m -94.72 85.81 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -151.57 -172.73 20.69 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.502 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.96 136.94 36.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.4 pt -106.87 165.63 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -162.66 114.32 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.866 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 28.1 mtm -103.47 96.99 9.44 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.585 0.707 . . . . 0.0 110.878 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 157.28 61.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.619 2.213 . . . . 0.0 112.4 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -67.23 121.66 16.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -76.01 52.71 0.73 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.408 ' HB3' ' CB ' ' A' ' 260' ' ' LEU . 23.7 m-85 -51.75 132.33 31.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -139.03 134.27 32.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.87 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 36.0 t -55.29 125.47 10.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 238' ' ' ASN . 7.0 t80 -142.1 140.67 32.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.403 ' N ' ' CD1' ' A' ' 237' ' ' TYR . 4.1 p30 -101.46 111.24 23.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 158.9 26.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -94.51 -58.06 2.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 11.1 p -44.22 151.08 0.57 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.668 0.747 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 116.21 4.46 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.659 2.239 . . . . 0.0 112.329 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 13.1 m -116.2 132.27 56.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.113 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -110.21 153.24 25.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.3 t -71.15 137.07 48.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -88.52 9.19 24.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -120.93 -68.4 0.91 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.3 p -77.67 -14.34 59.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 57.05 52.67 49.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.496 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 10.6 p -138.06 157.72 45.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.836 0.351 . . . . 0.0 111.108 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.96 166.6 7.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.508 ' C ' ' CE3' ' A' ' 253' ' ' TRP . 3.2 mt -113.59 -177.77 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.508 ' CE3' ' C ' ' A' ' 252' ' ' LEU . 6.6 m-90 -151.14 -175.89 5.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 98.1 172.06 32.62 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 255' ' ' LEU . 7.2 tt -111.68 -51.27 2.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.92 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -105.15 -64.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 40.5 ttm-85 -75.69 70.69 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -93.28 99.13 11.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.921 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 50.35 -165.41 0.6 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.501 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.408 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 8.6 mt -126.6 163.14 24.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.88 0.372 . . . . 0.0 110.887 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -139.37 123.6 18.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.6 t -62.43 131.76 50.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -95.41 15.87 18.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.814 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.521 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -115.88 -66.61 1.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.123 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.4 p -88.52 -47.02 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 111.67 65.16 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.48 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 12.9 ttp -125.97 152.95 45.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.884 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -117.3 115.18 24.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.893 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 20.7 m -136.03 159.61 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.1 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.466 ' NE2' HD23 ' A' ' 252' ' ' LEU . 11.1 m80 -65.87 -175.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -76.09 -39.29 55.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 33.4 ttm-85 -89.82 -47.06 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 86.4 m -44.91 -25.04 0.26 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.427 ' CG ' ' N ' ' A' ' 275' ' ' THR . 1.2 pt20 -57.45 -44.88 85.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.864 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 27.5 p -64.5 -6.94 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -94.7 -30.89 14.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.885 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 2.1 t -72.9 126.93 34.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -47.84 173.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.123 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 27.8 p30 -99.9 46.57 0.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 53.9 mt -124.88 93.37 3.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 42.4 t -93.82 115.07 27.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.64 -29.15 3.74 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.5 mt -75.7 -28.56 19.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.894 0.378 . . . . 0.0 111.16 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.2 t30 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.917 179.949 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.64 129.55 1.94 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.0 110.9 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.7 t -109.03 89.89 3.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.925 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -65.34 138.63 38.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.468 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.0 t -78.42 145.41 35.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.853 0.358 . . . . 0.0 110.87 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 32.3 p -160.64 125.73 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.803 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -137.74 124.25 2.95 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.461 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -72.56 142.45 48.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.916 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.9 pt -90.92 144.11 9.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.136 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -120.07 133.87 55.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.871 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 12.1 mtm -107.52 97.03 17.94 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.528 0.68 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 127.05 13.98 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.649 2.233 . . . . 0.0 112.348 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -48.37 115.59 1.27 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 22.5 mtp180 -74.62 61.96 1.0 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.545 ' CE1' ' CG2' ' A' ' 269' ' ' VAL . 43.4 m-85 -52.68 139.87 25.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.66 127.23 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.443 ' CG1' ' HG3' ' A' ' 257' ' ' ARG . 54.0 t -54.94 124.65 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -134.27 138.56 45.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.441 ' ND2' ' H ' ' A' ' 238' ' ' ASN . 0.5 OUTLIER -100.39 97.66 8.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.946 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.515 ' CZ ' ' HB3' ' A' ' 258' ' ' GLN . 2.1 p90 -125.04 120.45 31.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -83.15 67.89 9.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.915 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 8.8 m -142.07 145.14 34.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.707 0.765 . . . . 0.0 110.864 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 77.87 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.681 ' O ' HD13 ' A' ' 252' ' ' LEU . 18.6 m -95.09 142.55 27.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.163 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -111.5 128.34 55.98 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 9.4 t -46.92 139.77 5.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.61 3.15 56.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 43.5 t60 -110.94 -73.02 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.66 -31.33 59.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 75.16 53.1 6.33 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.41 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 251' ' ' LEU . 55.3 p -137.03 131.85 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 111.125 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 252' ' ' LEU . 1.0 OUTLIER -34.58 126.16 0.5 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.681 HD13 ' O ' ' A' ' 243' ' ' THR . 9.9 mp -67.46 135.41 53.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.449 ' C ' ' O ' ' A' ' 252' ' ' LEU . 70.4 m95 -34.64 -74.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 118.96 56.43 0.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 258' ' ' GLN . 4.6 mp -129.69 165.97 20.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.837 0.351 . . . . 0.0 110.92 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -41.66 -25.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.504 ' CD ' ' NE2' ' A' ' 271' ' ' HIS . 13.3 ttp180 -100.49 34.81 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.515 ' HB3' ' CZ ' ' A' ' 239' ' ' TYR . 6.6 mm-40 -36.04 94.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 34.8 -148.89 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 10.4 mt -131.6 141.87 49.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.876 0.37 . . . . 0.0 110.939 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.26 104.84 10.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 11.8 t -47.99 118.55 2.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.79 4.41 6.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.89 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.9 -74.52 0.63 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.088 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.2 p -80.7 -46.0 16.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 109.36 45.07 1.02 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.6 ttp -104.88 145.17 30.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.767 0.317 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -106.08 116.14 31.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.893 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.545 ' CG2' ' CE1' ' A' ' 234' ' ' PHE . 2.6 m -139.55 149.67 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -54.92 -174.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.504 ' NE2' ' CD ' ' A' ' 257' ' ' ARG . 1.5 m-70 -82.1 -34.24 29.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.849 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -94.0 -25.61 17.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.843 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 98.0 m -71.69 -25.98 62.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.914 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 2.8 pt20 -63.23 -38.45 91.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.949 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 18.4 p -74.68 -5.34 42.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.141 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.565 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 41.4 mttm -98.5 -10.48 23.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.6 t -83.42 165.6 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.418 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -88.32 156.14 19.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.554 ' O ' HD23 ' A' ' 280' ' ' LEU . 23.4 p30 -84.89 56.66 4.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 279' ' ' ASN . 56.2 mt -131.19 81.04 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 18.7 t -91.01 111.31 22.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 96.11 -26.27 21.74 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.494 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.523 HG13 HD22 ' A' ' 280' ' ' LEU . 6.6 mm -45.81 -28.33 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 111.117 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.855 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 34.1 t -148.4 161.99 40.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.842 0.353 . . . . 0.0 110.859 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.0 t -68.17 122.96 19.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -127.63 88.61 0.33 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.516 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 4.2 m -149.26 131.37 15.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.843 0.354 . . . . 0.0 110.858 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.1 t -157.14 148.53 22.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 148.67 121.17 1.14 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.514 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -103.21 143.91 32.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.797 0.332 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.658 ' H ' HD12 ' A' ' 228' ' ' ILE . 1.1 mp -101.58 131.11 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.164 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -126.72 -179.16 4.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.01 97.01 44.18 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.574 0.702 . . . . 0.0 110.896 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 169.49 18.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.699 2.266 . . . . 0.0 112.373 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -85.69 118.17 25.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.87 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -78.97 59.38 2.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 39.5 m-85 -55.99 126.24 25.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt -131.54 133.7 45.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.91 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.535 ' CG1' ' NE ' ' A' ' 257' ' ' ARG . 2.2 t -51.58 134.99 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.132 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -144.27 157.09 44.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.15 109.5 18.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.915 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -49.17 130.81 19.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.88 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.02 11.62 3.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.944 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 32.5 m -167.73 149.29 5.06 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.642 0.734 . . . . 0.0 110.845 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 78.82 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.321 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' ' 268' ' ' ASN . 1.2 m -98.33 143.68 28.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.097 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.532 ' CD2' ' HG ' ' A' ' 251' ' ' LEU . 5.4 m-85 -102.24 151.34 22.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.923 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 4.3 t -61.56 137.81 58.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -92.91 -3.45 54.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.585 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 81.4 t60 -101.56 -70.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 20.0 p -77.2 -19.38 56.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 70.2 43.59 63.09 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.45 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.1 p -140.0 150.68 44.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 111.164 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.532 ' HG ' ' CD2' ' A' ' 244' ' ' PHE . 15.8 mt -62.18 154.55 26.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -124.68 54.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 78.6 m95 -39.12 94.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 252' ' ' LEU . . . -177.36 140.4 4.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 3.9 mt -135.04 172.51 12.91 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 255' ' ' LEU . . . 71.81 47.54 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.078 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.535 ' NE ' ' CG1' ' A' ' 236' ' ' VAL . 4.7 mmm180 74.89 50.49 0.09 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.855 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -102.57 -4.35 25.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -140.18 -164.49 9.92 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.437 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 7.4 mt -137.85 158.7 43.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -142.12 114.56 8.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.892 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 10.3 t -58.57 119.1 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.863 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -83.76 2.39 38.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.465 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -95.3 -57.57 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.126 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.3 p -104.35 -34.61 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 99.0 73.87 1.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.446 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 6.0 ttp -138.44 140.56 39.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.435 ' HB2' HG21 ' A' ' 243' ' ' THR . 0.2 OUTLIER -105.33 122.35 45.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.897 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 34.4 m -139.81 164.85 22.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.858 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.8 m80 -60.07 177.79 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -73.37 -32.04 64.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 10.3 tpp85 -93.96 -46.89 6.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.557 ' O ' HG23 ' A' ' 277' ' ' VAL . 98.5 m -45.84 -24.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.575 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 11.6 pt20 -60.11 -47.88 84.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.486 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 1.6 p -70.09 -13.23 62.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.585 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 26.0 mtpp -85.44 -33.96 21.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.9 t -62.12 142.4 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.095 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . . . . . . . . . . . -70.51 173.65 6.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.105 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.42 50.67 1.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.56 73.55 0.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.928 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 23.3 t -93.77 116.08 28.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.14 -4.89 85.39 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 283' ' ' ILE . 10.4 mm -58.25 -20.51 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.832 0.349 . . . . 0.0 111.108 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 22.4 p -119.82 179.1 4.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 63.0 p -140.44 173.94 11.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.825 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -128.92 162.4 22.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.0 m -132.42 137.69 47.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 35.6 p -143.04 120.05 11.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.86 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -135.21 148.09 19.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.81 123.6 28.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.766 0.317 . . . . 0.0 110.931 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.9 pt -69.41 179.63 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -124.19 115.27 20.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.404 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 37.8 mtp -107.79 97.05 18.89 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.617 0.722 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 153.45 69.01 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 0.0 112.358 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.474 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.5 m-70 -66.09 116.19 6.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.875 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.406 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 73.1 mtt85 -73.46 64.9 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 232' ' ' HIS . 35.3 m-85 -67.89 125.85 27.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.856 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -127.18 139.61 52.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.898 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.525 ' HA ' HD23 ' A' ' 260' ' ' LEU . 91.4 t -60.63 132.43 26.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.136 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -148.49 154.75 40.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -86.29 128.42 34.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.466 ' CE1' ' O ' ' A' ' 258' ' ' GLN . 55.5 m-85 -107.09 116.85 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.927 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -92.45 26.01 2.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 3.2 m -170.69 156.38 5.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.677 0.751 . . . . 0.0 110.838 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 139.2 39.73 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.662 2.241 . . . . 0.0 112.405 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.492 ' OG1' HD12 ' A' ' 252' ' ' LEU . 4.7 p -139.14 159.64 41.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.175 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -106.37 144.75 32.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 5.5 t -76.0 121.49 22.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -76.38 5.79 6.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.495 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 58.7 t60 -110.03 -73.25 0.69 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.873 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 27.1 p -75.56 -33.88 60.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.844 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 43.29 5.94 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.491 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.439 ' O ' ' C ' ' A' ' 251' ' ' LEU . 43.0 p -139.99 138.13 35.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.788 0.327 . . . . 0.0 111.164 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.439 ' C ' ' O ' ' A' ' 250' ' ' THR . 10.0 mt -34.78 146.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 270' ' ' HIS . 70.1 mt -94.01 121.42 35.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.913 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -102.63 148.6 25.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 147.49 157.32 7.37 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.525 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.0 mp -87.87 -69.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.809 0.338 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -111.6 -41.66 4.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 259' ' ' GLY . 0.2 OUTLIER -80.07 12.36 2.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 -179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.466 ' O ' ' CE1' ' A' ' 239' ' ' TYR . 22.7 tt0 -37.84 93.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 257' ' ' ARG . . . 59.16 -171.7 4.85 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.467 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.525 HD23 ' HA ' ' A' ' 236' ' ' VAL . 8.7 mt -130.78 160.98 32.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.916 0.388 . . . . 0.0 110.922 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -122.32 126.49 48.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.858 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.485 ' O ' ' N ' ' A' ' 266' ' ' GLY . 11.5 t -77.27 104.38 7.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -67.45 -5.71 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -87.15 -53.14 5.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 28.0 p -115.97 -29.5 6.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.859 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 262' ' ' CYS . . . 91.23 83.88 1.43 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 11.5 ttp -144.45 130.05 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -90.14 119.13 30.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 28.4 m -138.78 154.67 26.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.496 ' CE1' HD23 ' A' ' 252' ' ' LEU . 23.0 m80 -59.04 -175.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -75.43 -32.59 60.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 57.3 mtm180 -92.91 -41.44 10.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.866 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.542 ' O ' HG23 ' A' ' 277' ' ' VAL . 78.4 m -57.06 -12.58 2.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -63.79 -41.03 98.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.949 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.56 11.77 37.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.495 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 34.2 mtmt -100.85 -24.93 14.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.692 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.1 t -73.69 -179.22 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.692 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -83.69 150.0 26.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.151 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -84.78 27.13 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 23.8 mt -108.9 79.48 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 48.3 t -86.88 129.31 34.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.38 -21.82 19.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.492 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 36.7 mm -61.44 -28.19 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.368 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.871 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 9.2 t -171.94 161.47 5.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.875 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.0 m -112.37 104.06 12.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -89.39 39.2 3.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.545 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.7 t -64.86 125.33 24.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.2 m -140.79 159.34 42.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.834 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -116.75 174.1 15.05 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.458 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -100.01 153.51 19.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 110.891 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 3.9 mt -114.47 106.47 20.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.124 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -153.07 126.32 8.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.43 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 32.9 mtm -116.15 97.09 48.91 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.553 0.692 . . . . 0.0 110.856 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.7 Cg_endo -69.74 127.51 14.71 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.666 2.244 . . . . 0.0 112.374 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 97.2 m-70 -44.86 117.78 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 57.6 mtp85 -72.99 65.8 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.529 ' CE2' ' HB2' ' A' ' 274' ' ' GLN . 43.1 m-85 -60.87 139.81 57.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 1.7 mmpt? -143.54 132.87 23.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.506 HG11 ' HD2' ' A' ' 257' ' ' ARG . 19.6 t -60.38 122.72 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.6 163.96 33.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -90.12 128.32 36.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -80.15 123.73 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -102.64 -5.62 23.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.959 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 65.1 m -142.83 153.3 60.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.595 0.712 . . . . 0.0 110.867 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 88.57 0.53 Allowed 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.688 2.259 . . . . 0.0 112.371 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 244' ' ' PHE . 15.5 m -93.88 161.47 14.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.145 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.5 ' N ' HG22 ' A' ' 243' ' ' THR . 39.8 m-85 -122.91 124.42 43.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.46 146.81 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.838 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -91.23 -0.66 57.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.881 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 78.1 t60 -115.94 -67.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 14.6 p -78.18 -15.95 58.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 54.04 62.6 5.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 38.1 p -139.43 179.41 6.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 252' ' ' LEU . 0.3 OUTLIER -94.57 113.13 24.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.917 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -88.71 112.08 22.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.867 179.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -45.6 141.24 2.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . -111.54 47.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.465 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.6 -64.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.949 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -172.8 144.18 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.061 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.506 ' HD2' HG11 ' A' ' 236' ' ' VAL . 12.5 mmt85 44.7 50.25 8.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -116.45 147.09 42.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 47.59 -170.41 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.432 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.445 ' CB ' ' HB3' ' A' ' 234' ' ' PHE . 3.0 mt -146.46 161.17 41.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 0.0 110.913 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -126.87 138.76 53.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 6.2 t -86.72 122.76 31.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -85.59 8.74 18.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.485 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -106.54 -67.39 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 30.5 p -88.58 -44.69 10.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.942 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 115.22 22.87 4.72 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 4.1 ttp -86.97 156.34 19.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 22.6 m-20 -130.33 115.59 17.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 274' ' ' GLN . 6.2 m -131.27 166.08 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.917 ' CD2' HD23 ' A' ' 252' ' ' LEU . 16.4 m80 -70.12 -176.43 1.15 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -74.57 -37.56 62.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.44 -37.43 12.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.21 -25.1 65.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.582 ' HA ' HG21 ' A' ' 269' ' ' VAL . 13.4 pt20 -60.87 -43.33 98.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.838 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 7.6 p -69.82 -6.63 33.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.55 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 1.4 mmpt? -96.09 -13.07 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.84 158.82 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.558 ' HB1' HD23 ' A' ' 280' ' ' LEU . . . -79.75 141.62 36.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.116 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.453 ' C ' HD22 ' A' ' 280' ' ' LEU . 9.7 p30 -80.06 52.08 1.47 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.558 HD23 ' HB1' ' A' ' 278' ' ' ALA . 2.8 mm? -127.75 70.75 1.34 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 52.9 t -90.7 155.96 18.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 60.68 18.19 51.53 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.433 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 8.2 mm -101.57 -25.41 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 111.138 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.841 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 4.7 m -136.8 136.88 39.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.88 0.372 . . . . 0.0 110.857 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 9.5 m -106.91 136.07 47.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 169.21 61.43 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.491 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.4 t -151.17 131.04 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.84 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 89.9 p -55.48 117.05 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.91 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -109.8 -82.17 1.32 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.54 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 11.1 mmmm -123.74 107.45 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.329 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.82 120.09 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.124 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -162.09 137.53 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.894 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.443 ' SD ' HD11 ' A' ' 283' ' ' ILE . 3.9 ptp -126.69 97.0 34.07 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.537 0.684 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.0 Cg_endo -69.75 163.58 37.73 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.746 2.297 . . . . 0.0 112.324 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.489 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 95.0 m-70 -86.66 115.4 24.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.889 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.468 ' N ' ' SG ' ' A' ' 262' ' ' CYS . 26.5 mtt-85 -72.23 66.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.752 ' CE1' HG22 ' A' ' 269' ' ' VAL . 53.9 m-85 -62.28 149.9 40.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 234' ' ' PHE . 68.3 mttt -158.61 137.97 11.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 99.2 t -64.48 137.31 25.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.174 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -148.23 146.52 28.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.881 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -97.94 96.86 8.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -122.28 141.86 51.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.927 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 94.96 5.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 10.1 t -176.1 146.71 0.81 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.648 0.737 . . . . 0.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.64 87.04 0.54 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.711 2.274 . . . . 0.0 112.377 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . . . . . . . . . 15.1 m -106.71 138.21 43.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.147 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 244' ' ' PHE . 4.5 m-85 -106.36 140.21 39.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.1 t -56.56 129.55 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.856 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -86.93 5.8 35.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.581 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 37.3 t60 -110.64 -70.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.887 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.61 -33.11 60.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 88.1 39.31 6.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 28.4 p -138.08 150.13 46.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' CZ2' ' A' ' 253' ' ' TRP . 16.8 mt -64.33 175.71 1.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.951 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 253' ' ' TRP . 1.7 pt? -155.39 152.1 28.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.928 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 251' ' ' LEU . 0.0 OUTLIER -154.8 158.54 39.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 155.78 -172.05 33.78 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.48 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.37 179.96 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.851 0.358 . . . . 0.0 110.869 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -43.32 -34.48 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.083 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 -70.39 69.32 0.38 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.429 ' O ' ' C ' ' A' ' 259' ' ' GLY . 8.0 mm100 -85.13 114.97 22.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 260' ' ' LEU . . . 34.96 -146.55 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.496 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 259' ' ' GLY . 3.0 mt -147.35 131.01 16.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 15.6 ttmt -102.08 118.26 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 233' ' ' ARG . 8.4 t -64.59 104.68 0.84 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -57.87 -18.68 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -76.29 -73.17 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.08 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.1 p -86.19 -42.05 14.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.0 60.76 0.75 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 9.4 ttp -125.33 119.86 29.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 110.882 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.429 ' N ' ' OD1' ' A' ' 268' ' ' ASN . 0.7 OUTLIER -90.09 120.19 31.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.841 -179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.752 HG22 ' CE1' ' A' ' 234' ' ' PHE . 31.6 m -137.53 179.57 3.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.098 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -70.32 165.2 22.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -62.46 -31.77 72.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.829 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 26.6 ttm180 -91.81 -47.75 7.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.553 ' O ' HG23 ' A' ' 277' ' ' VAL . 84.4 m -50.71 -32.18 18.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.674 ' NE2' HG23 ' A' ' 275' ' ' THR . 0.9 OUTLIER -53.12 -37.44 61.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.885 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.674 HG23 ' NE2' ' A' ' 274' ' ' GLN . 2.2 p -85.77 -11.83 52.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.581 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -87.03 -23.36 25.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.88 179.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 273' ' ' CYS . 1.2 t -70.47 143.3 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.091 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.754 ' HB1' ' CD1' ' A' ' 280' ' ' LEU . . . -50.09 150.49 2.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.084 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -83.22 41.36 0.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 278' ' ' ALA . 2.8 mp -127.94 104.63 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 15.4 t -93.65 140.77 29.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 87.85 -33.94 3.86 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.451 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 280' ' ' LEU . 3.8 mp -63.79 -17.63 20.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.34 . . . . 0.0 111.104 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 2.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 29.5 t -83.26 -72.42 0.45 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.841 0.353 . . . . 0.0 110.82 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.6 t -145.7 145.88 31.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.869 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 101.93 124.32 5.39 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.517 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 9.6 p -86.46 107.96 18.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 73.5 m -60.73 131.19 49.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -69.24 148.96 48.26 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.504 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -73.84 94.77 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.758 0.313 . . . . 0.0 110.896 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 7.9 pt -115.82 164.75 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.123 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -140.24 130.48 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.423 ' C ' ' OD1' ' A' ' 279' ' ' ASN . 55.3 mtm -107.16 96.99 16.68 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.555 0.693 . . . . 0.0 110.886 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.437 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 53.7 Cg_endo -69.74 164.65 33.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.701 2.268 . . . . 0.0 112.338 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.44 ' HB2' ' CE2' ' A' ' 234' ' ' PHE . 98.8 m-70 -78.24 121.04 23.87 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -73.95 64.57 1.01 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.553 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 30.8 m-85 -63.79 131.31 47.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -141.74 130.86 23.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.847 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 75.7 t -45.82 132.91 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 238' ' ' ASN . 82.1 t80 -148.22 161.04 42.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.939 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.591 ' O ' ' CE2' ' A' ' 237' ' ' TYR . 0.6 OUTLIER -92.12 144.76 25.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.845 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -106.35 133.76 50.55 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.57 4.49 3.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 35.3 m -139.36 154.55 71.92 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.687 0.756 . . . . 0.0 110.818 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 92.83 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.299 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.517 ' O ' HD23 ' A' ' 251' ' ' LEU . 53.8 m -113.76 149.97 34.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.116 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -117.94 128.61 54.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.856 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 2.0 t -39.35 140.76 0.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.851 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.01 9.05 26.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.55 ' CE1' ' CB ' ' A' ' 276' ' ' LYS . 71.1 t60 -123.56 -66.87 0.97 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.853 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 18.7 p -78.87 -17.42 55.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 64.31 48.06 78.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.514 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 9.3 p -137.71 152.65 49.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.357 . . . . 0.0 111.092 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.594 ' O ' ' CZ3' ' A' ' 253' ' ' TRP . 11.4 mt -64.73 159.66 21.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.578 HD13 ' NE2' ' A' ' 270' ' ' HIS . 3.5 mm? -87.46 174.37 8.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.953 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . 0.594 ' CZ3' ' O ' ' A' ' 251' ' ' LEU . 2.8 p90 -173.52 129.7 0.43 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.946 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . 0.889 ' C ' HD23 ' A' ' 255' ' ' LEU . . . 151.07 -124.98 1.8 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.536 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.889 HD23 ' C ' ' A' ' 254' ' ' GLY . 0.0 OUTLIER -135.35 179.76 6.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.874 0.368 . . . . 0.0 110.881 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 238' ' ' ASN . . . -39.08 -35.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.107 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 29.9 mtt-85 -93.56 57.61 2.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . 0.446 ' NE2' ' O ' ' A' ' 253' ' ' TRP . 30.2 tp60 -113.74 157.21 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . 0.467 ' O ' HD23 ' A' ' 260' ' ' LEU . . . 41.05 -159.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.456 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.518 ' CD1' ' NE2' ' A' ' 274' ' ' GLN . 18.2 mt -153.98 161.34 42.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.86 0.362 . . . . 0.0 110.932 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.22 139.53 51.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 5.5 t -91.88 114.75 27.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -78.19 7.03 6.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -102.4 -65.1 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 27.6 p -93.69 -40.4 10.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 104.81 33.85 3.68 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 17.0 ttp -106.52 119.04 38.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.745 0.307 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 -87.56 139.95 30.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 4.1 m -150.34 164.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.578 ' NE2' HD13 ' A' ' 252' ' ' LEU . 14.0 m80 -67.54 -176.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.846 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -73.22 -36.57 66.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.778 ' O ' HG22 ' A' ' 275' ' ' THR . 0.0 OUTLIER -94.07 -42.05 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 67.9 m -48.71 -22.37 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.553 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 3.0 pt20 -64.01 -41.08 97.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.778 HG22 ' O ' ' A' ' 272' ' ' ARG . 10.6 t -74.46 -6.03 45.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.55 ' CB ' ' CE1' ' A' ' 247' ' ' HIS . 35.4 mttt -95.21 -12.41 26.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -85.5 171.27 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.55 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -92.9 171.73 8.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.649 ' C ' HD22 ' A' ' 280' ' ' LEU . 35.2 t-20 -104.12 50.95 0.79 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.649 HD22 ' C ' ' A' ' 279' ' ' ASN . 3.0 mm? -128.12 59.43 1.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . . . . . . . . . 42.5 t -84.45 128.93 34.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.843 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 89.77 -17.86 50.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.488 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 2.4 mt -87.69 -28.23 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.112 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 28.7 p30 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.924 179.955 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 3.2 m -166.11 147.06 6.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.918 0.389 . . . . 0.0 110.821 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.8 t -121.67 132.24 54.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 148.8 117.52 0.91 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 1.6 t -110.17 117.59 34.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.916 0.389 . . . . 0.0 110.806 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.6 p -60.55 167.84 2.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -150.55 -168.27 15.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.54 109.36 21.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.772 0.32 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 47.1 mt -89.37 124.23 41.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -151.79 159.67 43.84 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.413 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 11.0 mmt -112.78 97.04 39.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 54.1 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.693 2.262 . . . . 0.0 112.344 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -83.44 115.74 22.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.43 ' HB3' ' NH1' ' A' ' 233' ' ' ARG . 14.3 mtp-105 -74.72 62.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 274' ' ' GLN . 36.9 m-85 -60.58 135.84 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -141.49 132.45 26.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.3 129.67 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -143.61 115.6 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.972 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.411 ' OD1' ' C ' ' A' ' 238' ' ' ASN . 36.0 t-20 -88.61 108.27 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . 0.404 ' CD1' ' N ' ' A' ' 239' ' ' TYR . 0.1 OUTLIER -126.93 173.62 9.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 241' ' ' SER . 0.3 OUTLIER -109.81 -53.16 2.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 240' ' ' LYS . 84.5 p -36.34 150.78 0.11 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.654 0.74 . . . . 0.0 110.82 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 116.56 4.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.71 2.273 . . . . 0.0 112.282 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.421 HG21 ' CB ' ' A' ' 268' ' ' ASN . 3.8 m -121.32 141.79 50.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -119.85 145.01 47.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 3.3 t -67.78 125.03 24.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.8 9.25 4.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 276' ' ' LYS . 84.5 t60 -119.13 -73.22 0.65 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . 0.462 ' SG ' HG23 ' A' ' 250' ' ' THR . 15.3 p -75.48 -22.82 56.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 66.76 46.19 77.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.447 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . 0.462 HG23 ' SG ' ' A' ' 248' ' ' CYS . 5.8 p -133.23 153.72 51.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.85 0.357 . . . . 0.0 111.135 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 251' ' ' LEU . 13.0 mt -65.21 160.72 20.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 0.537 HD13 ' NE2' ' A' ' 270' ' ' HIS . 2.8 mm? -87.47 179.53 6.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.97 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 52.5 m95 -141.15 151.44 43.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 92.69 -156.57 23.2 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.495 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.411 ' N ' HD12 ' A' ' 255' ' ' LEU . 5.4 mp -125.75 -70.09 0.75 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.837 0.351 . . . . 0.0 110.909 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -88.02 -178.0 5.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.049 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.466 ' HD3' ' N ' ' A' ' 257' ' ' ARG . 4.7 mpt_? 44.88 26.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.848 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -54.2 108.3 0.36 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.906 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . 37.95 -151.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.489 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 2.6 mt -134.82 170.46 15.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 110.957 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -142.84 128.29 18.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.912 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.4 t -72.06 114.36 10.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.893 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -71.88 -10.13 59.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.479 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -83.86 -71.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.144 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 26.7 p -86.39 -46.5 10.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 107.88 60.37 0.56 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.463 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . . . . . . . . . 10.5 ttp -118.83 146.85 44.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.811 0.338 . . . . 0.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.421 ' CB ' HG21 ' A' ' 243' ' ' THR . 0.9 OUTLIER -106.96 122.33 46.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 15.3 m -143.19 179.89 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.141 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 0.537 ' NE2' HD13 ' A' ' 252' ' ' LEU . 11.1 m80 -86.24 -176.01 5.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.402 ' O ' ' NE2' ' A' ' 274' ' ' GLN . 67.8 m-70 -77.55 -35.28 53.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -94.09 -38.53 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . . . . . . . . . 95.0 m -55.61 -27.32 48.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.924 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' HB2' ' CD2' ' A' ' 234' ' ' PHE . 24.6 pt20 -61.53 -35.16 76.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.921 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 31.8 p -80.01 7.04 9.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.176 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.415 ' HB3' ' CE1' ' A' ' 247' ' ' HIS . 49.8 mttt -114.31 -8.19 12.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.5 t -84.09 174.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.141 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.651 ' HB1' HD12 ' A' ' 280' ' ' LEU . . . -84.57 -178.64 6.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.09 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -117.57 30.88 7.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.651 HD12 ' HB1' ' A' ' 278' ' ' ALA . 3.9 mp -106.83 65.79 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 44.5 t -83.6 122.84 29.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.822 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 85.58 -38.34 3.02 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.53 -19.65 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.839 0.352 . . . . 0.0 111.099 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.924 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.472 -0.251 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 39.3 t -110.33 153.4 24.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.846 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 28.0 m -144.62 123.69 12.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -145.52 175.97 24.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.454 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 38.9 m -78.84 140.43 38.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.904 0.383 . . . . 0.0 110.851 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 61.7 m -63.42 171.35 2.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.863 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -125.52 155.8 19.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.486 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -70.25 122.9 20.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 4.5 pt -122.45 72.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -125.66 140.99 52.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.831 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.435 ' HA ' ' HD2' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -111.52 97.08 35.02 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.56 0.695 . . . . 0.0 110.847 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 230' ' ' MET . 53.3 Cg_endo -69.8 153.51 68.65 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.708 2.272 . . . . 0.0 112.335 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 234' ' ' PHE . 99.0 m-70 -70.05 116.94 11.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -70.96 70.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.849 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' PHE . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 232' ' ' HIS . 51.0 m-85 -62.21 139.16 58.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.892 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.443 ' HA ' ' CE ' ' A' ' 235' ' ' LYS . 0.1 OUTLIER -146.2 135.13 22.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' HD23 ' A' ' 260' ' ' LEU . 2.5 t -52.67 126.85 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.166 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -147.85 145.19 28.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.955 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -85.2 108.45 17.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -79.62 82.13 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 29.5 tttm -51.14 -33.29 26.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.864 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.4 149.75 41.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.648 0.737 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 111.94 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.677 2.251 . . . . 0.0 112.346 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' THR . . . . . 0.747 HG21 HD22 ' A' ' 268' ' ' ASN . 93.7 m -115.58 126.26 53.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' PHE . . . . . 0.63 ' CE2' HD11 ' A' ' 251' ' ' LEU . 37.8 m-85 -70.04 122.31 19.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' CYS . . . . . . . . . . . . . 12.9 t -47.93 124.7 7.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.859 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -78.95 7.29 7.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' HIS . . . . . 0.553 ' CE1' ' HB2' ' A' ' 276' ' ' LYS . 52.3 t60 -110.89 -70.81 0.79 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.819 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.09 -15.41 53.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 87.29 -20.09 28.06 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.507 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.13 152.51 29.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.139 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.63 HD11 ' CE2' ' A' ' 244' ' ' PHE . 6.4 mt -76.44 -174.85 3.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' LEU . . . . . 1.091 HD23 ' CD2' ' A' ' 270' ' ' HIS . 0.1 OUTLIER -136.57 160.83 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -143.68 155.53 44.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.895 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' GLY . . . . . . . . . . . . . . . 157.6 -177.71 34.27 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.511 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 mt -105.41 -40.02 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 0.0 110.937 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 257' ' ' ARG . . . -144.51 159.24 43.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.112 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . 0.531 ' CB ' HG13 ' A' ' 236' ' ' VAL . 24.9 ptt180 36.15 44.98 0.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -54.45 -39.66 67.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLY . . . . . . . . . . . . . . . -147.82 -168.07 13.88 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.505 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 236' ' ' VAL . 4.8 mt -126.13 131.07 52.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.847 0.356 . . . . 0.0 110.909 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -103.49 144.57 31.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' CYS . . . . . . . . . . . . . 7.7 t -85.13 119.7 25.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -84.34 3.65 34.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.507 ' HB3' ' SG ' ' A' ' 281' ' ' CYS . . . -97.63 -48.65 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' CYS . . . . . . . . . . . . . 31.3 p -113.12 -39.82 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' GLY . . . . . . . . . . . . . . . 102.79 65.11 0.72 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' A' ' 268' ' ' ASN . 7.0 ttp -121.66 159.44 26.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.886 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.747 HD22 HG21 ' A' ' 243' ' ' THR . 10.7 m-20 -122.81 122.68 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.0 m -143.39 171.38 8.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . 1.091 ' CD2' HD23 ' A' ' 252' ' ' LEU . 12.8 m80 -71.77 -177.95 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.845 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' HIS . . . . . 0.406 ' NE2' ' O ' ' A' ' 257' ' ' ARG . 46.7 m-70 -72.19 -36.38 69.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 51.7 mtm-85 -93.95 -44.06 8.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' CYS . . . . . 0.571 ' O ' HG23 ' A' ' 277' ' ' VAL . 81.5 m -47.36 -31.84 4.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.877 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.536 ' CG ' ' N ' ' A' ' 275' ' ' THR . 9.8 pt20 -52.66 -50.54 63.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . 0.536 ' N ' ' CG ' ' A' ' 274' ' ' GLN . 24.8 p -76.5 -5.36 47.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.553 ' HB2' ' CE1' ' A' ' 247' ' ' HIS . 0.0 OUTLIER -94.69 -17.82 21.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 278' ' ' ALA . 1.9 t -74.49 176.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.094 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ALA . . . . . 0.716 ' H ' HG12 ' A' ' 277' ' ' VAL . . . -84.54 162.58 19.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.097 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 279' ' ' ASN . 0.3 OUTLIER -98.25 50.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.904 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 92.4 mt -128.82 75.07 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.944 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 264' ' ' ALA . 48.9 t -82.0 140.97 33.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.889 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 83.2 -36.01 2.76 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.57 ' N ' HD12 ' A' ' 283' ' ' ILE . 2.1 mp -65.03 -24.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ASN . . . . . . . . . . . . . 31.3 p30 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.922 179.952 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_